This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid005a |
1. Entschädigung für Praxisschließung wegen Coronavirus. | *C7201907* C7201907 | ||
2. COVID-19 und Krebsdiagnostik: Warnsignal aus den Niederlanden. | *C7201905* C7201905 | ||
3. Droht bei Krebs durch COVID-19 schlechtere Versorgung in Deutschland? | *C7201912* C7201912 | ||
4. Neue EBM-Leistung bei mittel- und unmittelbarem Kontakt. | *C7201906* C7201906 | ||
5. COVID-19-Infektion ist kein Arbeitsunfall. | *C7198845* C7198845 | ||
6. Gute Frage - gute Antwort: Zahnmedizin in Corona-Zeiten: Wie arbeitet es sich Seite an Seite mit dem Virus? | *C7197238* C7197238 | ||
7. Campus traffic and e-Learning during COVID-19 pandemic. | *C7204766* C7204766 | ||
8. The Impact of the COVID-19 Pandemic on Spine Care Providers and Patients. | *C7203046* C7203046 | ||
9. Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection☆. | *C7203031* C7203031 | ||
10. COVID -19 – Journal de Bord – Les étudiants en médecine et la pandémie. | *C7204732* C7204732 | ||
11. Imagerie de la pneumonie COVID-19. | *C7203047* C7203047 | ||
12. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19☆. | *C7203037* C7203037 | ||
13. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies☆☆☆. | *C7200324* C7200324 | ||
14. Modelling COVID-19. | *C7201389* C7201389 | ||
15. A Nanoparticle Pseudo Pathogen for Rapid Detection and Diagnosis of Virus Infection. | *C7200353* C7200353 | ||
16. Practical recommendations for the perioperative management of patients with suspicion or serious infection by coronavirus SARS-CoV☆. | *C7198218* C7198218 | ||
17. Corticothérapie en ORL en contexte de pandémie COVID-19. | *C7198192* C7198192 | ||
18. Suspected Acute Abdomen as an Extrapulmonary Manifestation of COVID-19 Infection☆. | *C7198139* C7198139 | ||
19. COVID-19 and the Future of Microfinance: Evidence and Insights from Pakistan. | *C7197568* C7197568 | ||
20. Transparenz Teilhabe und introjektive Identifizierung. | *C7197361* C7197361 | ||
21. Facharztstandard und Leitlinien im Arzthaftungsrecht. | *C7197244* C7197244 | ||
22. Dental autopsy recommendations in SARS-CoV-2 infected cases. | *C7196553* C7196553 | ||
23. European Human Rights Dimension of the Online Access to Cultural Heritage in Times of the COVID-19 Outbreak. | *C7197032* C7197032 | ||
24. Recomendaciones en reanimación cardiopulmonar en pacientes con COVID-19. | *C7198147* C7198147 | ||
25. Surgical Management of Patients With COVID-19 Infection. Recommendations of the Spanish Association of Surgeons☆. | *C7196403* C7196403 | ||
26. ACEI inhibitors and ARBs do not increase severity of COVID-19. | *C7197241* C7197241 | ||
27. Safety concerns with higher dosage chloroquine in COVID-19 patients. | *C7197234* C7197234 | ||
28. Editor’s Note: Applied Intelligence and COVID-19 Research. | *C7195908* C7195908 | ||
29. Antimalarial use in COVID-19 patients requires close monitoring. | *C7197245* C7197245 | ||
30. High incidence of ADRs in COVID-19 patients in China. | *C7197236* C7197236 | ||
31. If Everything Has Changed Why Such a Focus on Bailing Out Capitalism? The Somber Reality Underpinning Covid-19. | *C7193138* C7193138 | ||
32. Corporate growth sustainability and business ethics in twenty-first century. | *C7192320* C7192320 | ||
33. The COVID-19 pandemic: considerations for the waste and wastewater services sector. | *C7191284* C7191284 | ||
34. COVID-19 et rhinologie: conseils de bonne pratique de la consultation au bloc opératoire. | *C7190505* C7190505 | ||
35. Neue EBM-Leistung bei mittel- und unmittelbarem Kontakt. | *C7165249* C7165249 | ||
36. Six Feet Apart: Lessons Learned from COVID-19 and Social Distancing. | *C7197617* C7197617 | ||
37. Nerven der Anleger liegen blank. | *C7188490* C7188490 | ||
38. Auch Kinder können schwer an COVID-19 erkranken. | *C7165248* C7165248 | ||
39. Researching the Future of Purchasing and Supply Management: The purpose and potential of scenarios. | *C7187814* C7187814 | ||
40. Access Denied: Academic Life Under Lockdown. | *C7186769* C7186769 | ||
41. Resumption of activity in gastroenterology departments. Recommendations by SEPD AEEH GETECCU and AEG. | *C7186212* C7186212 | ||
42. Startups in times of crisis – A rapid response to the COVID-19 pandemic. | *C7183981* C7183981 | ||
43. Status of SARS-CoV-2 infection in patients on renal replacement therapy Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN). | *C7183935* C7183935 | ||
44. Das Gesundheitssystem muss resilienter werden. | *C7160436* C7160436 | ||
45. How the COVID Pandemic May Change the World of Retailing. | *C7183942* C7183942 | ||
46. Neurologie in Zeiten von COVID-19. | *C7160435* C7160435 | ||
47. Managing disasters amid COVID-19 pandemic: Approaches of response to flood disasters. | *C7182510* C7182510 | ||
48. Implicaciones de la pandemia por COVID-19 para el paciente con insuficiencia cardiaca trasplante cardiaco y asistencia ventricular. Recomendaciones de la Asociación de Insuficiencia Cardiaca de la Sociedad Española de Cardiología. | *C7194925* C7194925 | ||
49. Estimating the COVID-19 cash crunch: Global evidence and policy☆. | *C7194614* C7194614 | ||
50. Co-infections: potentially lethal and unexplored in COVID-19. | *C7195315* C7195315 | ||
51. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19☆. | *C7180357* C7180357 | ||
52. The COVID-19 Pandemic and Implications for Gynaecologic Cancer Care. | *C7180676* C7180676 | ||
53. Achilles heel of the killer virus: the highly important molecular targets for hitting SARS-CoV-2 that causes COVID-19. | *C7180667* C7180667 | ||
54. Management of neurological care during the COVID-19 pandemic☆. | *C7177056* C7177056 | ||
55. COVID-19 et Chirurgie ORL. | *C7176377* C7176377 | ||
56. Deep learning system to screen coronavirus disease 2019 pneumonia. | *C7175452* C7175452 | ||
57. Recommandations de la Société Fran"aise de Médecine du Travail (SFMT) : Avis relatif l’affectation dans le contexte de l’épidémie SARS-CoV-2 (Covid-19) des professionnels exer"ant en milieu de soins et travailleurs assimilés présentant une pathologie chronique traitée par anti-inflammatoires non stéroïdiens (AINS). 05 avril 2020. | *C7174157* C7174157 | ||
58. Ambulante Versorgung in der Corona-Krise: Großteil der COVID-19-Patienten wird in den Praxen behandelt. | *C7147196* C7147196 | ||
59. Zwischen Infektionsschutz und Versorgungsauftrag: Eine Zwischenbilanz vier Wochen nach Ausbruch der Pandemie. | *C7147143* C7147143 | ||
60. Attacks on hospitals increase as criminals exploit pandemic. | *C7173807* C7173807 | ||
61. Covid-19 products. | *C7173834* C7173834 | ||
62. SARS-CoV-2 cellular tropism. | *C7173832* C7173832 | ||
63. Impact on biometrics of Covid-19. | *C7173828* C7173828 | ||
64. Comparative tropism replication kinetics and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations transmissibility and laboratory studies of COVID-19: an observational study. | *C7173822* C7173822 | ||
65. Intelligent technologies help operating mobile cabin hospitals effectively cope with COVID-19. | *C7171436* C7171436 | ||
66. Coronavirus-Pandemie und ihre Auswirkungen auf Orthopädie und Unfallchirurgie: Operationen Risiken und Prävention? | *C7168570* C7168570 | ||
67. Conseils de bonnes pratiques pour les praticiens spécialisés en laryngologie et en phoniatrie en contexte d’épidémie COVID-19. | *C7167575* C7167575 | ||
68. Pandémie de covid-19: rôle diagnostique fondamental de l’imagerie. | *C7167555* C7167555 | ||
69. COVID-19: Risikoabschätzung und Planungsgrundlagen für unsere Praxen. | *C7149296* C7149296 | ||
70. COVID-19-Pandemie: Wie können sich onkologische Kliniken wappnen? . | *C7149294* C7149294 | ||
71. Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19. | *C7149288* C7149288 | ||
72. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients. | *C7190525* C7190525 | ||
1. Entschädigung für Praxisschließung wegen Coronavirus. | *C7201907* C7201907 | ||
2. COVID-19 und Krebsdiagnostik: Warnsignal aus den Niederlanden. | *C7201905* C7201905 | ||
3. Droht bei Krebs durch COVID-19 schlechtere Versorgung in Deutschland? | *C7201912* C7201912 | ||
4. Neue EBM-Leistung bei mittel- und unmittelbarem Kontakt. | *C7201906* C7201906 | ||
5. COVID-19-Infektion ist kein Arbeitsunfall. | *C7198845* C7198845 | ||
6. Gute Frage - gute Antwort: Zahnmedizin in Corona-Zeiten: Wie arbeitet es sich Seite an Seite mit dem Virus? | *C7197238* C7197238 | ||
7. Campus traffic and e-Learning during COVID-19 pandemic. | *C7204766* C7204766 | ||
8. The Impact of the COVID-19 Pandemic on Spine Care Providers and Patients. | *C7203046* C7203046 | ||
9. Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection☆. | *C7203031* C7203031 | ||
10. COVID -19 – Journal de Bord – Les étudiants en médecine et la pandémie. | *C7204732* C7204732 | ||
11. Imagerie de la pneumonie COVID-19. | *C7203047* C7203047 | ||
12. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19☆. | *C7203037* C7203037 | ||
13. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies☆☆☆. | *C7200324* C7200324 | ||
14. Modelling COVID-19. | *C7201389* C7201389 | ||
15. A Nanoparticle Pseudo Pathogen for Rapid Detection and Diagnosis of Virus Infection. | *C7200353* C7200353 | ||
16. Practical recommendations for the perioperative management of patients with suspicion or serious infection by coronavirus SARS-CoV☆. | *C7198218* C7198218 | ||
17. Corticothérapie en ORL en contexte de pandémie COVID-19. | *C7198192* C7198192 | ||
18. Suspected Acute Abdomen as an Extrapulmonary Manifestation of COVID-19 Infection☆. | *C7198139* C7198139 | ||
19. COVID-19 and the Future of Microfinance: Evidence and Insights from Pakistan. | *C7197568* C7197568 | ||
20. Transparenz Teilhabe und introjektive Identifizierung. | *C7197361* C7197361 | ||
21. Facharztstandard und Leitlinien im Arzthaftungsrecht. | *C7197244* C7197244 | ||
22. Dental autopsy recommendations in SARS-CoV-2 infected cases. | *C7196553* C7196553 | ||
23. European Human Rights Dimension of the Online Access to Cultural Heritage in Times of the COVID-19 Outbreak. | *C7197032* C7197032 | ||
24. Recomendaciones en reanimación cardiopulmonar en pacientes con COVID-19. | *C7198147* C7198147 | ||
25. Surgical Management of Patients With COVID-19 Infection. Recommendations of the Spanish Association of Surgeons☆. | *C7196403* C7196403 | ||
26. ACEI inhibitors and ARBs do not increase severity of COVID-19. | *C7197241* C7197241 | ||
27. Safety concerns with higher dosage chloroquine in COVID-19 patients. | *C7197234* C7197234 | ||
28. Editor’s Note: Applied Intelligence and COVID-19 Research. | *C7195908* C7195908 | ||
29. Antimalarial use in COVID-19 patients requires close monitoring. | *C7197245* C7197245 | ||
30. High incidence of ADRs in COVID-19 patients in China. | *C7197236* C7197236 | ||
31. If Everything Has Changed Why Such a Focus on Bailing Out Capitalism? The Somber Reality Underpinning Covid-19. | *C7193138* C7193138 | ||
32. Corporate growth sustainability and business ethics in twenty-first century. | *C7192320* C7192320 | ||
33. The COVID-19 pandemic: considerations for the waste and wastewater services sector. | *C7191284* C7191284 | ||
34. COVID-19 et rhinologie: conseils de bonne pratique de la consultation au bloc opératoire. | *C7190505* C7190505 | ||
35. Neue EBM-Leistung bei mittel- und unmittelbarem Kontakt. | *C7165249* C7165249 | ||
36. Six Feet Apart: Lessons Learned from COVID-19 and Social Distancing. | *C7197617* C7197617 | ||
37. Nerven der Anleger liegen blank. | *C7188490* C7188490 | ||
38. Auch Kinder können schwer an COVID-19 erkranken. | *C7165248* C7165248 | ||
39. Researching the Future of Purchasing and Supply Management: The purpose and potential of scenarios. | *C7187814* C7187814 | ||
40. Access Denied: Academic Life Under Lockdown. | *C7186769* C7186769 | ||
41. Resumption of activity in gastroenterology departments. Recommendations by SEPD AEEH GETECCU and AEG. | *C7186212* C7186212 | ||
42. Startups in times of crisis – A rapid response to the COVID-19 pandemic. | *C7183981* C7183981 | ||
43. Status of SARS-CoV-2 infection in patients on renal replacement therapy Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN). | *C7183935* C7183935 | ||
44. Das Gesundheitssystem muss resilienter werden. | *C7160436* C7160436 | ||
45. How the COVID Pandemic May Change the World of Retailing. | *C7183942* C7183942 | ||
46. Neurologie in Zeiten von COVID-19. | *C7160435* C7160435 | ||
47. Managing disasters amid COVID-19 pandemic: Approaches of response to flood disasters. | *C7182510* C7182510 | ||
48. Implicaciones de la pandemia por COVID-19 para el paciente con insuficiencia cardiaca trasplante cardiaco y asistencia ventricular. Recomendaciones de la Asociación de Insuficiencia Cardiaca de la Sociedad Española de Cardiología. | *C7194925* C7194925 | ||
49. Estimating the COVID-19 cash crunch: Global evidence and policy☆. | *C7194614* C7194614 | ||
50. Co-infections: potentially lethal and unexplored in COVID-19. | *C7195315* C7195315 | ||
51. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19☆. | *C7180357* C7180357 | ||
52. The COVID-19 Pandemic and Implications for Gynaecologic Cancer Care. | *C7180676* C7180676 | ||
53. Achilles heel of the killer virus: the highly important molecular targets for hitting SARS-CoV-2 that causes COVID-19. | *C7180667* C7180667 | ||
54. Management of neurological care during the COVID-19 pandemic☆. | *C7177056* C7177056 | ||
55. COVID-19 et Chirurgie ORL. | *C7176377* C7176377 | ||
56. Deep learning system to screen coronavirus disease 2019 pneumonia. | *C7175452* C7175452 | ||
57. Recommandations de la Société Fran"aise de Médecine du Travail (SFMT) : Avis relatif l’affectation dans le contexte de l’épidémie SARS-CoV-2 (Covid-19) des professionnels exer"ant en milieu de soins et travailleurs assimilés présentant une pathologie chronique traitée par anti-inflammatoires non stéroïdiens (AINS). 05 avril 2020. | *C7174157* C7174157 | ||
58. Ambulante Versorgung in der Corona-Krise: Großteil der COVID-19-Patienten wird in den Praxen behandelt. | *C7147196* C7147196 | ||
59. Zwischen Infektionsschutz und Versorgungsauftrag: Eine Zwischenbilanz vier Wochen nach Ausbruch der Pandemie. | *C7147143* C7147143 | ||
60. Attacks on hospitals increase as criminals exploit pandemic. | *C7173807* C7173807 | ||
61. Covid-19 products. | *C7173834* C7173834 | ||
62. SARS-CoV-2 cellular tropism. | *C7173832* C7173832 | ||
63. Impact on biometrics of Covid-19. | *C7173828* C7173828 | ||
64. Comparative tropism replication kinetics and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations transmissibility and laboratory studies of COVID-19: an observational study. | *C7173822* C7173822 | ||
65. Intelligent technologies help operating mobile cabin hospitals effectively cope with COVID-19. | *C7171436* C7171436 | ||
66. Coronavirus-Pandemie und ihre Auswirkungen auf Orthopädie und Unfallchirurgie: Operationen Risiken und Prävention? | *C7168570* C7168570 | ||
67. Conseils de bonnes pratiques pour les praticiens spécialisés en laryngologie et en phoniatrie en contexte d’épidémie COVID-19. | *C7167575* C7167575 | ||
68. Pandémie de covid-19: rôle diagnostique fondamental de l’imagerie. | *C7167555* C7167555 | ||
69. COVID-19: Risikoabschätzung und Planungsgrundlagen für unsere Praxen. | *C7149296* C7149296 | ||
70. COVID-19-Pandemie: Wie können sich onkologische Kliniken wappnen? . | *C7149294* C7149294 | ||
71. Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19. | *C7149288* C7149288 | ||
72. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients. | *C7190525* C7190525 | ||
73. Entschädigung für Praxisschließung. | *C7144504* C7144504 | ||
74. Auswirkungen auf nervenärztliche neurologische psychiatrische Praxen. | *C7149297* C7149297 | ||
75. Die Digitalisierung verändert Praxen und Kliniken signifikant! | *C7149295* C7149295 | ||
76. Was Krebspatienten jetzt wissen wollen. | *C7149292* C7149292 | ||
77. COVID-19 bei Krebspatienten: Achtsamkeit und Abwägung sind erforderlich! | *C7149290* C7149290 | ||
78. The Postdigital in Pandemic Times: a Comment on the Covid-19 Crisis and its Political Epistemologies. | *C7166254* C7166254 | ||
79. Implications for forensic death investigations from first Swiss post-mortem CT in a case of non-hospital treatment with COVID-19. | *C7166113* C7166113 | ||
80. Should we expect neurological symptoms in the SARS-CoV-2 epidemic?☆. | *C7164915* C7164915 | ||
81. COVID-19 y enfermedad cardiovascular. | *C7164891* C7164891 | ||
82. Dental practice during a pandemic. | *C7163177* C7163177 | ||
83. SARS-CoV-2 et ORL pédiatrique en contexte de pandémie SARS-CoV-2 (COVID-19). | *C7164908* C7164908 | ||
84. Therapeutic management of patients with COVID-19: a systematic review. | *C7162768* C7162768 | ||
85. Aufklärung bald nur noch via Skype?!: Zu den Möglichkeiten und Grenzen der Fernaufklärung. | *C7160816* C7160816 | ||
86. Financial markets under the global pandemic of COVID-19. | *C7160643* C7160643 | ||
87. Management of the SARS-CoV-2 (Covid 19) coronavirus epidemic in hemodialysis units. | *C7158839* C7158839 | ||
88. Neonatal COVID-19: little evidence and the need for more information. | *C7158793* C7158793 | ||
89. Personal Protection Prior to Preoperative Assessment—Little more an anaesthesiologist can do to prevent SARS-CoV-2 transmission and COVID-19 infection. | *C7158264* C7158264 | ||
90. Schattenseiten der Globalisierung. | *C7156272* C7156272 | ||
91. CT radiomics can help screen the Coronavirus disease 2019 (COVID-19): a preliminary study. | *C7166002* C7166002 | ||
92. The intriguing features of COVID-19 in children and its impact on the pandemic. | *C7158814* C7158814 | ||
93. China’s ongoing battle against the coronavirus: Why did the lockdown strategy work well? | *C7158267* C7158267 | ||
94. Introduction to “Five Years of the Sendai Framework for Disaster Risk Reduction”. | *C7158265* C7158265 | ||
95. SARS-CoV-2 pandemic and pediatric endoscopic surgery. | *C7154214* C7154214 | ||
96. Entschädigung für Praxisschließung wegen Coronavirus. | *C7149271* C7149271 | ||
97. Biomimetic nanoparticles as universal influenza vaccine. | *C7152890* C7152890 | ||
98. An increasing risk of family violence during the Covid-19 pandemic: Strengthening community collaborations to save lives. | *C7152912* C7152912 | ||
99. EMA: continue use of ACE inhibitors sartans during COVID-19 pandemic. | *C7169649* C7169649 | ||
100. SFM India Oriented Guidelines for Ultrasound Establishments During the COVID 19 Pandemic. | *C7150531* C7150531 | ||
101. Identification of critical airports for controlling global infectious disease outbreaks: Stress-tests focusing in Europe. | *C7151290* C7151290 | ||
102. Leere Plätze: Covid-19 hat die deutsche Wirtschaft fest im Griff. Soziale Kontakte werden auf ein Minimum begrenzt Massenveranstaltungen im großen Stile abgesagt Notfallpläne aktiviert. Versicherer könnten in ihrer Rolle als Stabilitätsanker mit ihren Produkten gerade jetzt wichtige Signale aussenden doch sie halten sich zurück. Fragen von außen. . | *C7147137* C7147137 | ||
103. Perspectives on the death investigation during the COVID-19 pandemic. | *32412012* 32412012 | ||
104. The Downside of Globalization. | *C7149308* C7149308 | ||
105. Mit Immanuel Kant in die zweite Welle der gegenwärtigen Pandemie. | *C7149306* C7149306 | ||
106. Die Anwendung der Traditionellen Chinesischen Medizin (TCM)/Akupunktur in der Therapie und Prävention von SARS-CoV-2-Infektionen: White Paper des Wissenschaftszentrums der deutschen Ärztegesellschaft für Akupunktur. | *C7149307* C7149307 | ||
107. Protocol against coronavirus diseases in patients on renal replacement therapy: Dialysis and kidney transplant☆. | *C7144849* C7144849 | ||
108. Infection control since HIV. | *C7149282* C7149282 | ||
109. Cuidado respiratorio en COVID-19. | *C7144845* C7144845 | ||
110. Global Supply Chains: Globalization Research in a Changing World. | *C7166523* C7166523 | ||
111. Coronaviruserkrankung 2019 (COVID-19) und Schwangerschaft: Übersicht und Bericht des ersten deutschen Falls mit COVID-19 bei Gestationsdiabetes. | *C7149285* C7149285 | ||
112. Protocolo de diagnóstico y tratamiento para COVID-19 mediante medicina tradicional china☆. | *C7144855* C7144855 | ||
113. Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients☆. | *C7144844* C7144844 | ||
114. Regulatory agencies issue advice on use of NSAIDs for COVID-19. | *C7149289* C7149289 | ||
115. A Cured COVID-19 case of 86-year-old with 13 chronic diseases: A Case Report. | *C7148978* C7148978 | ||
116. Global implications of bio-aerosol in pandemic. | *C7149279* C7149279 | ||
117. Potential TRPV1 blockade to treat severe lung dysfunction in COVID-19 infection. | *C7147214* C7147214 | ||
118. Assessment of the SARS-CoV-2 basic reproduction number R0 based on the early phase of COVID-19 outbreak in Italy. | *C7148916* C7148916 | ||
119. Chloroquin gegen Corona? | *C7162107* C7162107 | ||
120. Case Study: A Patient with Asthma Covid-19 Pneumonia and Cytokine Release Syndrome Treated with Corticosteroids and Tocilizumab. | *C7187784* C7187784 | ||
121. Social Dimensions of COVID-19 in South Africa: A Neglected Element of the Treatment Plan. | *C7187742* C7187742 | ||
122. Coronavirus Disease 2019 (COVID-19) Resources. | *C7187738* C7187738 | ||
123. Patient guide - COVID 19. | *C7187736* C7187736 | ||
124. COVID-19: The Concept of Herd Immunity – Is It A Strategy for South Africa? | *C7187745* C7187745 | ||
125. COVID-19 Preparedness in a Neonatal Unit at a Tertiary Hospital in Johannesburg South Africa. | *C7187743* C7187743 | ||
126. Clinical Ethical Challenges in the Covid-19 Crisis in South Africa. | *C7187741* C7187741 | ||
127. Potential Impact of SARS-CoV-2 Infection in HIV-positive Patients in South Africa. | *C7187739* C7187739 | ||
128. COVID-19 and the Rationale for Pharmacotherapy: A South African Perspective. | *C7187737* C7187737 | ||
129. International Committee of the Red Cross (ICRC): General guidance for the management of the dead related to COVID-19. | *32412013* 32412013 | ||
130. Alcohol and isolation: Experts comment on drinking behavior during COVID‐19. | *C7161783* C7161783 | ||
131. Addiction telemedicine comes into its own with COVID‐19. | *C7161888* C7161888 | ||
132. The appropriate position of radiology in COVID-19 diagnosis and treatment—current status and opinion from China. | *C7141599* C7141599 | ||
133. A Primer on Biodefense Data Science for Pandemic Preparedness. | *C7194817* C7194817 | ||
134. Can developing countries face novel coronavirus outbreak alone? The Iraqi situation. | *C7194717* C7194717 | ||
135. Schutz vor und Hilfe bei Covid‐19‐Infektionen. | *C7167691* C7167691 | ||
136. Building resilience against biological hazards and pandemics: COVID-19 and its implications for the Sendai Framework. | *C7148717* C7148717 | ||
137. Promising methods for detection of novel coronavirus SARS‐CoV‐2. | *C7169335* C7169335 | ||
138. COVID-19 (Coronavirus Disease-19): Traditionelle Chinesische Medizin einschließlich Akupunktur zur Linderung — Ein Bericht aus Wuhan Hubei Provinz in China. | *C7149252* C7149252 | ||
139. Progress and prospect on imaging diagnosis of COVID-19. | *C7149076* C7149076 | ||
140. Diagnosis and treatment plan of Corona Virus Disease 2019 (tentative sixth edition). | *C7148673* C7148673 | ||
141. Interpretation of the diagnosis and treatment plan of Corona Virus Disease 2019 (tentative sixth edition). | *C7148677* C7148677 | ||
142. Chinese experts’ consensus on the Internet of Things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19). | *C7148716* C7148716 | ||
143. Modeling the dynamics of novel coronavirus (2019-nCov) with fractional derivative. | *C7148705* C7148705 | ||
144. Prevention and Treatment of Skin Damage Caused by Personal Protective Equipment: Experience of the First-Line Clinicians Treating 2019-nCoV Infection. | *C7147274* C7147274 | ||
73. Entschädigung für Praxisschließung. | *C7144504* C7144504 | ||
74. Auswirkungen auf nervenärztliche neurologische psychiatrische Praxen. | *C7149297* C7149297 | ||
75. Die Digitalisierung verändert Praxen und Kliniken signifikant! | *C7149295* C7149295 | ||
76. Was Krebspatienten jetzt wissen wollen. | *C7149292* C7149292 | ||
77. COVID-19 bei Krebspatienten: Achtsamkeit und Abwägung sind erforderlich! | *C7149290* C7149290 | ||
78. The Postdigital in Pandemic Times: a Comment on the Covid-19 Crisis and its Political Epistemologies. | *C7166254* C7166254 | ||
79. Implications for forensic death investigations from first Swiss post-mortem CT in a case of non-hospital treatment with COVID-19. | *C7166113* C7166113 | ||
80. Should we expect neurological symptoms in the SARS-CoV-2 epidemic?☆. | *C7164915* C7164915 | ||
81. COVID-19 y enfermedad cardiovascular. | *C7164891* C7164891 | ||
82. Dental practice during a pandemic. | *C7163177* C7163177 | ||
83. SARS-CoV-2 et ORL pédiatrique en contexte de pandémie SARS-CoV-2 (COVID-19). | *C7164908* C7164908 | ||
84. Therapeutic management of patients with COVID-19: a systematic review. | *C7162768* C7162768 | ||
85. Aufklärung bald nur noch via Skype?!: Zu den Möglichkeiten und Grenzen der Fernaufklärung. | *C7160816* C7160816 | ||
86. Financial markets under the global pandemic of COVID-19. | *C7160643* C7160643 | ||
87. Management of the SARS-CoV-2 (Covid 19) coronavirus epidemic in hemodialysis units. | *C7158839* C7158839 | ||
88. Neonatal COVID-19: little evidence and the need for more information. | *C7158793* C7158793 | ||
89. Personal Protection Prior to Preoperative Assessment—Little more an anaesthesiologist can do to prevent SARS-CoV-2 transmission and COVID-19 infection. | *C7158264* C7158264 | ||
90. Schattenseiten der Globalisierung. | *C7156272* C7156272 | ||
91. CT radiomics can help screen the Coronavirus disease 2019 (COVID-19): a preliminary study. | *C7166002* C7166002 | ||
92. The intriguing features of COVID-19 in children and its impact on the pandemic. | *C7158814* C7158814 | ||
93. China’s ongoing battle against the coronavirus: Why did the lockdown strategy work well? | *C7158267* C7158267 | ||
94. Introduction to “Five Years of the Sendai Framework for Disaster Risk Reduction”. | *C7158265* C7158265 | ||
95. SARS-CoV-2 pandemic and pediatric endoscopic surgery. | *C7154214* C7154214 | ||
96. Entschädigung für Praxisschließung wegen Coronavirus. | *C7149271* C7149271 | ||
97. Biomimetic nanoparticles as universal influenza vaccine. | *C7152890* C7152890 | ||
98. An increasing risk of family violence during the Covid-19 pandemic: Strengthening community collaborations to save lives. | *C7152912* C7152912 | ||
99. EMA: continue use of ACE inhibitors sartans during COVID-19 pandemic. | *C7169649* C7169649 | ||
100. SFM India Oriented Guidelines for Ultrasound Establishments During the COVID 19 Pandemic. | *C7150531* C7150531 | ||
101. Identification of critical airports for controlling global infectious disease outbreaks: Stress-tests focusing in Europe. | *C7151290* C7151290 | ||
102. Leere Plätze: Covid-19 hat die deutsche Wirtschaft fest im Griff. Soziale Kontakte werden auf ein Minimum begrenzt Massenveranstaltungen im großen Stile abgesagt Notfallpläne aktiviert. Versicherer könnten in ihrer Rolle als Stabilitätsanker mit ihren Produkten gerade jetzt wichtige Signale aussenden doch sie halten sich zurück. Fragen von außen. . | *C7147137* C7147137 | ||
103. Perspectives on the death investigation during the COVID-19 pandemic. | *32412012* 32412012 | ||
104. The Downside of Globalization. | *C7149308* C7149308 | ||
105. Mit Immanuel Kant in die zweite Welle der gegenwärtigen Pandemie. | *C7149306* C7149306 | ||
106. Die Anwendung der Traditionellen Chinesischen Medizin (TCM)/Akupunktur in der Therapie und Prävention von SARS-CoV-2-Infektionen: White Paper des Wissenschaftszentrums der deutschen Ärztegesellschaft für Akupunktur. | *C7149307* C7149307 | ||
107. Protocol against coronavirus diseases in patients on renal replacement therapy: Dialysis and kidney transplant☆. | *C7144849* C7144849 | ||
108. Infection control since HIV. | *C7149282* C7149282 | ||
109. Cuidado respiratorio en COVID-19. | *C7144845* C7144845 | ||
110. Global Supply Chains: Globalization Research in a Changing World. | *C7166523* C7166523 | ||
111. Coronaviruserkrankung 2019 (COVID-19) und Schwangerschaft: Übersicht und Bericht des ersten deutschen Falls mit COVID-19 bei Gestationsdiabetes. | *C7149285* C7149285 | ||
112. Protocolo de diagnóstico y tratamiento para COVID-19 mediante medicina tradicional china☆. | *C7144855* C7144855 | ||
113. Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients☆. | *C7144844* C7144844 | ||
114. Regulatory agencies issue advice on use of NSAIDs for COVID-19. | *C7149289* C7149289 | ||
115. A Cured COVID-19 case of 86-year-old with 13 chronic diseases: A Case Report. | *C7148978* C7148978 | ||
116. Global implications of bio-aerosol in pandemic. | *C7149279* C7149279 | ||
117. Potential TRPV1 blockade to treat severe lung dysfunction in COVID-19 infection. | *C7147214* C7147214 | ||
118. Assessment of the SARS-CoV-2 basic reproduction number R0 based on the early phase of COVID-19 outbreak in Italy. | *C7148916* C7148916 | ||
119. Chloroquin gegen Corona? | *C7162107* C7162107 | ||
120. Case Study: A Patient with Asthma Covid-19 Pneumonia and Cytokine Release Syndrome Treated with Corticosteroids and Tocilizumab. | *C7187784* C7187784 | ||
121. Social Dimensions of COVID-19 in South Africa: A Neglected Element of the Treatment Plan. | *C7187742* C7187742 | ||
122. Coronavirus Disease 2019 (COVID-19) Resources. | *C7187738* C7187738 | ||
123. Patient guide - COVID 19. | *C7187736* C7187736 | ||
124. COVID-19: The Concept of Herd Immunity – Is It A Strategy for South Africa? | *C7187745* C7187745 | ||
125. COVID-19 Preparedness in a Neonatal Unit at a Tertiary Hospital in Johannesburg South Africa. | *C7187743* C7187743 | ||
126. Clinical Ethical Challenges in the Covid-19 Crisis in South Africa. | *C7187741* C7187741 | ||
127. Potential Impact of SARS-CoV-2 Infection in HIV-positive Patients in South Africa. | *C7187739* C7187739 | ||
128. COVID-19 and the Rationale for Pharmacotherapy: A South African Perspective. | *C7187737* C7187737 | ||
129. International Committee of the Red Cross (ICRC): General guidance for the management of the dead related to COVID-19. | *32412013* 32412013 | ||
130. Alcohol and isolation: Experts comment on drinking behavior during COVID‐19. | *C7161783* C7161783 | ||
131. Addiction telemedicine comes into its own with COVID‐19. | *C7161888* C7161888 | ||
132. The appropriate position of radiology in COVID-19 diagnosis and treatment—current status and opinion from China. | *C7141599* C7141599 | ||
133. A Primer on Biodefense Data Science for Pandemic Preparedness. | *C7194817* C7194817 | ||
134. Can developing countries face novel coronavirus outbreak alone? The Iraqi situation. | *C7194717* C7194717 | ||
135. Schutz vor und Hilfe bei Covid‐19‐Infektionen. | *C7167691* C7167691 | ||
136. Building resilience against biological hazards and pandemics: COVID-19 and its implications for the Sendai Framework. | *C7148717* C7148717 | ||
137. Promising methods for detection of novel coronavirus SARS‐CoV‐2. | *C7169335* C7169335 | ||
138. COVID-19 (Coronavirus Disease-19): Traditionelle Chinesische Medizin einschließlich Akupunktur zur Linderung — Ein Bericht aus Wuhan Hubei Provinz in China. | *C7149252* C7149252 | ||
139. Progress and prospect on imaging diagnosis of COVID-19. | *C7149076* C7149076 | ||
140. Diagnosis and treatment plan of Corona Virus Disease 2019 (tentative sixth edition). | *C7148673* C7148673 | ||
141. Interpretation of the diagnosis and treatment plan of Corona Virus Disease 2019 (tentative sixth edition). | *C7148677* C7148677 | ||
142. Chinese experts’ consensus on the Internet of Things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19). | *C7148716* C7148716 | ||
143. Modeling the dynamics of novel coronavirus (2019-nCov) with fractional derivative. | *C7148705* C7148705 | ||
144. Prevention and Treatment of Skin Damage Caused by Personal Protective Equipment: Experience of the First-Line Clinicians Treating 2019-nCoV Infection. | *C7147274* C7147274 | ||
145. Consensus on Pre-examination and Triage in Clinic of Dermatology During Outbreak of COVID-19 From Chinese Experts#. | *C7153734* C7153734 | ||
146. Modelling the Economic Impact and Ripple Effects of Disease Outbreaks. | *C7149074* C7149074 | ||
147. Emergence of COVID-19 Infection: What Is Known and What Is to Be Expected-Narrative Review Article. | *C7179703* C7179703 | ||
148. Caring for persons in detention suffering with mental illness during the Covid-19 outbreak. | *C7147918* C7147918 | ||
149. Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agents. | *C7148653* C7148653 | ||
150. Prospect and application of Internet of Things technology for prevention of SARIs. | *C7148604* C7148604 | ||
151. Technical guidance for laboratory testing of 2019-nCoV infection (Third Edition). | *C7144506* C7144506 | ||
152. A strategy to prevent future epidemics similar to the 2019-nCoV outbreak. | *C7144510* C7144510 | ||
153. Laboratory biosafety guide for 2019-nCoV (Second Edition). | *C7144515* C7144515 | ||
154. Political Incentives to Suppress Negative Information: Evidence from Chinese Listed Firms. | *C7166360* C7166360 | ||
155. A Review of Catastrophic Risks for Life Insurers. | *C7169237* C7169237 | ||
156. Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report. | *C7172437* C7172437 | ||
157. Coronavirus Disease 2019: In-Home Isolation Room Construction. | *C7172440* C7172440 | ||
158. Long-Lasting Solutions to the Problem of Migration in Europe. | *C7183294* C7183294 | ||
159. CT manifestations and clinical characteristics of 1115 patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. | *C7200137* C7200137 | ||
160. Neurologic Involvement in COVID-19: Radiologists’ Perspective. | *32402785* 32402785 | ||
161. Aspiration Pneumonia or COVID-19 Infection: A Diagnostic Challenge. | *32381329* 32381329 | ||
162. The Role of Repeat Chest CT Scan in the COVID-19 Pandemic. | *32389601* 32389601 | ||
163. Lung ultrasound in COVID-19 pneumonia; prospects and limitations. | *32444253* 32444253 | ||
164. 18FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19. | *32386948* 32386948 | ||
165. Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease. | *32391184* 32391184 | ||
166. Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19. | *C7202249* C7202249 | ||
167. Assay Techniques and Test Development for COVID-19 Diagnosis. | *32382657* 32382657 | ||
168. SARS-CoV-2: Olfaction Brain Infection and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection. | *C7160911* C7160911 | ||
169. Impacto de la pandemia COVID-19 en los tratamientos inmunomoduladores/inmunosupresores en dermatología: actitudes de los pacientes y los dermatólogos en Argentina. | *C7188639* C7188639 | ||
170. Organización de un Servicio de Dermatología en la pandemia del COVID-19. | *32389322* 32389322 | ||
171. Experiencing the Surge: Report from a Large New York Radiation Oncology Department During the COVID-19 Pandemic. | *32377596* 32377596 | ||
172. How to reorganize the access of children in a radiotherapy department in the era of COVID19 in order to protect themselves and elderly patients. | *C7151398* C7151398 | ||
173. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. | *32377965* 32377965 | ||
174. Challenges to HIV Care and Psychological Health During the COVID-19 Pandemic Among People Living with HIV in China. | *32382824* 32382824 | ||
175. HIV Care Continuum and COVID-19 Outcomes Among People Living with HIV During the COVID-19 Pandemic Chicago IL. | *32382823* 32382823 | ||
176. Glukokortikoide und Covid-19. | *C7189003* C7189003 | ||
177. Biologika und Covid-19. | *C7189010* C7189010 | ||
178. Impact of COVID-19 epidemic on coronary care unit accesses for acute coronary syndrome in Veneto region Italy. | *C7201234* C7201234 | ||
179. Gun violence during COVID-19 pandemic: Paradoxical trends in New York City Chicago Los Angeles and Baltimore. | *32444297* 32444297 | ||
180. Use of drape/patient covering during potentially aerosolizing procedures. | *32402501* 32402501 | ||
181. Non-evidenced based treatment: An unintended cause of morbidity and mortality related to COVID-19. | *32402498* 32402498 | ||
182. Importance of respiratory airway management as well as psychological and rehabilitative treatments to COVID-19 patients. | *C7192120* C7192120 | ||
183. Alarming trends in US domestic violence during the COVID-19 pandemic. | *32402499* 32402499 | ||
184. Imaging & other potential predictors of deterioration in COVID-19☆☆☆. | *32386804* 32386804 | ||
185. COVID-19: POSTMORTEM DIAGNOSTIC AND BIOSAFETY CONSIDERATIONS. | *32379077* 32379077 | ||
186. Trainees and COVID-19: A Call to Arms. | *32379076* 32379076 | ||
187. SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease. | *C7172485* C7172485 | ||
188. Ethical and Logistical Considerations Of Caring for Older Adults on Inpatient Psychiatry during the COVID-19 Pandemic. | *32409192* 32409192 | ||
189. Preventing and Controlling Measures of 2019 Coronavirus Disease (COVID-19) : Practice in Psychogeriatric Ward. | *32409194* 32409194 | ||
190. Atypical presentation of Covid-19 in an older adult with severe Alzheimer Disease. | *32381283* 32381283 | ||
191. Application of fluorescence method in the process of personal protective equipment removal. | *32389627* 32389627 | ||
192. Community-based prevention and control of COVID-19: Experience from China. | *C7151256* C7151256 | ||
193. The Pandemic Challenge: End Separate and Unequal Healthcare. | *32423751* 32423751 | ||
194. Intensive Care Unit Admissions for Pregnant and Non-Pregnant Women with COVID-19. | *32387323* 32387323 | ||
195. Psychological Impact of COVID-19 in pregnant women. | *32387321* 32387321 | ||
196. SARS-CoV-2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg. | *32387327* 32387327 | ||
197. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract. | *32376320* 32376320 | ||
198. Evidence for and against vertical transmission for SARS-CoV-2 (COVID-19). | *32376317* 32376317 | ||
199. Outcome of Coronavirus spectrum infections (SARS MERS COVID 1 -19) during pregnancy: a systematic review and meta-analysis. | *C7104131* C7104131 | ||
200. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. | *32377594* 32377594 | ||
201. Safe tracheotomy for patients with COVID-19. | *32409163* 32409163 | ||
202. Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income. | *32430225* 32430225 | ||
203. COVID-19 and the Correctional Environment: The American Prison as a Focal Point for Public Health. | *32387174* 32387174 | ||
204. The impact of COVID-19 on medical student surgical education: Implementing extreme pandemic response measures in a widely distributed surgical clerkship experience. | *32389331* 32389331 | ||
205. Lesiones Cutáneas Tipo Perniosis Durante La Epidemia Covid-19. | *32418860* 32418860 | ||
206. Perniosis del confinamiento una vieja conocida en el contexto del COVID-19. | *32402775* 32402775 | ||
207. COVID 19: SINDROME FEBRIL Y CLÍNICA NEURÓLOGICA EN NEONATO. | *C7164917* C7164917 | ||
208. COVID-19 and ethical considerations: Valuable decision-making tools from the leading medical societies in France. | *32414630* 32414630 | ||
209. Urgent development of an anaesthesiology-based intensive care unit for critical COVID-19 infected patients. | *32389563* 32389563 | ||
210. COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept. | *32418867* 32418867 | ||
211. Sedation of Mechanically Ventilated COVID-19 Patients: Challenges and Special Considerations. | *32392023* 32392023 | ||
212. Barrier System for Airway Management of COVID-19 Patients. | *C7179052* C7179052 | ||
213. Asthma Biologics Corticosteroids and COVID-19. | *32387535* 32387535 | ||
214. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019. | *32387167* 32387167 | ||
215. Extensive aortic thrombosis in a patient with Covid-19. | *C7196387* C7196387 | ||
216. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532). | *32387456* 32387456 | ||
145. Consensus on Pre-examination and Triage in Clinic of Dermatology During Outbreak of COVID-19 From Chinese Experts#. | *C7153734* C7153734 | ||
146. Modelling the Economic Impact and Ripple Effects of Disease Outbreaks. | *C7149074* C7149074 | ||
147. Emergence of COVID-19 Infection: What Is Known and What Is to Be Expected-Narrative Review Article. | *C7179703* C7179703 | ||
148. Caring for persons in detention suffering with mental illness during the Covid-19 outbreak. | *C7147918* C7147918 | ||
149. Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agents. | *C7148653* C7148653 | ||
150. Prospect and application of Internet of Things technology for prevention of SARIs. | *C7148604* C7148604 | ||
151. Technical guidance for laboratory testing of 2019-nCoV infection (Third Edition). | *C7144506* C7144506 | ||
152. A strategy to prevent future epidemics similar to the 2019-nCoV outbreak. | *C7144510* C7144510 | ||
153. Laboratory biosafety guide for 2019-nCoV (Second Edition). | *C7144515* C7144515 | ||
154. Political Incentives to Suppress Negative Information: Evidence from Chinese Listed Firms. | *C7166360* C7166360 | ||
155. A Review of Catastrophic Risks for Life Insurers. | *C7169237* C7169237 | ||
156. Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report. | *C7172437* C7172437 | ||
157. Coronavirus Disease 2019: In-Home Isolation Room Construction. | *C7172440* C7172440 | ||
158. Long-Lasting Solutions to the Problem of Migration in Europe. | *C7183294* C7183294 | ||
159. CT manifestations and clinical characteristics of 1115 patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. | *C7200137* C7200137 | ||
160. Neurologic Involvement in COVID-19: Radiologists’ Perspective. | *32402785* 32402785 | ||
161. Aspiration Pneumonia or COVID-19 Infection: A Diagnostic Challenge. | *32381329* 32381329 | ||
162. The Role of Repeat Chest CT Scan in the COVID-19 Pandemic. | *32389601* 32389601 | ||
163. Lung ultrasound in COVID-19 pneumonia; prospects and limitations. | *32444253* 32444253 | ||
164. 18FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19. | *32386948* 32386948 | ||
165. Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease. | *32391184* 32391184 | ||
166. Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19. | *C7202249* C7202249 | ||
167. Assay Techniques and Test Development for COVID-19 Diagnosis. | *32382657* 32382657 | ||
168. SARS-CoV-2: Olfaction Brain Infection and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection. | *C7160911* C7160911 | ||
169. Impacto de la pandemia COVID-19 en los tratamientos inmunomoduladores/inmunosupresores en dermatología: actitudes de los pacientes y los dermatólogos en Argentina. | *C7188639* C7188639 | ||
170. Organización de un Servicio de Dermatología en la pandemia del COVID-19. | *32389322* 32389322 | ||
171. Experiencing the Surge: Report from a Large New York Radiation Oncology Department During the COVID-19 Pandemic. | *32377596* 32377596 | ||
172. How to reorganize the access of children in a radiotherapy department in the era of COVID19 in order to protect themselves and elderly patients. | *C7151398* C7151398 | ||
173. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. | *32377965* 32377965 | ||
174. Challenges to HIV Care and Psychological Health During the COVID-19 Pandemic Among People Living with HIV in China. | *32382824* 32382824 | ||
175. HIV Care Continuum and COVID-19 Outcomes Among People Living with HIV During the COVID-19 Pandemic Chicago IL. | *32382823* 32382823 | ||
176. Glukokortikoide und Covid-19. | *C7189003* C7189003 | ||
177. Biologika und Covid-19. | *C7189010* C7189010 | ||
178. Impact of COVID-19 epidemic on coronary care unit accesses for acute coronary syndrome in Veneto region Italy. | *C7201234* C7201234 | ||
179. Gun violence during COVID-19 pandemic: Paradoxical trends in New York City Chicago Los Angeles and Baltimore. | *32444297* 32444297 | ||
180. Use of drape/patient covering during potentially aerosolizing procedures. | *32402501* 32402501 | ||
181. Non-evidenced based treatment: An unintended cause of morbidity and mortality related to COVID-19. | *32402498* 32402498 | ||
182. Importance of respiratory airway management as well as psychological and rehabilitative treatments to COVID-19 patients. | *C7192120* C7192120 | ||
183. Alarming trends in US domestic violence during the COVID-19 pandemic. | *32402499* 32402499 | ||
184. Imaging & other potential predictors of deterioration in COVID-19☆☆☆. | *32386804* 32386804 | ||
185. COVID-19: POSTMORTEM DIAGNOSTIC AND BIOSAFETY CONSIDERATIONS. | *32379077* 32379077 | ||
186. Trainees and COVID-19: A Call to Arms. | *32379076* 32379076 | ||
187. SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease. | *C7172485* C7172485 | ||
188. Ethical and Logistical Considerations Of Caring for Older Adults on Inpatient Psychiatry during the COVID-19 Pandemic. | *32409192* 32409192 | ||
189. Preventing and Controlling Measures of 2019 Coronavirus Disease (COVID-19) : Practice in Psychogeriatric Ward. | *32409194* 32409194 | ||
190. Atypical presentation of Covid-19 in an older adult with severe Alzheimer Disease. | *32381283* 32381283 | ||
191. Application of fluorescence method in the process of personal protective equipment removal. | *32389627* 32389627 | ||
192. Community-based prevention and control of COVID-19: Experience from China. | *C7151256* C7151256 | ||
193. The Pandemic Challenge: End Separate and Unequal Healthcare. | *32423751* 32423751 | ||
194. Intensive Care Unit Admissions for Pregnant and Non-Pregnant Women with COVID-19. | *32387323* 32387323 | ||
195. Psychological Impact of COVID-19 in pregnant women. | *32387321* 32387321 | ||
196. SARS-CoV-2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg. | *32387327* 32387327 | ||
197. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract. | *32376320* 32376320 | ||
198. Evidence for and against vertical transmission for SARS-CoV-2 (COVID-19). | *32376317* 32376317 | ||
199. Outcome of Coronavirus spectrum infections (SARS MERS COVID 1 -19) during pregnancy: a systematic review and meta-analysis. | *C7104131* C7104131 | ||
200. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. | *32377594* 32377594 | ||
201. Safe tracheotomy for patients with COVID-19. | *32409163* 32409163 | ||
202. Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income. | *32430225* 32430225 | ||
203. COVID-19 and the Correctional Environment: The American Prison as a Focal Point for Public Health. | *32387174* 32387174 | ||
204. The impact of COVID-19 on medical student surgical education: Implementing extreme pandemic response measures in a widely distributed surgical clerkship experience. | *32389331* 32389331 | ||
205. Lesiones Cutáneas Tipo Perniosis Durante La Epidemia Covid-19. | *32418860* 32418860 | ||
206. Perniosis del confinamiento una vieja conocida en el contexto del COVID-19. | *32402775* 32402775 | ||
207. COVID 19: SINDROME FEBRIL Y CLÍNICA NEURÓLOGICA EN NEONATO. | *C7164917* C7164917 | ||
208. COVID-19 and ethical considerations: Valuable decision-making tools from the leading medical societies in France. | *32414630* 32414630 | ||
209. Urgent development of an anaesthesiology-based intensive care unit for critical COVID-19 infected patients. | *32389563* 32389563 | ||
210. COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept. | *32418867* 32418867 | ||
211. Sedation of Mechanically Ventilated COVID-19 Patients: Challenges and Special Considerations. | *32392023* 32392023 | ||
212. Barrier System for Airway Management of COVID-19 Patients. | *C7179052* C7179052 | ||
213. Asthma Biologics Corticosteroids and COVID-19. | *32387535* 32387535 | ||
214. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019. | *32387167* 32387167 | ||
215. Extensive aortic thrombosis in a patient with Covid-19. | *C7196387* C7196387 | ||
216. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532). | *32387456* 32387456 | ||
217. Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy. | *C7197610* C7197610 | ||
218. Antibody therapies for the treatment of COVID-19. | *C7197606* C7197606 | ||
219. Tromboembolia pulmonar aguda y enfermedad por coronavirus (COVID-19): ¿una asociación frecuente en pacientes graves? | *32386987* 32386987 | ||
220. Paciente con neumonía COVID-19: hallazgos quirúrgicos y correlación radiológica de lesiones pulmonares. | *32386880* 32386880 | ||
221. Mysterious Virus: A Review on Behavior and Treatment Approaches of the Novel Coronavirus 2019-nCoV. | *32448490* 32448490 | ||
222. A Review of Current Interventions for COVID-19 Prevention. | *32409144* 32409144 | ||
223. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) infection. | *32402576* 32402576 | ||
224. COVID-19 and Moral Imperialism in Multinational Clinical Research. | *32387041* 32387041 | ||
225. Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were we Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial? | *32387040* 32387040 | ||
226. Tackling the COVID-19 Pandemic. | *32381375* 32381375 | ||
227. A Reusable Mask for Coronavirus Disease 2019 (COVID-19). | *32448491* 32448491 | ||
228. COVID-19 in pediatric patients: what the prehospital teams need to know. | *32402434* 32402434 | ||
229. Child with liver transplant recovers from COVID-19 infection. A case report. | *32402433* 32402433 | ||
230. Auditoría inmunitaria de COVID-19 en el servicio de Oftalmología de un hospital de tercer nivel antes del desconfinamiento. | *32376126* 32376126 | ||
231. Recomendaciones para la atención oftalmológica durante el estado de alarma por la pandemia de enfermedad por coronavirus COVID-19. | *32409243* 32409243 | ||
232. Introduction to Artificial Intelligence in Economics and Finance Theories. Artificial Intelligence in Economics and Finance Theories 2020; (): 1-12 | *C7204330* C7204330 | ||
233. Handling the COVID-19 Pandemic: Proposing a Community Based Toolkit for Psycho-social Management and Preparedness. | *32416531* 32416531 | ||
234. Pandemics and Psychiatry: repositioning research in context of COVID-19. | *32442894* 32442894 | ||
235. Why all COVID-19 hospitals should have mental health professionals: The importance of mental health in a worldwide crisis! | *32473537* 32473537 | ||
236. Online Mental Health Services in Indonesia During the COVID-19 Outbreak. | *32403025* 32403025 | ||
237. Working in the emergency and inpatient COVID-19 special wards: a different experience for Iranian psychiatric trainees amid the outbreak: Running title: Experience of Iranian psychiatric trainees in COVID-19 special wards. | *32416532* 32416532 | ||
238. Psychological interventions during COVID-19: Challenges for low and middle income countries. | *32380441* 32380441 | ||
239. Telemedicine in the face of the COVID-19 pandemic. | *32402477* 32402477 | ||
240. Enfermedad por Coronavirus 2019 (COVID-19) en América Latina: Papel de la atención primaria en la preparación y respuesta. | *32386927* 32386927 | ||
241. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion. | *32376399* 32376399 | ||
242. Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? | *32376396* 32376396 | ||
243. Convalescent plasma in Covid-19: Possible mechanisms of action. | *32380316* 32380316 | ||
244. Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection. | *32380318* 32380318 | ||
245. SARS-CoV-2 infection among patients with systemic autoimmune diseases. | *32376395* 32376395 | ||
246. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? | *32387470* 32387470 | ||
247. Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risk for systemic sclerosis patients? | *32380317* 32380317 | ||
248. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis. | *32380315* 32380315 | ||
249. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. | *32376392* 32376392 | ||
250. Stability of RNA sequences derived from the coronavirus genome in human cells. | *32446559* 32446559 | ||
251. Biochemical characterization of SARS-CoV-2 nucleocapsid protein. | *32416961* 32416961 | ||
252. A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization. | *32451080* 32451080 | ||
253. COVID-19: the First Documented Coronavirus Pandemic in History. | *32387617* 32387617 | ||
254. The impact of biosensing in a pandemic outbreak: COVID-19. | *32421627* 32421627 | ||
255. Other Viral Bacterial Parasitic and Prion-Based Infectious Complications. | *C7152373* C7152373 | ||
256. CT differential diagnosis of COVID-19 and non-COVID-19 in symptomatic suspects: a practical scoring method. | *32381057* 32381057 | ||
257. COVID-19 outcomes in patients with hematologic disease. | *32376969* 32376969 | ||
258. OMFS and ENT surgeons issue new COVID-19 PPE guidance . | *C7180632* C7180632 | ||
259. Ultra-portable low-cost improvised powered air-purifying respirator: feasibility study. | *32446500* 32446500 | ||
260. Rapid training of healthcare staff for protected cardiopulmonary resuscitation in the COVID-19 pandemic. | *32416987* 32416987 | ||
261. ECMO for COVID-19 associated severe ARDS and risk of thrombosis. | *32414510* 32414510 | ||
262. Evidence of mother-newborn infection with COVID-19. | *32386820* 32386820 | ||
263. Failure Modes and Effect Analysis to develop transfer protocols in the management of COVID-19 patients. | *32416989* 32416989 | ||
264. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission. | *32381262* 32381262 | ||
265. Prevention is better than the cure but the cure cannot be worse than the disease: fibreoptic tracheal intubation in COVID-19 patients. | *32386832* 32386832 | ||
266. Percutaneous tracheostomy in patients with COVID-19: sealing the bronchoscope with an in-line suction sheath. | *32386837* 32386837 | ||
267. The Airway Lead: opportunities to improve institutional and personal preparedness for airway management. | *32386835* 32386835 | ||
268. Minimising droplet and virus spread during and after tracheal extubation. | *32416988* 32416988 | ||
269. A multipurpose portable negative air flow isolation chamber for aerosol-generating procedures during the COVID-19 pandemic. | *32386834* 32386834 | ||
270. Considerations for resuscitation and transfer of paediatric patients with COVID-19. | *32386833* 32386833 | ||
271. Modified tracheal extubation for patients with COVID–19. | *32402375* 32402375 | ||
272. Rational perioperative utilization and management during the COVID-19 pandemic. | *32376006* 32376006 | ||
273. Equality or utility? Ethics and law of rationing ventilators. | *32381261* 32381261 | ||
274. A perspective from a NYC chief oral and maxillofacial surgery resident during the COVID-19 pandemic. | *32417018* 32417018 | ||
275. Aerosol prevention in Osteosynthesis for Maxillofacial Trauma — a Technical Note. | *32418760* 32418760 | ||
276. Droplet nuclei aerosol and Covid 19 - a risk to healthcare staff. | *C7196379* C7196379 | ||
277. Management in oral and maxillofacial surgery during the COVID-19 pandemic: Our experience. | *32386671* 32386671 | ||
278. Social Work in the Time of the COVID-19 Pandemic: All in This Together? | *32390668* 32390668 | ||
279. Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series. | *32389697* 32389697 | ||
280. Psychopathological responses and face mask restrictions during the COVID-19 outbreak: Results from a nationwide survey. | *32389696* 32389696 | ||
281. Pain: A Potential New Label of COVID-19. | *32389704* 32389704 | ||
282. A Case of COVID-19 Encephalitis. | *32387508* 32387508 | ||
283. SARS-CoV-2: “Three-steps” infection model and CSF diagnostic implication. | *32387343* 32387343 | ||
284. Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19. | *32387342* 32387342 | ||
285. Home quarantine or centralized quarantine which is more conducive to fighting COVID-19 pandemic? | *32387346* 32387346 | ||
286. An infant with a mild SARS-CoV-2 infection detected only by anal swabs: a case report. | *32389618* 32389618 | ||
287. Dépistage et diagnostic du cancer du sein la fin de période de confinement COVID-19 aspects pratiques et hiérarchisation des priorités. | *32416925* 32416925 | ||
288. COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE). | *32387061* 32387061 | ||
217. Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy. | *C7197610* C7197610 | ||
218. Antibody therapies for the treatment of COVID-19. | *C7197606* C7197606 | ||
219. Tromboembolia pulmonar aguda y enfermedad por coronavirus (COVID-19): ¿una asociación frecuente en pacientes graves? | *32386987* 32386987 | ||
220. Paciente con neumonía COVID-19: hallazgos quirúrgicos y correlación radiológica de lesiones pulmonares. | *32386880* 32386880 | ||
221. Mysterious Virus: A Review on Behavior and Treatment Approaches of the Novel Coronavirus 2019-nCoV. | *32448490* 32448490 | ||
222. A Review of Current Interventions for COVID-19 Prevention. | *32409144* 32409144 | ||
223. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) infection. | *32402576* 32402576 | ||
224. COVID-19 and Moral Imperialism in Multinational Clinical Research. | *32387041* 32387041 | ||
225. Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were we Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial? | *32387040* 32387040 | ||
226. Tackling the COVID-19 Pandemic. | *32381375* 32381375 | ||
227. A Reusable Mask for Coronavirus Disease 2019 (COVID-19). | *32448491* 32448491 | ||
228. COVID-19 in pediatric patients: what the prehospital teams need to know. | *32402434* 32402434 | ||
229. Child with liver transplant recovers from COVID-19 infection. A case report. | *32402433* 32402433 | ||
230. Auditoría inmunitaria de COVID-19 en el servicio de Oftalmología de un hospital de tercer nivel antes del desconfinamiento. | *32376126* 32376126 | ||
231. Recomendaciones para la atención oftalmológica durante el estado de alarma por la pandemia de enfermedad por coronavirus COVID-19. | *32409243* 32409243 | ||
232. Introduction to Artificial Intelligence in Economics and Finance Theories. Artificial Intelligence in Economics and Finance Theories 2020; (): 1-12 | *C7204330* C7204330 | ||
233. Handling the COVID-19 Pandemic: Proposing a Community Based Toolkit for Psycho-social Management and Preparedness. | *32416531* 32416531 | ||
234. Pandemics and Psychiatry: repositioning research in context of COVID-19. | *32442894* 32442894 | ||
235. Why all COVID-19 hospitals should have mental health professionals: The importance of mental health in a worldwide crisis! | *32473537* 32473537 | ||
236. Online Mental Health Services in Indonesia During the COVID-19 Outbreak. | *32403025* 32403025 | ||
237. Working in the emergency and inpatient COVID-19 special wards: a different experience for Iranian psychiatric trainees amid the outbreak: Running title: Experience of Iranian psychiatric trainees in COVID-19 special wards. | *32416532* 32416532 | ||
238. Psychological interventions during COVID-19: Challenges for low and middle income countries. | *32380441* 32380441 | ||
239. Telemedicine in the face of the COVID-19 pandemic. | *32402477* 32402477 | ||
240. Enfermedad por Coronavirus 2019 (COVID-19) en América Latina: Papel de la atención primaria en la preparación y respuesta. | *32386927* 32386927 | ||
241. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion. | *32376399* 32376399 | ||
242. Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? | *32376396* 32376396 | ||
243. Convalescent plasma in Covid-19: Possible mechanisms of action. | *32380316* 32380316 | ||
244. Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection. | *32380318* 32380318 | ||
245. SARS-CoV-2 infection among patients with systemic autoimmune diseases. | *32376395* 32376395 | ||
246. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? | *32387470* 32387470 | ||
247. Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risk for systemic sclerosis patients? | *32380317* 32380317 | ||
248. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis. | *32380315* 32380315 | ||
249. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. | *32376392* 32376392 | ||
250. Stability of RNA sequences derived from the coronavirus genome in human cells. | *32446559* 32446559 | ||
251. Biochemical characterization of SARS-CoV-2 nucleocapsid protein. | *32416961* 32416961 | ||
252. A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization. | *32451080* 32451080 | ||
253. COVID-19: the First Documented Coronavirus Pandemic in History. | *32387617* 32387617 | ||
254. The impact of biosensing in a pandemic outbreak: COVID-19. | *32421627* 32421627 | ||
255. Other Viral Bacterial Parasitic and Prion-Based Infectious Complications. | *C7152373* C7152373 | ||
256. CT differential diagnosis of COVID-19 and non-COVID-19 in symptomatic suspects: a practical scoring method. | *32381057* 32381057 | ||
257. COVID-19 outcomes in patients with hematologic disease. | *32376969* 32376969 | ||
258. OMFS and ENT surgeons issue new COVID-19 PPE guidance . | *C7180632* C7180632 | ||
259. Ultra-portable low-cost improvised powered air-purifying respirator: feasibility study. | *32446500* 32446500 | ||
260. Rapid training of healthcare staff for protected cardiopulmonary resuscitation in the COVID-19 pandemic. | *32416987* 32416987 | ||
261. ECMO for COVID-19 associated severe ARDS and risk of thrombosis. | *32414510* 32414510 | ||
262. Evidence of mother-newborn infection with COVID-19. | *32386820* 32386820 | ||
263. Failure Modes and Effect Analysis to develop transfer protocols in the management of COVID-19 patients. | *32416989* 32416989 | ||
264. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission. | *32381262* 32381262 | ||
265. Prevention is better than the cure but the cure cannot be worse than the disease: fibreoptic tracheal intubation in COVID-19 patients. | *32386832* 32386832 | ||
266. Percutaneous tracheostomy in patients with COVID-19: sealing the bronchoscope with an in-line suction sheath. | *32386837* 32386837 | ||
267. The Airway Lead: opportunities to improve institutional and personal preparedness for airway management. | *32386835* 32386835 | ||
268. Minimising droplet and virus spread during and after tracheal extubation. | *32416988* 32416988 | ||
269. A multipurpose portable negative air flow isolation chamber for aerosol-generating procedures during the COVID-19 pandemic. | *32386834* 32386834 | ||
270. Considerations for resuscitation and transfer of paediatric patients with COVID-19. | *32386833* 32386833 | ||
271. Modified tracheal extubation for patients with COVID–19. | *32402375* 32402375 | ||
272. Rational perioperative utilization and management during the COVID-19 pandemic. | *32376006* 32376006 | ||
273. Equality or utility? Ethics and law of rationing ventilators. | *32381261* 32381261 | ||
274. A perspective from a NYC chief oral and maxillofacial surgery resident during the COVID-19 pandemic. | *32417018* 32417018 | ||
275. Aerosol prevention in Osteosynthesis for Maxillofacial Trauma — a Technical Note. | *32418760* 32418760 | ||
276. Droplet nuclei aerosol and Covid 19 - a risk to healthcare staff. | *C7196379* C7196379 | ||
277. Management in oral and maxillofacial surgery during the COVID-19 pandemic: Our experience. | *32386671* 32386671 | ||
278. Social Work in the Time of the COVID-19 Pandemic: All in This Together? | *32390668* 32390668 | ||
279. Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series. | *32389697* 32389697 | ||
280. Psychopathological responses and face mask restrictions during the COVID-19 outbreak: Results from a nationwide survey. | *32389696* 32389696 | ||
281. Pain: A Potential New Label of COVID-19. | *32389704* 32389704 | ||
282. A Case of COVID-19 Encephalitis. | *32387508* 32387508 | ||
283. SARS-CoV-2: “Three-steps” infection model and CSF diagnostic implication. | *32387343* 32387343 | ||
284. Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19. | *32387342* 32387342 | ||
285. Home quarantine or centralized quarantine which is more conducive to fighting COVID-19 pandemic? | *32387346* 32387346 | ||
286. An infant with a mild SARS-CoV-2 infection detected only by anal swabs: a case report. | *32389618* 32389618 | ||
287. Dépistage et diagnostic du cancer du sein la fin de période de confinement COVID-19 aspects pratiques et hiérarchisation des priorités. | *32416925* 32416925 | ||
288. COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE). | *32387061* 32387061 | ||
289. SARS-CoV-2 et Cancer en France: les internes d’oncologie en première ligne. Témoignage des internes d’oncologie de deux clusters fran"ais le Grand Est et l’Île de France. | *32387062* 32387062 | ||
290. Multidisciplinary management of the burn injured patient during a pandemic -– The role of telemedicine. | *C7192084* C7192084 | ||
291. The role of enzymatic debridement in burn care in the COVID-19 pandemic. Commentary by the Italian Society of Burn Surgery (SIUST). | *32381447* 32381447 | ||
292. COVID-19 pandemic and the burn survivor community: A call for action☆. | *C7180154* C7180154 | ||
293. Burn center function during the COVID-19 pandemic: An international multi-center report of strategy and experience. | *32416984* 32416984 | ||
294. Management strategies for the burn ward during COVID-19 pandemic. | *32381449* 32381449 | ||
295. Common breaches in biosafety during donning and doffing of protective personal equipment used in the care of COVID-19 patients. | *C7155949* C7155949 | ||
296. Social distancing: implications for the operating room in the face of COVID-19. | *C7155950* C7155950 | ||
297. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Societies. | *32380228* 32380228 | ||
298. Management and Treatment of COVID-19: The Chinese Experience. | *32439306* 32439306 | ||
299. An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience under Real-world Suboptimal Conditions. | *32376346* 32376346 | ||
300. Sociodemographic and Psychological Correlates of Compliance with the COVID-19 Public Health Measures in France. | *C7203163* C7203163 | ||
301. COVID-19 as a Complex Intergovernmental Problem. | *C7184146* C7184146 | ||
302. Continuity of Constitutional Government during a Pandemic: Considering the Concept in Canada s Emergency Management Act. | *C7184142* C7184142 | ||
303. Public Policy and Constitutional Rights in Times of Crisis. | *C7167486* C7167486 | ||
304. The COVID-19 & Cancer Consortium (CCC19): a collaborative effort to understand the effects of COVID-19 on patients with cancer. | *32454025* 32454025 | ||
305. Radiothérapie mammaire dans le contexte de la pandémie de COVID-19 : astuces pratiques en période épidémique et conseils pour la reprise de l’activité en fin de crise. | *32389580* 32389580 | ||
306. Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak. | *32391172* 32391172 | ||
307. The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic. | *C7175912* C7175912 | ||
308. High-flow Nasal Cannula Oxygenation Revisited in COVID-19. | *32377387* 32377387 | ||
309. Reappraisal on pharmacological and mechanical treatments of heart failure. | *32375806* 32375806 | ||
310. EMERGING SPECTRUM OF CARDIOPULMONARY PATHOLOGY OF THE CORONAVIRUS DISEASE 2019 (COVID-19): REPORT OF THREE AUTOPSIES FROM HOUSTON TEXAS AND REVIEW OF AUTOPSY FINDINGS FROM OTHER UNITED STATES CITIES. | *32434133* 32434133 | ||
311. STEMI During the COVID-19 Pandemic - An Evaluation of Incidence. | *32454398* 32454398 | ||
312. Severe COVID-19 infection in pregnancy requiring intubation without preterm delivery: A case report. | *32382516* 32382516 | ||
313. Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. | *32386545* 32386545 | ||
314. Trained immunity: a tool for reducing susceptibility and severity of SARS-CoV-2 infection. | *32437659* 32437659 | ||
315. Clinically Applicable AI System for Accurate Diagnosis Quantitative Measurements and Prognosis of COVID-19 Pneumonia Using Computed Tomography. | *32416069* 32416069 | ||
316. SnapShot: COVID-19. | *32413300* 32413300 | ||
317. Could an endo-lysosomal ion channel be the Achilles heel of SARS-CoV2? | *32402856* 32402856 | ||
318. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. | *32377375* 32377375 | ||
319. Heightened innate immune responses in the respiratory tract of COVID-19 patients. | *32407669* 32407669 | ||
320. Protective humoral immunity in SARS-CoV-2 infected pediatric patients. | *32382126* 32382126 | ||
321. NKG2A and COVID-19: another brick in the wall. | *32382127* 32382127 | ||
322. COVID-19: a new challenge for human beings. | *32235915* 32235915 | ||
323. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. | *32203188* 32203188 | ||
324. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. | *32203186* 32203186 | ||
325. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV. | *32132669* 32132669 | ||
326. COVID-19: towards understanding of pathogenesis. | *32346073* 32346073 | ||
327. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. | *32231345* 32231345 | ||
328. Coronavirus infections: Epidemiological clinical and immunological features and hypotheses. | *C7064018* C7064018 | ||
329. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? | *32314313* 32314313 | ||
330. Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective. | *32376238* 32376238 | ||
331. Traditional Chinese medicine contributes to the treatment of COVID-19 patients. | *32391065* 32391065 | ||
332. Perforación intestinal en paciente covid-19 en tratamiento con tocilizumab y corticoides. A propósito de un caso. | *32402416* 32402416 | ||
333. ATENCIÓN DE LA URGENCIA QUIRÚRGICA DURANTE LA PANDEMIA COVID-19. RECOMENDACIONES DE LA ASOCIACIÓN ESPAÑOLA DE CIRUJANOS. | *32439139* 32439139 | ||
334. Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target sequences. | *32387093* 32387093 | ||
335. PROPOSED USE OF THALIDOMIDE FOR THE CYTOKINE STORM OF COVID-19☆. | *C7186126* C7186126 | ||
336. Update on the Cutaneous Manifestations of COVID 19☆. | *C7194632* C7194632 | ||
337. Covid-19 pandemic and the skin - What should dermatologists know?☆☆☆☆☆☆. | *C7102542* C7102542 | ||
338. ERA-EDTA sharing Milan experience on coronavirus management in dialysis centres. | *C7184441* C7184441 | ||
339. Coronavirus disease (COVID-19) in neurology and neurosurgery: A scoping review of the early literature. | *32389893* 32389893 | ||
340. EEG during the COVID-19 pandemic: What remains the same and what is different. | *32388156* 32388156 | ||
341. Notfällige Neurointerventionen Covid-19 und Thorax-CT: SOP und Literaturübersicht. | *32382877* 32382877 | ||
342. Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic. | *32418675* 32418675 | ||
343. Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic – Rapid Review. | *32389318* 32389318 | ||
344. COVID-19: a novel coronavirus and a novel challenge for oral healthcare. | *32382932* 32382932 | ||
345. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. | *32382418* 32382418 | ||
346. Open access epidemiologic data and an interactive dashboard to monitor the COVID-19 outbreak in Canada. | *32392510* 32392510 | ||
347. Transmission of coronavirus by nebulizer: a serious underappreciated risk. | *32392488* 32392488 | ||
348. Schlaganfälle und Enzephalitis bei COVID-19? | *32390789* 32390789 | ||
349. Prediction of numbers of the accumulative confirmed patients (NACP) and the plateau phase of 2019-nCoV in China. | *32341718* 32341718 | ||
350. Colorectal cancer care in the age of coronavirus: strategies to reduce risk and maintain benefit. | *C7170009* C7170009 | ||
351. COVID-19 Epidemic Peer Support and Crisis Intervention Via Social Media. | *32378126* 32378126 | ||
352. Remarks on the Classification of Viruses. | *C7182114* C7182114 | ||
353. Herbal medicine for treatment of children diagnosed with COVID-19: A review of guidelines. | *32379639* 32379639 | ||
354. Traditional Chinese Medicine treatment of COVID-19. | *32379692* 32379692 | ||
355. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. | *32379637* 32379637 | ||
356. How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician s guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive Research Network (OCRN) of the European College of Neuropsychopharmacology. | *32388123* 32388123 | ||
357. COVID-19 detection using deep learning models to exploit Social Mimic Optimization and structured chest X-ray images using fuzzy color and stacking approaches. | *C7202857* C7202857 | ||
358. Application of deep learning technique to manage COVID-19 in routine clinical practice using CT images: Results of 10 convolutional neural networks. | *C7190523* C7190523 | ||
359. Automated detection of COVID-19 cases using deep neural networks with X-ray images. | *C7187882* C7187882 | ||
360. COVID-19 Coronavirus spike protein analysis for synthetic vaccines a peptidomimetic antagonist and therapeutic drugs and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance. | *C7151553* C7151553 | ||
289. SARS-CoV-2 et Cancer en France: les internes d’oncologie en première ligne. Témoignage des internes d’oncologie de deux clusters fran"ais le Grand Est et l’Île de France. | *32387062* 32387062 | ||
290. Multidisciplinary management of the burn injured patient during a pandemic -– The role of telemedicine. | *C7192084* C7192084 | ||
291. The role of enzymatic debridement in burn care in the COVID-19 pandemic. Commentary by the Italian Society of Burn Surgery (SIUST). | *32381447* 32381447 | ||
292. COVID-19 pandemic and the burn survivor community: A call for action☆. | *C7180154* C7180154 | ||
293. Burn center function during the COVID-19 pandemic: An international multi-center report of strategy and experience. | *32416984* 32416984 | ||
294. Management strategies for the burn ward during COVID-19 pandemic. | *32381449* 32381449 | ||
295. Common breaches in biosafety during donning and doffing of protective personal equipment used in the care of COVID-19 patients. | *C7155949* C7155949 | ||
296. Social distancing: implications for the operating room in the face of COVID-19. | *C7155950* C7155950 | ||
297. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Societies. | *32380228* 32380228 | ||
298. Management and Treatment of COVID-19: The Chinese Experience. | *32439306* 32439306 | ||
299. An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience under Real-world Suboptimal Conditions. | *32376346* 32376346 | ||
300. Sociodemographic and Psychological Correlates of Compliance with the COVID-19 Public Health Measures in France. | *C7203163* C7203163 | ||
301. COVID-19 as a Complex Intergovernmental Problem. | *C7184146* C7184146 | ||
302. Continuity of Constitutional Government during a Pandemic: Considering the Concept in Canada s Emergency Management Act. | *C7184142* C7184142 | ||
303. Public Policy and Constitutional Rights in Times of Crisis. | *C7167486* C7167486 | ||
304. The COVID-19 & Cancer Consortium (CCC19): a collaborative effort to understand the effects of COVID-19 on patients with cancer. | *32454025* 32454025 | ||
305. Radiothérapie mammaire dans le contexte de la pandémie de COVID-19 : astuces pratiques en période épidémique et conseils pour la reprise de l’activité en fin de crise. | *32389580* 32389580 | ||
306. Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak. | *32391172* 32391172 | ||
307. The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic. | *C7175912* C7175912 | ||
308. High-flow Nasal Cannula Oxygenation Revisited in COVID-19. | *32377387* 32377387 | ||
309. Reappraisal on pharmacological and mechanical treatments of heart failure. | *32375806* 32375806 | ||
310. EMERGING SPECTRUM OF CARDIOPULMONARY PATHOLOGY OF THE CORONAVIRUS DISEASE 2019 (COVID-19): REPORT OF THREE AUTOPSIES FROM HOUSTON TEXAS AND REVIEW OF AUTOPSY FINDINGS FROM OTHER UNITED STATES CITIES. | *32434133* 32434133 | ||
311. STEMI During the COVID-19 Pandemic - An Evaluation of Incidence. | *32454398* 32454398 | ||
312. Severe COVID-19 infection in pregnancy requiring intubation without preterm delivery: A case report. | *32382516* 32382516 | ||
313. Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. | *32386545* 32386545 | ||
314. Trained immunity: a tool for reducing susceptibility and severity of SARS-CoV-2 infection. | *32437659* 32437659 | ||
315. Clinically Applicable AI System for Accurate Diagnosis Quantitative Measurements and Prognosis of COVID-19 Pneumonia Using Computed Tomography. | *32416069* 32416069 | ||
316. SnapShot: COVID-19. | *32413300* 32413300 | ||
317. Could an endo-lysosomal ion channel be the Achilles heel of SARS-CoV2? | *32402856* 32402856 | ||
318. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. | *32377375* 32377375 | ||
319. Heightened innate immune responses in the respiratory tract of COVID-19 patients. | *32407669* 32407669 | ||
320. Protective humoral immunity in SARS-CoV-2 infected pediatric patients. | *32382126* 32382126 | ||
321. NKG2A and COVID-19: another brick in the wall. | *32382127* 32382127 | ||
322. COVID-19: a new challenge for human beings. | *32235915* 32235915 | ||
323. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. | *32203188* 32203188 | ||
324. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. | *32203186* 32203186 | ||
325. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV. | *32132669* 32132669 | ||
326. COVID-19: towards understanding of pathogenesis. | *32346073* 32346073 | ||
327. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. | *32231345* 32231345 | ||
328. Coronavirus infections: Epidemiological clinical and immunological features and hypotheses. | *C7064018* C7064018 | ||
329. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? | *32314313* 32314313 | ||
330. Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective. | *32376238* 32376238 | ||
331. Traditional Chinese medicine contributes to the treatment of COVID-19 patients. | *32391065* 32391065 | ||
332. Perforación intestinal en paciente covid-19 en tratamiento con tocilizumab y corticoides. A propósito de un caso. | *32402416* 32402416 | ||
333. ATENCIÓN DE LA URGENCIA QUIRÚRGICA DURANTE LA PANDEMIA COVID-19. RECOMENDACIONES DE LA ASOCIACIÓN ESPAÑOLA DE CIRUJANOS. | *32439139* 32439139 | ||
334. Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target sequences. | *32387093* 32387093 | ||
335. PROPOSED USE OF THALIDOMIDE FOR THE CYTOKINE STORM OF COVID-19☆. | *C7186126* C7186126 | ||
336. Update on the Cutaneous Manifestations of COVID 19☆. | *C7194632* C7194632 | ||
337. Covid-19 pandemic and the skin - What should dermatologists know?☆☆☆☆☆☆. | *C7102542* C7102542 | ||
338. ERA-EDTA sharing Milan experience on coronavirus management in dialysis centres. | *C7184441* C7184441 | ||
339. Coronavirus disease (COVID-19) in neurology and neurosurgery: A scoping review of the early literature. | *32389893* 32389893 | ||
340. EEG during the COVID-19 pandemic: What remains the same and what is different. | *32388156* 32388156 | ||
341. Notfällige Neurointerventionen Covid-19 und Thorax-CT: SOP und Literaturübersicht. | *32382877* 32382877 | ||
342. Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic. | *32418675* 32418675 | ||
343. Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic – Rapid Review. | *32389318* 32389318 | ||
344. COVID-19: a novel coronavirus and a novel challenge for oral healthcare. | *32382932* 32382932 | ||
345. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. | *32382418* 32382418 | ||
346. Open access epidemiologic data and an interactive dashboard to monitor the COVID-19 outbreak in Canada. | *32392510* 32392510 | ||
347. Transmission of coronavirus by nebulizer: a serious underappreciated risk. | *32392488* 32392488 | ||
348. Schlaganfälle und Enzephalitis bei COVID-19? | *32390789* 32390789 | ||
349. Prediction of numbers of the accumulative confirmed patients (NACP) and the plateau phase of 2019-nCoV in China. | *32341718* 32341718 | ||
350. Colorectal cancer care in the age of coronavirus: strategies to reduce risk and maintain benefit. | *C7170009* C7170009 | ||
351. COVID-19 Epidemic Peer Support and Crisis Intervention Via Social Media. | *32378126* 32378126 | ||
352. Remarks on the Classification of Viruses. | *C7182114* C7182114 | ||
353. Herbal medicine for treatment of children diagnosed with COVID-19: A review of guidelines. | *32379639* 32379639 | ||
354. Traditional Chinese Medicine treatment of COVID-19. | *32379692* 32379692 | ||
355. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. | *32379637* 32379637 | ||
356. How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician s guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive Research Network (OCRN) of the European College of Neuropsychopharmacology. | *32388123* 32388123 | ||
357. COVID-19 detection using deep learning models to exploit Social Mimic Optimization and structured chest X-ray images using fuzzy color and stacking approaches. | *C7202857* C7202857 | ||
358. Application of deep learning technique to manage COVID-19 in routine clinical practice using CT images: Results of 10 convolutional neural networks. | *C7190523* C7190523 | ||
359. Automated detection of COVID-19 cases using deep neural networks with X-ray images. | *C7187882* C7187882 | ||
360. COVID-19 Coronavirus spike protein analysis for synthetic vaccines a peptidomimetic antagonist and therapeutic drugs and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance. | *C7151553* C7151553 | ||
PMC7161861 1. Emergency Management of the Prevention and Control of Novel Coronavirus Pneumonia in Specialized Branches of Hospital. | *32147890* 32147890 | ||
PMC7094139 2. Cell-Membrane-Mimicking Nanodecoys against Infectious Diseases. | *32129977* 32129977 | ||
PMC7147513 3. Infodemic and Risk Communication in the Era of CoV-19. | *32309248* 32309248 | ||
PMC7161833 4. Host Cell Mimic Polymersomes for Rapid Detection of Highly Pathogenic Influenza Virus via a Viral Fusion and Cell Entry Mechanism. | *32313543* 32313543 | ||
PMC5858183 5. Progress Toward the Clinical Translation of Bioinspired Peptide and Protein Assemblies. | *29115746* 29115746 | ||
PMC7161883 6. Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens. | *29717819* 29717819 | ||
PMC7161897 7. Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses. | *28945945* 28945945 | ||
PMC7161847 8. PDZ Domains as Drug Targets. | *32313833* 32313833 | ||
PMC7188132 9. Double-Edged Spike. | *32322898* 32322898 | ||
PMC7165094 10. Acrylic window as physical barrier for Personal Protective Equipment (PPE) conservation. | *32331959* 32331959 | ||
PMC7163183 11. NOW!: protection for obstetrical providers and patients. | *32309798* 32309798 | ||
PMC7119451 12. Ophthalmologists Are More Than Eye Doctors-In Memoriam Li Wenliang. | *32169251* 32169251 | ||
PMC7174188 13. Vulnerable Populations: Weathering the Pandemic Storm. | *32371018* 32371018 | ||
PMC7193851 14. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection. | *32200654* 32200654 | ||
15. Early management of severe abdominal trauma. | *31843714* 31843714 | ||
PMC7133774 16. Coronavirus disease 2019 : Mehr Sicherheit durch kompakte Fakten und Handlungsempfehlungen. | *32253484* 32253484 | ||
PMC7176271 17. Setup of a Dedicated Coronavirus Intensive Care Unit: Logistical Aspects. | *32235155* 32235155 | ||
PMC7155906 18. Preventing Infection of Patients and Healthcare Workers Should Be the New Normal in the Era of Novel Coronavirus Epidemics. | *32195701* 32195701 | ||
PMC7143230 19. Eco-Virological Preliminary Study of Potentially Emerging Pathogens in Hedgehogs (Erinaceus europaeus) Recovered at a Wildlife Treatment and Rehabilitation Center in Northern Italy. | *32121543* 32121543 | ||
PMC7167663 20. Evolutionary ecology of virus emergence. | *28036113* 28036113 | ||
PMC7167773 21. Observed and projected drivers of emerging infectious diseases in Europe. | *27434370* 27434370 | ||
PMC7175144 22. A New Penicillin? | *32168863* 32168863 | ||
PMC7038234 23. Screening of Natural Extracts for Inhibitors against Japanese Encephalitis Virus Infection. | *31871089* 31871089 | ||
PMC7179581 24. Tilorone, a Broad-Spectrum Antiviral for Emerging Viruses. | *32205350* 32205350 | ||
PMC4356770 25. Biochemical characterization of recombinant Enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay. | *25421478* 25421478 | ||
PMC7111628 26. Inhibition of herpes simplex virus by myricetin through targeting viral gD protein and cellular EGFR/PI3K/Akt pathway. | *32165083* 32165083 | ||
PMC7113668 27. Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. | *29128390* 29128390 | ||
PMC7113789 28. Accessory proteins of SARS-CoV and other coronaviruses. | *24995382* 24995382 | ||
PMC3018546 29. Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model. | *21093489* 21093489 | ||
PMC7114283 30. Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus. | *20727913* 20727913 | ||
PMC7114261 31. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin. | *16621037* 16621037 | ||
PMC7112052 32. Interleukin-17 suppresses grass carp reovirus infection in Ctenopharyngodon idellus kidney cells by activating NF-kappaB signaling. | *32287459* 32287459 | ||
PMC7133384 33. Proposal for prevention and control of the 2019 novel coronavirus disease in newborn infants. | *32132140* 32132140 | ||
PMC7161747 34. Synthesis and anti-coronavirus activity of a series of 1-thia-4-azaspiro[4.5]decan-3-one derivatives. | *31073993* 31073993 | ||
PMC7093265 35. Preprints: What is their role in medical journals? | *32203987* 32203987 | ||
PMC7136941 36. The emotional toll of global infectious diseases. | *32248926* 32248926 | ||
PMC7139255 37. What can we do for people exposed to multiple traumatic events during the coronavirus pandemic? | *32298970* 32298970 | ||
PMC7179484 38. Psychological impact of coronavirus outbreak on borderline personality disorder from the perspective of mentalizing model: A case report. | *32361209* 32361209 | ||
PMC7161472 39. Mental Health and Psychosocial Aspects of Coronavirus Outbreak in Pakistan: Psychological Intervention for Public Mental Health Crisis. | *32344331* 32344331 | ||
PMC7161508 40. Two cases report of epidemic stress disorder to novel coronavirus pneumonia. | *32325392* 32325392 | ||
PMC7151292 41. Coronaphobia and chronophobia - A psychiatric perspective. | *32302963* 32302963 | ||
PMC7172683 42. Influence of fireworks emission on aerosol aging process at lower troposphere and associated health risks in an urban region of eastern central India. | *32322156* 32322156 | ||
PMC7194706 43. Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING. | *32223926* 32223926 | ||
PMC7092853 44. Cephalotaxine inhibits Zika infection by impeding viral replication and stability. | *31818462* 31818462 | ||
PMC7162792 45. The seafood Musculus senhousei shows anti-influenza A virus activity by targeting virion envelope lipids. | *32305436* 32305436 | ||
PMC7188661 46. Exercise-induced immune system response: Anti-inflammatory status on peripheral and central organs. | *32360589* 32360589 | ||
PMC6371793 47. Limiting Respiratory Viral Infection by Targeting Antiviral and Immunological Functions of BST-2/Tetherin: Knowledge and Gaps. | *30113067* 30113067 | ||
PMC7161894 48. Autoimmunity and the microbiome: T-cell receptor mimicry of "self" and microbial antigens mediates self tolerance in holobionts: The concepts of "holoimmunity" (TcR-mediated tolerance for the holobiont) and "holoautoimmunity" (loss of tolerance for the holobiont) are introduced. | *27594308* 27594308 | ||
PMC7161875 49. Introducing One Health to the Ethical Debate About Zoonotic Diseases in Southeast Asia. | *25675899* 25675899 | ||
PMC7161805 50. Palmitoylation of virus proteins. | *22548323* 22548323 | ||
PMC7023251 51. Cell Membrane-Interrupting Antimicrobial Peptides from Isatis indigotica Fortune Isolated by a Bacillus subtilis Expression System. | *31878275* 31878275 | ||
PMC7112834 52. Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules. | *32247750* 32247750 | ||
PMC7138182 53. The signal peptide as a new target for drug design. | *32209293* 32209293 | ||
54. The relationship between the structure and toxicity of aminoglycoside antibiotics. | *32360102* 32360102 | ||
PMC7161524 55. Multiscale Genome Organization: Dazzling Subject and Inventive Methods. | *32305070* 32305070 | ||
PMC7189491 56. Chloroquine and bafilomycin A mimic lysosomal storage disorders and impair mTORC1 signalling. | *32285908* 32285908 | ||
PMC7189284 57. Promoting platelets is a therapeutic option to combat severe viral infection of the lung. | *32315397* 32315397 | ||
PMC7179535 58. Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum. | *32172242* 32172242 | ||
PMC7161889 59. Delaying haematopoietic stem cell transplantation in children with viral respiratory infections reduces transplant-related mortality. | *31566733* 31566733 | ||
PMC7195597 60. Editorial: safe healthcare teams during the coronavirus outbreak. | *32224009* 32224009 | ||
PMC7135707 61. Host proteases as determinants of coronaviral neurotropism and virulence. | *32272221* 32272221 | ||
PMC7161744 62. Henipavirus Encephalitis: Recent Developments and Advances. | *26276024* 26276024 | ||
PMC7135734 63. Distance learning and telemedicine in the area of Otorhinolaryngology: lessons in times of pandemic. | *32295739* 32295739 | ||
PMC7117789 64. Mathematical Analysis of the Ross-Macdonald Model with Quarantine. | *32242279* 32242279 | ||
PMC7090637 65. The impact of high-flow nasal cannula (HFNC) on coughing distance: implications on its use during the novel coronavirus disease outbreak. | *32189218* 32189218 | ||
PMC7189635 66. Perioperative personal protective equipment stewardship (POPPiES). | *32350813* 32350813 | ||
PMC7187663 67. Equipements de protection individuelle (EPI) pour anesthesiologistes: la necessite de directives nationales. | *32347459* 32347459 | ||
PMC7169639 68. Keeping trainees safe in a pandemic: the evolving role of medical simulation training. | *32314263* 32314263 | ||
PMC7063753 69. Empagliflozin improves cardiac function in heart failure with reduced ejection fraction independent of loading conditions. | *32156272* 32156272 | ||
PMC7080068 70. Old Threat, New Enemy: Is Your Interventional Radiology Service Ready for the Coronavirus Disease 2019? | *32103304* 32103304 | ||
PMC7184394 71. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease. | *32267499* 32267499 | ||
PMC7154513 72. The Novel Coronavirus Outbreak: What We Know and What We Don't. | *32078801* 32078801 | ||
PMC7194104 73. Embracing the Landscape of Therapeutics. | *32243785* 32243785 | ||
PMC7161471 74. The Role of Chemical Biology in the Discovery and Understanding of Ferroptosis. | *32302581* 32302581 | ||
PMC7162240 75. Human microRNA-30 inhibits influenza virus infection by suppressing the expression of SOCS1, SOCS3, and NEDD4. | *31876380* 31876380 | ||
PMC7170033 76. Chloroquine reduces Th17 cell differentiation by stimulating T-bet expression in T cells. | *32313209* 32313209 | ||
PMC7154508 77. A Specialized Few Among Many: Identification of a Novel Lung Epithelial Stem Cell Population. | *32142655* 32142655 | ||
PMC7128675 78. The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future. | *32243808* 32243808 | ||
PMC7162012 79. AVCpred: an integrated web server for prediction and design of antiviral compounds. | *27490990* 27490990 | ||
PMC7161993 80. Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase. | *19031435* 19031435 | ||
PMC7162026 81. Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors. | *17722121* 17722121 | ||
PMC7162372 82. Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial. | *17806092* 17806092 | ||
PMC7156547 83. Ethical considerations in the allocation of critical care resources when capacity is overwhelmed. | *32223773* 32223773 | ||
PMC6797873 84. Vaccines for emerging pathogens: prospects for licensure. | *30972733* 30972733 | ||
PMC6468171 85. Emerging viruses and current strategies for vaccine intervention. | *30993690* 30993690 | ||
PMC3722928 86. Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome. | *23607598* 23607598 | ||
PMC7129333 87. First Atypical case of 2019 novel coronavirus in Yan'an, China. | *32087323* 32087323 | ||
PMC7162225 88. The value of flexible bronchoscopy in pulmonary infections of immunosuppressed children. | *31710418* 31710418 | ||
PMC7159285 89. Human immunodeficiency virus infection (HIV)-associated rheumatic manifestations in thepre- and post-HAART eras. | *32297034* 32297034 | ||
PMC7030942 90. Frontiers in antiviral therapy and immunotherapy. | *32099652* 32099652 | ||
PMC7134545 91. The Importance of Scientific Publications in Times of Pandemic Crisis. | *32294674* 32294674 | ||
PMC7162443 92. Pandemic palliative care: beyond ventilators and saving lives. | *32234725* 32234725 | ||
PMC7164858 93. Virtual special issue computers in human behavior technology enhanced distance learning should not forget how learning happens. | *32327879* 32327879 | ||
PMC7175448 94. IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome. | *32321563* 32321563 | ||
PMC7188034 95. Potential for Lung Recruitment and Ventilation-Perfusion Mismatch in Patients With the Acute Respiratory Distress Syndrome From Coronavirus Disease 2019. | *32317591* 32317591 | ||
PMC7113910 96. Host receptors: the key to establishing cells with broad viral tropism for vaccine production. | *32202955* 32202955 | ||
PMC7186104 97. Maintenance of Skill Proficiency for Emergency Skills With and Without Adjuncts Despite the Use of Level C Personal Protective Equipment. | *32351813* 32351813 | ||
PMC7195337 98. DNA vaccines: prime time is now. | *32259744* 32259744 | ||
PMC7162325 99. Biosafety: guidelines for working with pathogenic and infectious microorganisms. | *19412909* 19412909 | ||
PMC7162418 100. Overview of protein structural and functional folds. | *18429251* 18429251 | ||
PMC7174147 101. Type I interferon. | *32336557* 32336557 | ||
PMC7177079 102. The protective and pathogenic roles of CXCL17 in human health and disease: Potential in respiratory medicine. | *32345516* 32345516 | ||
103. Why Do Older Adults Taking Antidepressants Fall? | *31786145* 31786145 | ||
104. Invited Perspective on "A Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics on Time to Rehospitalization Within One Year of Discharge in Elderly Patients With Schizophrenia". | *31585691* 31585691 | ||
105. Musculoskeletal Ultrasonography to Diagnose Dislocated Shoulders: A Prospective Cohort. | *32111508* 32111508 | ||
106. The year of the nurse 2020: Let's celebrate psychiatric mental health nursing. | *32035582* 32035582 | ||
107. Lipofilling of the upper eyelid to treat paralytic lagophthalmos. | *32145955* 32145955 | ||
108. Empreinte carbone et cancer : l'heure de la green oncology ? | *32245606* 32245606 | ||
109. Immunotherapie et radiotherapie dans la prise en charge du cancer du sein : rationnel et synthese de la litterature sur les applications cliniques actuelles. | *32046913* 32046913 | ||
110. Margen de reseccion positivo tras la aplicacion de un examen estandarizado de la muestra de duodenopancreatectomia cefalica: inverted question marktiene un impacto real en la supervivencia a largo plazo? | *31784034* 31784034 | ||
111. On the mound with melanoma: The Jim Umbricht story. | *32197742* 32197742 | ||
112. Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn's Disease Likely to Achieve Endoscopic and Biochemical Remission. | *32109630* 32109630 | ||
361. Simple ideas to mitigate the impacts of the COVID-19 epidemic on refugees with chronic diseases. | *32391077* 32391077 | ||
362. Global Trends in Epidemiology of Coronavirus Disease 2019 (COVID-19). | *C7189403* C7189403 | ||
363. Clinical Characteristics and Differential Clinical Diagnosis of Novel Coronavirus Disease 2019 (COVID-19). | *C7189401* C7189401 | ||
364. Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection. | *C7189399* C7189399 | ||
365. Current Insight into the Novel Coronavirus Disease 2019 (COVID-19). | *C7189397* C7189397 | ||
366. Coping with Mental Health Challenges During COVID-19. | *C7189395* C7189395 | ||
367. Emergence and Reemergence of Severe Acute Respiratory Syndrome (SARS) Coronaviruses. | *C7189393* C7189393 | ||
368. Morphology Genome Organization Replication and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). | *C7189391* C7189391 | ||
369. Transmission Cycle of SARS-CoV and SARS-CoV-2. | *C7189389* C7189389 | ||
370. Laboratory Diagnosis of Novel Coronavirus Disease 2019 (COVID-19) Infection. | *C7189402* C7189402 | ||
371. Therapeutic Development and Drugs for the Treatment of COVID-19. | *C7189400* C7189400 | ||
372. Preparing for the Perpetual Challenges of Pandemics of Coronavirus Infections with Special Focus on SARS-CoV-2. | *C7189398* C7189398 | ||
373. Classical Coronaviruses. | *C7189396* C7189396 | ||
374. COVID-19: An Ophthalmological Update. | *C7189394* C7189394 | ||
375. Preparing Children for Pandemics. | *C7189392* C7189392 | ||
376. Coronavirus Infection Among Children and Adolescents. | *C7189390* C7189390 | ||
377. Prevention and Control Strategies for SARS-CoV-2 Infection. | *C7189388* C7189388 | ||
378. Intensive care for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a makeshift ICU in Wuhan. | *32375850* 32375850 | ||
379. Psychological stress of ICU nurses in the time of COVID-19. | *32375848* 32375848 | ||
380. Ethics guidelines on COVID-19 triage—an emerging international consensus. | *32375855* 32375855 | ||
381. Heating ventilation and air conditioning (HVAC) in intensive care unit. | *32375844* 32375844 | ||
382. Can computed tomography be a primary tool for COVID-19 detection? Evidence appraisal through meta-analysis. | *32375883* 32375883 | ||
383. Acute respiratory failure in COVID-19: is it “typical” ARDS? | *32375845* 32375845 | ||
384. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series. | *C7156900* C7156900 | ||
385. The model of epidemic (COVID-19) prevention and control in rural of China. | *C7155160* C7155160 | ||
386. How to transform a general hospital into an “infectious disease hospital” during the epidemic of COVID-19. | *C7155152* C7155152 | ||
387. Use of the Endoscopic Healing Index (EHI) for Monitoring of Disease Activity in Crohn’s Disease Patients in the COVID Era. | *C7197619* C7197619 | ||
388. The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients. | *32377636* 32377636 | ||
389. IBD in the Time of COVID19. | *C7184458* C7184458 | ||
390. Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease. | *32382463* 32382463 | ||
391. Closure of Universities Due to Coronavirus Disease 2019 (COVID-19): Impact on Education and Mental Health of Students and Academic Staff. | *32377489* 32377489 | ||
392. First Case of an Infant with COVID-19 in the Middle East. | *32377468* 32377468 | ||
393. To Tweet or Not to Tweet—a Review of the Viral Power of Twitter for Infectious Diseases. | *C7180651* C7180651 | ||
394. Innovations in structure-based antigen design and immune monitoring for next generation vaccines. | *32387642* 32387642 | ||
395. COVID-19 and Multi-Organ Response. | *32439197* 32439197 | ||
396. Association of Cardiovascular Disease with Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis. | *32402515* 32402515 | ||
397. Telemental Health in the Context of a Pandemic: the COVID-19 Experience. | *C7114953* C7114953 | ||
398. COVID-19: Pathogenesis cytokine storm and therapeutic potential of interferons. | *32418715* 32418715 | ||
399. Understanding novel COVID-19: its impact on organ failure and risk assessment for diabetic and cancer patients. | *32409230* 32409230 | ||
400. Cell-Based Therapies for COVID-19: Proper Clinical Investigations are Essential. | *C7163352* C7163352 | ||
401. Chaos game representation dataset of SARS-CoV-2 genome. | *32341946* 32341946 | ||
402. Three alternative ways to screen for hyperglycaemia in pregnancy during the COVID-19 pandemic. | *32387699* 32387699 | ||
403. A review of modern technologies for tackling COVID-19 pandemic. | *32413821* 32413821 | ||
404. Vitamin D concentrations and COVID-19 infection in UK Biobank. | *32413819* 32413819 | ||
405. Social isolation during Covid-19: Boon or bane to diabetes management. | *32413820* 32413820 | ||
406. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. | *32408118* 32408118 | ||
407. COVID-19 outbreak in Iraqi Kurdistan: The first report characterizing epidemiological clinical laboratory and radiological findings of the disease. | *32408119* 32408119 | ||
408. Internet of things (IoT) applications to fight against COVID-19 pandemic. | *32388333* 32388333 | ||
409. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects. | *32387864* 32387864 | ||
410. Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (COVID-19): A review. | *32388326* 32388326 | ||
411. COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone? | *32382358* 32382358 | ||
412. SARS-CoV-2 and gastrointestinal tract: the dark side of the pandemic. | *32423849* 32423849 | ||
413. Endoscopy during the Covid-19 outbreak: experience and recommendations from a single center in a high-incidence scenario. | *32386942* 32386942 | ||
414. ISDE guidance statement: management of upper gastrointestinal endoscopy and surgery in COVID-19 outbreak. | *C7197607* C7197607 | ||
415. COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus. | *32377559* 32377559 | ||
416. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment. | *32387262* 32387262 | ||
417. Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion. | *C7194243* C7194243 | ||
418. The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic. | *32383008* 32383008 | ||
419. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. | *C7171478* C7171478 | ||
420. Neuartiges Coronavirus (SARS-CoV-2). | *C7117074* C7117074 | ||
421. COVID-19 and potential global mortality - Revisited. | *32387001* 32387001 | ||
422. A glimpse into the eye of the COVID-19 cytokine storm. | *32388462* 32388462 | ||
423. Sedating ventilated COVID-19 patients with inhalational anesthetic drugs. | *32344199* 32344199 | ||
424. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. | *32361250* 32361250 | ||
425. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development. | *32344202* 32344202 | ||
426. Pandemic-related excess mortality (COVID-19) public health measures and funerary rituals. | *32377635* 32377635 | ||
427. Etymologia: Coronavirus. | *C7181939* C7181939 | ||
428. Emergent materials and industry 4.0 contribution toward pandemic diseases such as COVID-19. | *32382706* 32382706 | ||
361. Simple ideas to mitigate the impacts of the COVID-19 epidemic on refugees with chronic diseases. | *32391077* 32391077 | ||
362. Global Trends in Epidemiology of Coronavirus Disease 2019 (COVID-19). | *C7189403* C7189403 | ||
363. Clinical Characteristics and Differential Clinical Diagnosis of Novel Coronavirus Disease 2019 (COVID-19). | *C7189401* C7189401 | ||
364. Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection. | *C7189399* C7189399 | ||
365. Current Insight into the Novel Coronavirus Disease 2019 (COVID-19). | *C7189397* C7189397 | ||
366. Coping with Mental Health Challenges During COVID-19. | *C7189395* C7189395 | ||
367. Emergence and Reemergence of Severe Acute Respiratory Syndrome (SARS) Coronaviruses. | *C7189393* C7189393 | ||
368. Morphology Genome Organization Replication and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). | *C7189391* C7189391 | ||
369. Transmission Cycle of SARS-CoV and SARS-CoV-2. | *C7189389* C7189389 | ||
370. Laboratory Diagnosis of Novel Coronavirus Disease 2019 (COVID-19) Infection. | *C7189402* C7189402 | ||
371. Therapeutic Development and Drugs for the Treatment of COVID-19. | *C7189400* C7189400 | ||
372. Preparing for the Perpetual Challenges of Pandemics of Coronavirus Infections with Special Focus on SARS-CoV-2. | *C7189398* C7189398 | ||
373. Classical Coronaviruses. | *C7189396* C7189396 | ||
374. COVID-19: An Ophthalmological Update. | *C7189394* C7189394 | ||
375. Preparing Children for Pandemics. | *C7189392* C7189392 | ||
376. Coronavirus Infection Among Children and Adolescents. | *C7189390* C7189390 | ||
377. Prevention and Control Strategies for SARS-CoV-2 Infection. | *C7189388* C7189388 | ||
378. Intensive care for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a makeshift ICU in Wuhan. | *32375850* 32375850 | ||
379. Psychological stress of ICU nurses in the time of COVID-19. | *32375848* 32375848 | ||
380. Ethics guidelines on COVID-19 triage—an emerging international consensus. | *32375855* 32375855 | ||
381. Heating ventilation and air conditioning (HVAC) in intensive care unit. | *32375844* 32375844 | ||
382. Can computed tomography be a primary tool for COVID-19 detection? Evidence appraisal through meta-analysis. | *32375883* 32375883 | ||
383. Acute respiratory failure in COVID-19: is it “typical” ARDS? | *32375845* 32375845 | ||
384. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series. | *C7156900* C7156900 | ||
385. The model of epidemic (COVID-19) prevention and control in rural of China. | *C7155160* C7155160 | ||
386. How to transform a general hospital into an “infectious disease hospital” during the epidemic of COVID-19. | *C7155152* C7155152 | ||
387. Use of the Endoscopic Healing Index (EHI) for Monitoring of Disease Activity in Crohn’s Disease Patients in the COVID Era. | *C7197619* C7197619 | ||
388. The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients. | *32377636* 32377636 | ||
389. IBD in the Time of COVID19. | *C7184458* C7184458 | ||
390. Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease. | *32382463* 32382463 | ||
391. Closure of Universities Due to Coronavirus Disease 2019 (COVID-19): Impact on Education and Mental Health of Students and Academic Staff. | *32377489* 32377489 | ||
392. First Case of an Infant with COVID-19 in the Middle East. | *32377468* 32377468 | ||
393. To Tweet or Not to Tweet—a Review of the Viral Power of Twitter for Infectious Diseases. | *C7180651* C7180651 | ||
394. Innovations in structure-based antigen design and immune monitoring for next generation vaccines. | *32387642* 32387642 | ||
395. COVID-19 and Multi-Organ Response. | *32439197* 32439197 | ||
396. Association of Cardiovascular Disease with Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis. | *32402515* 32402515 | ||
397. Telemental Health in the Context of a Pandemic: the COVID-19 Experience. | *C7114953* C7114953 | ||
398. COVID-19: Pathogenesis cytokine storm and therapeutic potential of interferons. | *32418715* 32418715 | ||
399. Understanding novel COVID-19: its impact on organ failure and risk assessment for diabetic and cancer patients. | *32409230* 32409230 | ||
400. Cell-Based Therapies for COVID-19: Proper Clinical Investigations are Essential. | *C7163352* C7163352 | ||
401. Chaos game representation dataset of SARS-CoV-2 genome. | *32341946* 32341946 | ||
402. Three alternative ways to screen for hyperglycaemia in pregnancy during the COVID-19 pandemic. | *32387699* 32387699 | ||
403. A review of modern technologies for tackling COVID-19 pandemic. | *32413821* 32413821 | ||
404. Vitamin D concentrations and COVID-19 infection in UK Biobank. | *32413819* 32413819 | ||
405. Social isolation during Covid-19: Boon or bane to diabetes management. | *32413820* 32413820 | ||
406. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. | *32408118* 32408118 | ||
407. COVID-19 outbreak in Iraqi Kurdistan: The first report characterizing epidemiological clinical laboratory and radiological findings of the disease. | *32408119* 32408119 | ||
408. Internet of things (IoT) applications to fight against COVID-19 pandemic. | *32388333* 32388333 | ||
409. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects. | *32387864* 32387864 | ||
410. Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (COVID-19): A review. | *32388326* 32388326 | ||
411. COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone? | *32382358* 32382358 | ||
412. SARS-CoV-2 and gastrointestinal tract: the dark side of the pandemic. | *32423849* 32423849 | ||
413. Endoscopy during the Covid-19 outbreak: experience and recommendations from a single center in a high-incidence scenario. | *32386942* 32386942 | ||
414. ISDE guidance statement: management of upper gastrointestinal endoscopy and surgery in COVID-19 outbreak. | *C7197607* C7197607 | ||
415. COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus. | *32377559* 32377559 | ||
416. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment. | *32387262* 32387262 | ||
417. Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion. | *C7194243* C7194243 | ||
418. The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic. | *32383008* 32383008 | ||
419. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS. | *C7171478* C7171478 | ||
420. Neuartiges Coronavirus (SARS-CoV-2). | *C7117074* C7117074 | ||
421. COVID-19 and potential global mortality - Revisited. | *32387001* 32387001 | ||
422. A glimpse into the eye of the COVID-19 cytokine storm. | *32388462* 32388462 | ||
423. Sedating ventilated COVID-19 patients with inhalational anesthetic drugs. | *32344199* 32344199 | ||
424. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. | *32361250* 32361250 | ||
425. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development. | *32344202* 32344202 | ||
426. Pandemic-related excess mortality (COVID-19) public health measures and funerary rituals. | *32377635* 32377635 | ||
427. Etymologia: Coronavirus. | *C7181939* C7181939 | ||
428. Emergent materials and industry 4.0 contribution toward pandemic diseases such as COVID-19. | *32382706* 32382706 | ||
433. Informations relatives aux psychotropes et leurs adaptations éventuelles pour les patients souffrant de troubles psychiques en France pendant l’épidémie SARS-CoV-2. | *32376004* 32376004 | ||
434. N’oublions pas le moral des « troupes » ! La santé mentale des soignants et l’impact psychiatrique de la pandémie de covid-19. | *C7196409* C7196409 | ||
435. Repositionnement de la chlorpromazine dans le traitement du COVID-19: étude reCoVery. | *32387014* 32387014 | ||
436. A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System. | *C7118608* C7118608 | ||
437. Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID). | *C7102592* C7102592 | ||
438. COVID-19: The environmental implications of shedding SARS-CoV-2 in human faeces. | *32388248* 32388248 | ||
439. Airborne transmission of SARS-CoV-2: the world should face the reality. | *C7151430* C7151430 | ||
440. Visualising the expansion and spread of coronavirus disease 2019 by cartograms. | *C7140974* C7140974 | ||
441. Role of the chronic air pollution levels in the Covid-19 outbreak risk in Italy☆. | *32387671* 32387671 | ||
442. Disinfection technology of hospital wastes and wastewater: Suggestions for disinfection strategy during coronavirus Disease 2019 (COVID-19) pandemic in China. | *32443202* 32443202 | ||
443. First data analysis about possible COVID-19 virus airborne diffusion due to air particulate matter (PM): the case of Lombardy (Italy). | *C7204748* C7204748 | ||
444. Low ambient temperatures are associated with more rapid spread of COVID-19 in the early phase of the endemic. | *C7200345* C7200345 | ||
445. Decline in PM2.5 Concentrations over Major Cities Around the World Associated with COVID-19. | *32416359* 32416359 | ||
446. The Environmental Impacts of the Coronavirus. | *32382212* 32382212 | ||
447. Distinctive Cellular Response to Aluminum Based Adjuvants. | *32388105* 32388105 | ||
448. Optimizing status Epilepticus care during the COVID-19 pandemic. | *32387833* 32387833 | ||
449. Covid-19 et quelques problématiques éthiques en France. | *C7128296* C7128296 | ||
450. COVID-19 and rhinology from the consultation room to the operating theatre. | *32387072* 32387072 | ||
451. Nasal pharyngeal and laryngeal endoscopy procedures during COVID-19 pandemic: available recommendations from national and international societies. | *32377857* 32377857 | ||
452. SARS-COV-2 infection in cancer patients undergoing checkpoint blockade: clinical course and outcome. | *32388171* 32388171 | ||
453. The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan Lombardy Region. | *32380430* 32380430 | ||
454. Reorganization of Medical Oncology Departments during COVID-19 Pandemic: a Nationwide Italian Survey. | *C7136865* C7136865 | ||
455. COVID‐19: Lessons from SARS and MERS. | *C7163482* C7163482 | ||
456. Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19. | *C7129866* C7129866 | ||
457. Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern? | *32414639* 32414639 | ||
458. Reorganizing Italian Internal Medicine wards for COVID 19. | *32381324* 32381324 | ||
459. Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury. | *32381323* 32381323 | ||
460. Is low sodium intake a risk factor for severe and fatal COVID-19 infection? | *C7141546* C7141546 | ||
461. Tracheobronchitis signs observed on ventilation lung scintigraphy during the course of COVID-19 infection. | *32378021* 32378021 | ||
462. Re: Novel Coronavirus COVID-19 in late pregnancy: outcomes of first nine cases in an inner city London hospital. | *32402627* 32402627 | ||
463. How to reduce the potential risk of vertical transmission of SARS-CoV-2 during vaginal delivery? | *32418711* 32418711 | ||
464. Plastic surgery during the COVID-19 pandemic times. | *32382214* 32382214 | ||
465. Deep learning-based multi-view fusion model for screening 2019 novel coronavirus pneumonia: a multicentre study. | *32408222* 32408222 | ||
466. Early CT features and temporal lung changes in COVID-19 pneumonia in Wuhan China. | *32387924* 32387924 | ||
467. Taming COVID-19 by Regulation: An Opportunity for Self-Reflection. | *C7200841* C7200841 | ||
468. The COVID-19 Threat: An Opportunity to Rethink the European Economic Constitution and European Private Law. | *C7198464* C7198464 | ||
469. How Risk Perceptions Not Evidence Have Driven Harmful Policies on COVID-19. | *C7200839* C7200839 | ||
470. From Diversity to Coordination: A European Approach to COVID-19. | *C7203166* C7203166 | ||
471. More Competences than You Knew? The Web of Health Competence for European Union Action in Response to the COVID-19 Outbreak. | *C7188958* C7188958 | ||
472. COVID-19 Patents and the Never-Ending Tension between Proprietary Rights and the Protection of Public Health. | *C7156563* C7156563 | ||
473. Towards Stronger EU Governance of Health Threats after the COVID-19 Pandemic. | *C7174850* C7174850 | ||
474. Will COVID-19 Mark the End of an Egalitarian National Health Service? | *C7170808* C7170808 | ||
475. Coronavirus-Infected International Business Transactions: A Preliminary Diagnosis. | *C7160163* C7160163 | ||
476. The COVID-19 Pandemic and International Trade: Temporary Turbulence or Paradigm Shift? | *C7174848* C7174848 | ||
477. A Critical Appraisal of the World Health Organization’s International Health Regulations (2005) in Times of Pandemic: It Is Time for Revision. | *C7170810* C7170810 | ||
478. Reimagining the Administrative State in Times of Global Health Crisis: An Anatomy of Taiwan’s Regulatory Actions in Response to the COVID-19 Pandemic. | *C7156569* C7156569 | ||
479. The UK COVID-19 Response: A Behavioural Irony? | *C7201134* C7201134 | ||
480. State Liability for Failure to Control the COVID-19 Epidemic: International and Dutch Law. | *C7156574* C7156574 | ||
481. COVID-19 and cancer: Looking for evidence. | *32389523* 32389523 | ||
482. How technology can help in oncologic patient management during COVID-19 outbreak. | *32389524* 32389524 | ||
483. COVID-19 infection in patients following hepato-pancreatico-biliary intervention: An early experience. | *32389521* 32389521 | ||
484. Clinical Course Imaging Features and Outcomes of COVID-19 in Kidney Transplant Recipients. | *32409114* 32409114 | ||
485. Expression of ACE2 the SARS-CoV-2 Receptor and TMPRSS2 in Prostate Epithelial Cells. | *32418620* 32418620 | ||
486. Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic. | *32414626* 32414626 | ||
487. The Impact of COVID-19 on European Health Care and Urology Trainees. | *32376133* 32376133 | ||
488. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era☆. | *32376137* 32376137 | ||
489. Impact of COVID-19 on Urologists: Learning on the Go. | *32389498* 32389498 | ||
490. Preliminary design of an innovative simple and easy-to-build portable ventilator for COVID-19 patients. | *32391413* 32391413 | ||
491. FERRET BEHAVIOR. | *C7158301* C7158301 | ||
492. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. | *32382146* 32382146 | ||
493. Surgeon’s protection during ophthalmic surgery in the Covid-19 era: a novel fitted drape for ophthalmic operating microscopes. | *32382141* 32382141 | ||
494. Impact of the COVID-19 lockdown on basic science research in ophthalmology: the experience of a highly specialized research facility in France. | *32382143* 32382143 | ||
495. Changing trends of ocular trauma in the time of COVID-19 pandemic. | *32376977* 32376977 | ||
496. Epidemics and primary care in the UK. | *32377324* 32377324 | ||
497. Coronavirus disease 2019 and men’s reproductive health. | *32387274* 32387274 | ||
498. No evidence of severe acute respiratory syndrome–coronavirus 2 in semen of males recovering from coronavirus disease 2019. | *C7164916* C7164916 | ||
499. Forensic medicine in the time of COVID 19: An Editorial from Milano Italy. | *32387870* 32387870 | ||
500. Drug repurposing strategies for COVID-19. | *C7117595* C7117595 | ||
501. Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2. | *C7175784* C7175784 | ||
502. SARS-CoV-2 Testing Prevalence and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California. | *32387541* 32387541 | ||
503. How To Maximize Trainee Education During the COVID-19 Pandemic: Perspectives from Around the World. | *32387540* 32387540 | ||
504. Taste Changes (Dysgeusia) in COVID-19: A systematic review and metaanalysis. | *32387496* 32387496 | ||
433. Informations relatives aux psychotropes et leurs adaptations éventuelles pour les patients souffrant de troubles psychiques en France pendant l’épidémie SARS-CoV-2. | *32376004* 32376004 | ||
434. N’oublions pas le moral des « troupes » ! La santé mentale des soignants et l’impact psychiatrique de la pandémie de covid-19. | *C7196409* C7196409 | ||
435. Repositionnement de la chlorpromazine dans le traitement du COVID-19: étude reCoVery. | *32387014* 32387014 | ||
436. A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System. | *C7118608* C7118608 | ||
437. Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID). | *C7102592* C7102592 | ||
438. COVID-19: The environmental implications of shedding SARS-CoV-2 in human faeces. | *32388248* 32388248 | ||
439. Airborne transmission of SARS-CoV-2: the world should face the reality. | *C7151430* C7151430 | ||
440. Visualising the expansion and spread of coronavirus disease 2019 by cartograms. | *C7140974* C7140974 | ||
441. Role of the chronic air pollution levels in the Covid-19 outbreak risk in Italy☆. | *32387671* 32387671 | ||
442. Disinfection technology of hospital wastes and wastewater: Suggestions for disinfection strategy during coronavirus Disease 2019 (COVID-19) pandemic in China. | *32443202* 32443202 | ||
443. First data analysis about possible COVID-19 virus airborne diffusion due to air particulate matter (PM): the case of Lombardy (Italy). | *C7204748* C7204748 | ||
444. Low ambient temperatures are associated with more rapid spread of COVID-19 in the early phase of the endemic. | *C7200345* C7200345 | ||
445. Decline in PM2.5 Concentrations over Major Cities Around the World Associated with COVID-19. | *32416359* 32416359 | ||
446. The Environmental Impacts of the Coronavirus. | *32382212* 32382212 | ||
447. Distinctive Cellular Response to Aluminum Based Adjuvants. | *32388105* 32388105 | ||
448. Optimizing status Epilepticus care during the COVID-19 pandemic. | *32387833* 32387833 | ||
449. Covid-19 et quelques problématiques éthiques en France. | *C7128296* C7128296 | ||
450. COVID-19 and rhinology from the consultation room to the operating theatre. | *32387072* 32387072 | ||
451. Nasal pharyngeal and laryngeal endoscopy procedures during COVID-19 pandemic: available recommendations from national and international societies. | *32377857* 32377857 | ||
452. SARS-COV-2 infection in cancer patients undergoing checkpoint blockade: clinical course and outcome. | *32388171* 32388171 | ||
453. The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan Lombardy Region. | *32380430* 32380430 | ||
454. Reorganization of Medical Oncology Departments during COVID-19 Pandemic: a Nationwide Italian Survey. | *C7136865* C7136865 | ||
455. COVID‐19: Lessons from SARS and MERS. | *C7163482* C7163482 | ||
456. Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19. | *C7129866* C7129866 | ||
457. Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern? | *32414639* 32414639 | ||
458. Reorganizing Italian Internal Medicine wards for COVID 19. | *32381324* 32381324 | ||
459. Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury. | *32381323* 32381323 | ||
460. Is low sodium intake a risk factor for severe and fatal COVID-19 infection? | *C7141546* C7141546 | ||
461. Tracheobronchitis signs observed on ventilation lung scintigraphy during the course of COVID-19 infection. | *32378021* 32378021 | ||
462. Re: Novel Coronavirus COVID-19 in late pregnancy: outcomes of first nine cases in an inner city London hospital. | *32402627* 32402627 | ||
463. How to reduce the potential risk of vertical transmission of SARS-CoV-2 during vaginal delivery? | *32418711* 32418711 | ||
464. Plastic surgery during the COVID-19 pandemic times. | *32382214* 32382214 | ||
465. Deep learning-based multi-view fusion model for screening 2019 novel coronavirus pneumonia: a multicentre study. | *32408222* 32408222 | ||
466. Early CT features and temporal lung changes in COVID-19 pneumonia in Wuhan China. | *32387924* 32387924 | ||
467. Taming COVID-19 by Regulation: An Opportunity for Self-Reflection. | *C7200841* C7200841 | ||
468. The COVID-19 Threat: An Opportunity to Rethink the European Economic Constitution and European Private Law. | *C7198464* C7198464 | ||
469. How Risk Perceptions Not Evidence Have Driven Harmful Policies on COVID-19. | *C7200839* C7200839 | ||
470. From Diversity to Coordination: A European Approach to COVID-19. | *C7203166* C7203166 | ||
471. More Competences than You Knew? The Web of Health Competence for European Union Action in Response to the COVID-19 Outbreak. | *C7188958* C7188958 | ||
472. COVID-19 Patents and the Never-Ending Tension between Proprietary Rights and the Protection of Public Health. | *C7156563* C7156563 | ||
473. Towards Stronger EU Governance of Health Threats after the COVID-19 Pandemic. | *C7174850* C7174850 | ||
474. Will COVID-19 Mark the End of an Egalitarian National Health Service? | *C7170808* C7170808 | ||
475. Coronavirus-Infected International Business Transactions: A Preliminary Diagnosis. | *C7160163* C7160163 | ||
476. The COVID-19 Pandemic and International Trade: Temporary Turbulence or Paradigm Shift? | *C7174848* C7174848 | ||
477. A Critical Appraisal of the World Health Organization’s International Health Regulations (2005) in Times of Pandemic: It Is Time for Revision. | *C7170810* C7170810 | ||
478. Reimagining the Administrative State in Times of Global Health Crisis: An Anatomy of Taiwan’s Regulatory Actions in Response to the COVID-19 Pandemic. | *C7156569* C7156569 | ||
479. The UK COVID-19 Response: A Behavioural Irony? | *C7201134* C7201134 | ||
480. State Liability for Failure to Control the COVID-19 Epidemic: International and Dutch Law. | *C7156574* C7156574 | ||
481. COVID-19 and cancer: Looking for evidence. | *32389523* 32389523 | ||
482. How technology can help in oncologic patient management during COVID-19 outbreak. | *32389524* 32389524 | ||
483. COVID-19 infection in patients following hepato-pancreatico-biliary intervention: An early experience. | *32389521* 32389521 | ||
484. Clinical Course Imaging Features and Outcomes of COVID-19 in Kidney Transplant Recipients. | *32409114* 32409114 | ||
485. Expression of ACE2 the SARS-CoV-2 Receptor and TMPRSS2 in Prostate Epithelial Cells. | *32418620* 32418620 | ||
486. Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic. | *32414626* 32414626 | ||
487. The Impact of COVID-19 on European Health Care and Urology Trainees. | *32376133* 32376133 | ||
488. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era☆. | *32376137* 32376137 | ||
489. Impact of COVID-19 on Urologists: Learning on the Go. | *32389498* 32389498 | ||
490. Preliminary design of an innovative simple and easy-to-build portable ventilator for COVID-19 patients. | *32391413* 32391413 | ||
491. FERRET BEHAVIOR. | *C7158301* C7158301 | ||
492. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. | *32382146* 32382146 | ||
493. Surgeon’s protection during ophthalmic surgery in the Covid-19 era: a novel fitted drape for ophthalmic operating microscopes. | *32382141* 32382141 | ||
494. Impact of the COVID-19 lockdown on basic science research in ophthalmology: the experience of a highly specialized research facility in France. | *32382143* 32382143 | ||
495. Changing trends of ocular trauma in the time of COVID-19 pandemic. | *32376977* 32376977 | ||
496. Epidemics and primary care in the UK. | *32377324* 32377324 | ||
497. Coronavirus disease 2019 and men’s reproductive health. | *32387274* 32387274 | ||
498. No evidence of severe acute respiratory syndrome–coronavirus 2 in semen of males recovering from coronavirus disease 2019. | *C7164916* C7164916 | ||
499. Forensic medicine in the time of COVID 19: An Editorial from Milano Italy. | *32387870* 32387870 | ||
500. Drug repurposing strategies for COVID-19. | *C7117595* C7117595 | ||
501. Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2. | *C7175784* C7175784 | ||
502. SARS-CoV-2 Testing Prevalence and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California. | *32387541* 32387541 | ||
503. How To Maximize Trainee Education During the COVID-19 Pandemic: Perspectives from Around the World. | *32387540* 32387540 | ||
504. Taste Changes (Dysgeusia) in COVID-19: A systematic review and metaanalysis. | *32387496* 32387496 | ||
PMC7142273 113. Forty Years of Basic and Translational Heparanase Research. | *32274705* 32274705 | ||
PMC7169897 114. Exosomes as Sentinels against Bacterial Pathogens. | *32315610* 32315610 | ||
115. Adapting a GI Fellowship to a Pandemic: Novel Approaches to Accommodating a Novel Virus. | *32356258* 32356258 | ||
PMC7198465 116. Allocation of Scarce Resources in a Pandemic: A Systematic Review of US State Crisis Standards of Care Documents. | *32295662* 32295662 | ||
PMC7194552 117. Chemical evolution for taming the 'pathogenic kinase' PAK1. | *32348877* 32348877 | ||
PMC7196428 118. Corona crisis fuels racially profiled hate in social media networks. | *32368725* 32368725 | ||
PMC7046497 119. Emerging zoonoses: A one health challenge. | *32140676* 32140676 | ||
PMC7195113 120. The Italian war-like measures to fight coronavirus spreading: Re-open closed hospitals now. | *32373783* 32373783 | ||
PMC7088356 121. Synergistic China-US Ecological Research is Essential for Global Emerging Infectious Disease Preparedness. | *32016718* 32016718 | ||
PMC5014217 122. Network analysis of host-virus communities in bats and rodents reveals determinants of cross-species transmission. | *26299267* 26299267 | ||
PMC7158772 123. Coronavirus outbreak is a symptom of Gaia's sickness. | *32296258* 32296258 | ||
PMC6463209 124. Slicing and dicing viruses: antiviral RNA interference in mammals. | *30872283* 30872283 | ||
PMC7132176 125. Travelling to scientific meetings is a mission, not a vacation. | *32216085* 32216085 | ||
PMC3371787 126. SARS vaccine development. | *16022774* 16022774 | ||
PMC7128783 127. Animal Disease Control: Challenges and Perspectives. | *32288964* 32288964 | ||
PMC7153525 128. Reuse of N95 Masks. | *32292629* 32292629 | ||
PMC7118525 129. Preventing bat-born viral outbreaks in future using ecological interventions. | *32247155* 32247155 | ||
PMC7187803 130. Climatic changes and their role in emergence and re-emergence of diseases. | *32347486* 32347486 | ||
PMC7183819 131. A research on urban eco-security evaluation and analysis: complex system's brittle structure model. | *32337677* 32337677 | ||
PMC7099656 132. Environmental Engineers and Scientists Have Important Roles to Play in Stemming Outbreaks and Pandemics Caused by Enveloped Viruses. | *32207922* 32207922 | ||
PMC7026896 133. SARS to novel coronavirus - old lessons and new lessons. | *32019614* 32019614 | ||
PMC2870165 134. Factors associated with transmission of severe acute respiratory syndrome among health-care workers in Singapore. | *15473141* 15473141 | ||
PMC7188619 135. Novel Coronavirus disease 2019 (COVID-19) outbreak in Nigeria: how effective are government interventions? | *32352023* 32352023 | ||
PMC7189629 136. Moglichkeiten und Grenzen von Ethikberatung im Rahmen der COVID-19-Pandemie (Stand: 31.03.2020): Ein Diskussionspapier der Akademie fur Ethik in der Medizin. | *32351259* 32351259 | ||
PMC7196316 137. Digital technology in psychiatry: towards the implementation of a true person-centered care in psychiatry? | *32363502* 32363502 | ||
PMC7176573 138. The shortage of skilled workers in Europe: its impact on geriatric medicine. | *32328964* 32328964 | ||
PMC7197551 139. Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement. | *32363406* 32363406 | ||
PMC7188134 140. Immune-mediated mechanism in coronavirus fulminant myocarditis. | *32320031* 32320031 | ||
PMC7197536 141. Clinically suspected myocarditis in the course of coronavirus infection. | *32338758* 32338758 | ||
PMC7197537 142. Twitter-based learning for continuing medical education? | *32338736* 32338736 | ||
PMC7184997 143. Patients with cancer in the era of 2019 novel coronavirus disease. | *32353785* 32353785 | ||
PMC7165280 144. Cancer and coronavirus disease 2019; how do we manage cancer optimally through a public health crisis? | *32335477* 32335477 | ||
PMC7163529 145. Coronavirus disease 2019: The harms of exaggerated information and non-evidence-based measures. | *32191341* 32191341 | ||
PMC7163530 146. Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T-cell activation, differentiation and repertoire. | *27925643* 27925643 | ||
PMC7163762 147. Issues in vaccinology: Present challenges and future directions. | *28861908* 28861908 | ||
PMC7079932 148. Imaging features of 2019 novel coronavirus pneumonia. | *32060619* 32060619 | ||
PMC7180636 149. No time like the present: time to re-think our habits in science and continuous medical education? | *32333069* 32333069 | ||
PMC7152692 150. Radioaerosols and the updated EANM guideline in ventilation/perfusion imaging. | *32285154* 32285154 | ||
PMC7194586 151. Fabricated data - should we quarantine? A novel tool for risk assessment is proposed. | *32307205* 32307205 | ||
PMC7173674 152. Short-term outcomes of COVID-19 and risk factors for progression. | *32312863* 32312863 | ||
PMC7163694 153. Cancer in the time of COVID-19: expert opinion on how to adapt current practice. | *32299866* 32299866 | ||
PMC7113798 154. Will children reveal their secret? The coronavirus dilemma. | *32241833* 32241833 | ||
PMC7098484 155. Strategies for the prevention and management of coronavirus disease 2019. | *32217658* 32217658 | ||
PMC7098481 156. High-resolution computed tomography features of 17 cases of coronavirus disease 2019 in Sichuan province, China. | *32139463* 32139463 | ||
PMC7172651 157. Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat? | *32349935* 32349935 | ||
PMC7161482 158. Role of the Urologist During a Pandemic: Early Experience in Practicing on the Front Lines in Brooklyn, New York. | *32345525* 32345525 | ||
PMC7028117 159. The importance of caveolins and caveolae to dermatology: Lessons from the caves and beyond. | *31845391* 31845391 | ||
PMC7157950 160. Dioscin alleviates lipopolysaccharide-induced acute lung injury through suppression of TLR4 signaling pathways. | *31931639* 31931639 | ||
PMC7103689 161. Antiviral applications of RNAi for coronavirus. | *16433589* 16433589 | ||
PMC7197359 162. Diabetic retinopathy screening during the coronavirus disease 2019 pandemic. | *32367007* 32367007 | ||
PMC7091733 163. Revisiting the dangers of the coronavirus in the ophthalmology practice. | *32029919* 32029919 | ||
PMC7189179 164. Why ophthalmologists should mask: a perspective from Hong Kong. | *32350448* 32350448 | ||
PMC7186940 165. Coronavirus disease 2019 presenting with conjunctivitis as the first symptom. | *32346108* 32346108 | ||
PMC7103835 166. Contributions and challenges of general practitioners in China fighting against the novel coronavirus crisis. | *32257058* 32257058 | ||
PMC7046369 167. Challenges and responsibilities of family doctors in the new global coronavirus outbreak. | *32148740* 32148740 | ||
PMC7164057 168. Toward development of generic inhibitors against the 3C proteases of picornaviruses. | *30461192* 30461192 | ||
PMC7173641 169. The Return of the Plague: A Primer on Pandemic Ethics. | *32322145* 32322145 | ||
PMC7190074 170. Bacterial insertion sequences: their genomic impact and diversity. | *24499397* 24499397 | ||
PMC7010805 171. Specific Integration of Temperate Phage Decreases the Pathogenicity of Host Bacteria. | *32117795* 32117795 | ||
PMC7154102 172. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools. | *32318055* 32318055 | ||
PMC7093566 173. Grand Challenge in Human/Animal Virology: Unseen, Smallest Replicative Entities Shape the Whole Globe. | *32256480* 32256480 | ||
PMC7180189 174. Editorial: New Advances in RNA Targeting. | *32362826* 32362826 | ||
PMC7149807 175. Frequency of diarrhea in novel coronavirus 2019 infection. | *32308941* 32308941 | ||
PMC7181100 176. COVID-19 Pandemie und Gastroenterologie: Update. | *32341714* 32341714 | ||
PMC7167531 177. Open data in a deeply connected world. | *32312304* 32312304 | ||
PMC7165607 178. Governing Towards 'One Health': Establishing Knowledge Integration in Global Health Security Governance. | *32336994* 32336994 | ||
PMC7194026 179. Understanding China's growing involvement in global health and managing processes of change. | *32357894* 32357894 | ||
PMC7157944 180. Severe acute respiratory syndrome coronavirus 19 and human pregnancy. | *32270743* 32270743 | ||
PMC7201193 181. Preparing for uncertainty during public health emergencies: What Canadian health leaders can do now to optimize future emergency response. | *32228317* 32228317 | ||
PMC7168569 182. The Elabela-APJ axis: a promising therapeutic target for heart failure. | *32314083* 32314083 | ||
PMC7174538 183. Erhohtes Risiko bei COVID-19: Alter, Vorerkrankung, Demenz. | *32336767* 32336767 | ||
PMC7174537 184. Corona, COVID-19, SARS-CoV-2. | *32336766* 32336766 | ||
PMC7174545 185. Der Weg des Virus. | *32336765* 32336765 | ||
PMC7128154 186. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. | *32284281* 32284281 | ||
PMC7137405 187. Covid -19 in der Praxis. | *32287651* 32287651 | ||
PMC3927231 188. Antiviral T-cell therapy. | *24517423* 24517423 | ||
PMC7179770 189. The 2019 novel corona virus outbreak - An institutional guideline. | *32346175* 32346175 | ||
PMC7179063 190. All eyes on Coronavirus-What do we need to know as ophthalmologists. | *32174565* 32174565 | ||
PMC7074432 191. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach. | *32201439* 32201439 | ||
PMC7192658 192. Deja Vu: Surgery and SARS. | *32367911* 32367911 | ||
PMC7179065 193. Can imaging impact the coronavirus pandemic? | *32341629* 32341629 | ||
PMC7165818 194. Routes of transmission of influenza A H1N1, SARS CoV, and norovirus in air cabin: Comparative analyses. | *29244221* 29244221 | ||
PMC7165531 195. Emission strength of airborne pathogens during toilet flushing. | *28683156* 28683156 | ||
PMC7165847 196. Indoor bioaerosol dynamics. | *25483392* 25483392 | ||
PMC7137531 197. A potential protective role of losartan against coronavirus-induced lung damage. | *32248854* 32248854 | ||
PMC7156575 198. Artificial intelligence plays an important role in containing public health emergencies. | *32238219* 32238219 | ||
PMC7203170 199. Immediate-use steam sterilization sterilizes N95 masks without mask damage. | *32299520* 32299520 | ||
PMC7198467 200. Pasteurized blood samples for transfusion compatibility testing during the coronavirus disease 2019 outbreak. | *32297850* 32297850 | ||
PMC7180330 201. The largest epicenter of the coronavirus outbreak in Vietnam. | *32279697* 32279697 | ||
PMC7170723 202. What did we learn from preparing for cross-border transmission of Ebola virus disease into a complex humanitarian setting - The Republic of South Sudan? | *32312320* 32312320 | ||
PMC7106233 203. Pathogenic viruses: Molecular detection and characterization. | *32006706* 32006706 | ||
PMC6800307 204. Improving immunological insights into the ferret model of human viral infectious disease. | *31583825* 31583825 | ||
PMC7152898 205. Blocking drug-induced autophagy with chloroquine in HCT-116 colon cancer cells enhances DC maturation and T cell responses induced by tumor cell lysate. | *32298965* 32298965 | ||
PMC7102644 206. Viroporins and inflammasomes: A key to understand virus-induced inflammation. | *32156572* 32156572 | ||
PMC7037444 207. Does Wuhan Need to be in Lockdown during the Chinese Lunar New Year? | *32033382* 32033382 | ||
PMC7037295 208. Public Opinion Polarization by Individual Revenue from the Social Preference Theory. | *32033012* 32033012 | ||
PMC7128205 209. Discovery and development of safe-in-man broad-spectrum antiviral agents. | *32081774* 32081774 | ||
PMC7151455 210. Editorial: Studying the effects of the coronavirus pandemic on intercultural relations. | *32300260* 32300260 | ||
PMC3233444 211. Applications of next-generation sequencing technologies to diagnostic virology. | *22174638* 22174638 | ||
PMC7168550 212. A novel way to numerically characterize DNA sequences and its application. | *32327765* 32327765 | ||
PMC7138192 213. Revenge lawsuit is a puzzle piece of the global crisis of Italian healthcare system. | *32222571* 32222571 | ||
214. Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey. | *32122771* 32122771 | ||
215. Anatomo-radiological study supporting the use of ipsilateral nasoseptal flap for the transpterygoid management of temporo-sphenoidal meningoceles. A review of 21 cases. | *31631054* 31631054 | ||
216. Nonspecific intraventricular conduction delay is associated with future occurrence of atrial fibrillation in patients with structurally normal heart. | *31735548* 31735548 | ||
217. The challenge of implementing Less is More medicine: A European perspective. | *32303454* 32303454 | ||
218. Beyond anticoagulant therapy. The not benign impact of atrial fibrillation on patients' outcomes in a real world 'scenario'. | *32192858* 32192858 | ||
219. What is the value of pre-surgical variables in addition to cone dimensions in predicting cone margin status? | *31812841* 31812841 | ||
220. Frozen-thawed embryo transfer: the potential importance of the corpus luteum in preventing obstetrical complications. | *32106972* 32106972 | ||
221. Interpreting Reported Risks Associated With Use of Proton Pump Inhibitors: Residual Confounding in a 10-Year Analysis of National Ambulatory Data. | *31678304* 31678304 | ||
222. Febrile Temperature Critically Controls the Differentiation and Pathogenicity of T Helper 17 Cells. | *32049050* 32049050 | ||
223. Protocol for direct reporting of awareness in maternity patients (DREAMY): a prospective, multicentre cohort study of accidental awareness during general anaesthesia. | *32139144* 32139144 | ||
224. Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the Delivery of Postoperative Radiation Therapy in Complex Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN). | *32289475* 32289475 | ||
505. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study. | *32376408* 32376408 | ||
506. Psychological symptoms among frontline healthcare workers during COVID-19 outbreak in Wuhan. | *32381270* 32381270 | ||
507. Evolution of SARS Coronavirus and the Relevance of Modern Molecular Epidemiology. Genetics and Evolution of Infectious Disease 2011; (): 711-28 | *C7149542* C7149542 | ||
508. COVID‐19 Presents High Risk to Older Persons. | *C7128941* C7128941 | ||
509. Global Health – emergence hegemonic trends and biomedical reductionism. | *32375801* 32375801 | ||
510. Globalization and health scholarship in a time of pandemic: from critical past to uncertain future. | *C7157828* C7157828 | ||
511. Infektionsschutzrecht nach Inkrafttreten des Masernschutzgesetzes. | *32382165* 32382165 | ||
512. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak. | *32376043* 32376043 | ||
513. Coronavirus concerns: What do women with gynecologic cancer need to know during the COVID-19 crisis? | *32402631* 32402631 | ||
514. Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis☆. | *32386911* 32386911 | ||
515. COVID-19: Initial experience of hand surgeons in Northern Italy. | *32376511* 32376511 | ||
516. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. | *32375887* 32375887 | ||
517. A review of cardiac manifestations and predictors of outcome in patients with COVID – 19. | *C7196397* C7196397 | ||
518. Rural and Remote Cardiology During the COVID-19 Pandemic: Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement#. | *C7203036* C7203036 | ||
519. Consensus Guidelines for Interventional Cardiology Services Delivery During COVID-19 Pandemic in Australia and New Zealand. | *32471696* 32471696 | ||
520. Patients with Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement. | *32418874* 32418874 | ||
521. ENHANCED ECG MONITORING OF COVID-19 PATIENTS. | *32387247* 32387247 | ||
522. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. | *32387246* 32387246 | ||
523. Chloroquine-induced torsade de pointes in a COVID-19 patient. | *32380291* 32380291 | ||
524. Genetic Susceptibility for COVID-19-Associated Sudden Cardiac Death in African Americans. | *32380288* 32380288 | ||
525. COVID and hematology: special considerations regarding patient safety gold standard therapies and safety for health care professionals☆. | *32292885* 32292885 | ||
526. BLOQUEANTES DEL SISTEMA RENINA-ANGIOTENSINA E INFECCIÓN POR COVID-19. | *32448641* 32448641 | ||
527. Guillain-Barré Syndrome associated with SARS-CoV-2 infection. | *32313807* 32313807 | ||
528. Emerging Infectious Diseases of Immigrant Patients. | *C7170192* C7170192 | ||
529. Immunology of COVID-19: current state of the science. | *C7200337* C7200337 | ||
530. GTS-21 an α7nAChR agonist suppressed the production of key inflammatory mediators by PBMCs that are elevated in COPD patients and associated with impaired lung function. | *32387130* 32387130 | ||
531. Ventricular Arrhythmia Risk Due to Chloroquine / Hydroxychloroquine Treatment For COVID-19: should it be given. | *C7184982* C7184982 | ||
532. Coronavirus disease 2019 and the cardiovascular system: Impacts and implications. | *32423554* 32423554 | ||
533. Significant Applications of Big Data in COVID-19 Pandemic. | *32382166* 32382166 | ||
534. Initial Observations with Molecular Testing for COVID-19 in a Private Hospital in Mumbai India. | *32378133* 32378133 | ||
535. COVID-19 (SARS-CoV-2 Infection) and Children: Pediatric Neurologist’s Perspective. | *32378132* 32378132 | ||
536. Recommendations for Surgery During the Novel Coronavirus (COVID-19) Epidemic. | *C7150607* C7150607 | ||
537. Guiding Principles for Cancer Surgery during the COVID-19 Pandemic. | *32382219* 32382219 | ||
538. IASO COVID-19 Guidelines (Updated on 9th April 2020). | *32382218* 32382218 | ||
539. Tuberculosis and novel Wuhan coronavirus infection: Pathological interrelationship. | *C7130142* C7130142 | ||
540. Preparation and Response to COVID-19 outbreak in Singapore: A Case Report. | *32402779* 32402779 | ||
541. Propagation analysis and prediction of the COVID-19. | *C7118312* C7118312 | ||
542. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. | *32387564* 32387564 | ||
543. Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses. | *32387562* 32387562 | ||
544. Acute gastroenteritis viruses. | *C7173416* C7173416 | ||
545. Trauma service reorganization in Bologna (Italy) during COVID-19 pandemic. | *32386838* 32386838 | ||
546. Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin. | *32389720* 32389720 | ||
547. Tocilizumab in COVID-19: beware of risk of intestinal perforation. | *32389721* 32389721 | ||
548. Chloroquine as prophylactic agent against COVID-19? | *C7152897* C7152897 | ||
549. Lockdown—the only solution to defeat COVID-19. | *32377056* 32377056 | ||
550. The challenges facing indigenous communities in Latin America as they confront the COVID-19 pandemic. | *32381022* 32381022 | ||
551. From SARS to COVID-19: What we have learned about children infected with COVID-19. | *32389849* 32389849 | ||
552. COVID-19 and Religious Congregations: Implications for Spread of Novel Pathogens. | *32389851* 32389851 | ||
553. Characteristics of respiratory virus infection during the outbreak of 2019 novel coronavirus in Beijing. | *32389850* 32389850 | ||
554. Covid-19 health crisis management in Europe: decisive assessment is needed now. | *32389852* 32389852 | ||
555. Urgent need for evaluating agonists of Angiotensin-(1-7)/ Mas receptor axis for treatment of patients with COVID-19. | *32389847* 32389847 | ||
556. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients. | *32376309* 32376309 | ||
557. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. | *32376308* 32376308 | ||
558. Emergency mental health legislation in response to the Covid-19 (Coronavirus) pandemic in Ireland: Urgency necessity and proportionality. | *C7174175* C7174175 | ||
559. Safety management of nasopharyngeal specimen collection from suspected cases of coronavirus disease 2019☆. | *C7129371* C7129371 | ||
560. Holistic care for patients with severe coronavirus disease 2019: An expert consensus☆. | *C7128660* C7128660 | ||
561. A study on the psychological needs of nurses caring for patients with coronavirus disease 2019 from the perspective of the existence relatedness and growth theory☆. | *32292633* 32292633 | ||
562. A RAPID SYSTEMATIC REVIEW OF THE EFFICACY OF FACE MASKS AND RESPIRATORS AGAINST CORONAVIRUSES AND OTHER RESPIRATORY TRANSMISSIBLE VIRUSES FOR THE COMMUNITY HEALTHCARE WORKERS AND SICK PATIENTS. | *C7191274* C7191274 | ||
563. Nursing s Response to COVID-19: Lessons Learned from SARS in Taiwan. | *32388221* 32388221 | ||
564. Considerations and strategies in the organisation of obstetric anaesthesia care during the 2019 COVID-19 outbreak in Singapore. | *32386993* 32386993 | ||
565. Impact of COVID-19 on maxillofacial surgery practice: a worldwide survey. | *32414678* 32414678 | ||
566. The surgeon and the COVID-19 pandemic - Perspective☆. | *32387620* 32387620 | ||
567. Important considerations regarding the future management of Coronavirus (COVID-19). | *32387212* 32387212 | ||
568. Effects of the COVID-19 pandemic on mental well-being amongst individuals in society- A letter to the editor on “The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review”. | *32380230* 32380230 | ||
569. Optimizing response in surgical systems during and after COVID-19 pandemic: lessons from China and the UK – Perspective. | *32376240* 32376240 | ||
570. COVID-19 pneumonia: different respiratory treatments for different phenotypes? | *C7154064* C7154064 | ||
571. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment. | *32378044* 32378044 | ||
572. An Extended Statement by the British Cardiovascular Intervention Society President Regarding the COVID-19 Pandemic. | *32382317* 32382317 | ||
573. Early COVID-19 Impact on Adolescent Health and Medicine Programs in the United States: LEAH Program Leadership Reflections. | *32402799* 32402799 | ||
574. Coping with the COVID-19 crisis: A call for youth engagement and the inclusion of young people in matters that affect their lives. | *32402796* 32402796 | ||
575. Air pollution racial disparities and COVID-19 mortality. | *32389591* 32389591 | ||
576. Influence of immune aging on vaccine responses. | *32386655* 32386655 | ||
505. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study. | *32376408* 32376408 | ||
506. Psychological symptoms among frontline healthcare workers during COVID-19 outbreak in Wuhan. | *32381270* 32381270 | ||
507. Evolution of SARS Coronavirus and the Relevance of Modern Molecular Epidemiology. Genetics and Evolution of Infectious Disease 2011; (): 711-28 | *C7149542* C7149542 | ||
508. COVID‐19 Presents High Risk to Older Persons. | *C7128941* C7128941 | ||
509. Global Health – emergence hegemonic trends and biomedical reductionism. | *32375801* 32375801 | ||
510. Globalization and health scholarship in a time of pandemic: from critical past to uncertain future. | *C7157828* C7157828 | ||
511. Infektionsschutzrecht nach Inkrafttreten des Masernschutzgesetzes. | *32382165* 32382165 | ||
512. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak. | *32376043* 32376043 | ||
513. Coronavirus concerns: What do women with gynecologic cancer need to know during the COVID-19 crisis? | *32402631* 32402631 | ||
514. Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis☆. | *32386911* 32386911 | ||
515. COVID-19: Initial experience of hand surgeons in Northern Italy. | *32376511* 32376511 | ||
516. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. | *32375887* 32375887 | ||
517. A review of cardiac manifestations and predictors of outcome in patients with COVID – 19. | *C7196397* C7196397 | ||
518. Rural and Remote Cardiology During the COVID-19 Pandemic: Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement#. | *C7203036* C7203036 | ||
519. Consensus Guidelines for Interventional Cardiology Services Delivery During COVID-19 Pandemic in Australia and New Zealand. | *32471696* 32471696 | ||
520. Patients with Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement. | *32418874* 32418874 | ||
521. ENHANCED ECG MONITORING OF COVID-19 PATIENTS. | *32387247* 32387247 | ||
522. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. | *32387246* 32387246 | ||
523. Chloroquine-induced torsade de pointes in a COVID-19 patient. | *32380291* 32380291 | ||
524. Genetic Susceptibility for COVID-19-Associated Sudden Cardiac Death in African Americans. | *32380288* 32380288 | ||
525. COVID and hematology: special considerations regarding patient safety gold standard therapies and safety for health care professionals☆. | *32292885* 32292885 | ||
526. BLOQUEANTES DEL SISTEMA RENINA-ANGIOTENSINA E INFECCIÓN POR COVID-19. | *32448641* 32448641 | ||
527. Guillain-Barré Syndrome associated with SARS-CoV-2 infection. | *32313807* 32313807 | ||
528. Emerging Infectious Diseases of Immigrant Patients. | *C7170192* C7170192 | ||
529. Immunology of COVID-19: current state of the science. | *C7200337* C7200337 | ||
530. GTS-21 an α7nAChR agonist suppressed the production of key inflammatory mediators by PBMCs that are elevated in COPD patients and associated with impaired lung function. | *32387130* 32387130 | ||
531. Ventricular Arrhythmia Risk Due to Chloroquine / Hydroxychloroquine Treatment For COVID-19: should it be given. | *C7184982* C7184982 | ||
532. Coronavirus disease 2019 and the cardiovascular system: Impacts and implications. | *32423554* 32423554 | ||
533. Significant Applications of Big Data in COVID-19 Pandemic. | *32382166* 32382166 | ||
534. Initial Observations with Molecular Testing for COVID-19 in a Private Hospital in Mumbai India. | *32378133* 32378133 | ||
535. COVID-19 (SARS-CoV-2 Infection) and Children: Pediatric Neurologist’s Perspective. | *32378132* 32378132 | ||
536. Recommendations for Surgery During the Novel Coronavirus (COVID-19) Epidemic. | *C7150607* C7150607 | ||
537. Guiding Principles for Cancer Surgery during the COVID-19 Pandemic. | *32382219* 32382219 | ||
538. IASO COVID-19 Guidelines (Updated on 9th April 2020). | *32382218* 32382218 | ||
539. Tuberculosis and novel Wuhan coronavirus infection: Pathological interrelationship. | *C7130142* C7130142 | ||
540. Preparation and Response to COVID-19 outbreak in Singapore: A Case Report. | *32402779* 32402779 | ||
541. Propagation analysis and prediction of the COVID-19. | *C7118312* C7118312 | ||
542. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. | *32387564* 32387564 | ||
543. Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses. | *32387562* 32387562 | ||
544. Acute gastroenteritis viruses. | *C7173416* C7173416 | ||
545. Trauma service reorganization in Bologna (Italy) during COVID-19 pandemic. | *32386838* 32386838 | ||
546. Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin. | *32389720* 32389720 | ||
547. Tocilizumab in COVID-19: beware of risk of intestinal perforation. | *32389721* 32389721 | ||
548. Chloroquine as prophylactic agent against COVID-19? | *C7152897* C7152897 | ||
549. Lockdown—the only solution to defeat COVID-19. | *32377056* 32377056 | ||
550. The challenges facing indigenous communities in Latin America as they confront the COVID-19 pandemic. | *32381022* 32381022 | ||
551. From SARS to COVID-19: What we have learned about children infected with COVID-19. | *32389849* 32389849 | ||
552. COVID-19 and Religious Congregations: Implications for Spread of Novel Pathogens. | *32389851* 32389851 | ||
553. Characteristics of respiratory virus infection during the outbreak of 2019 novel coronavirus in Beijing. | *32389850* 32389850 | ||
554. Covid-19 health crisis management in Europe: decisive assessment is needed now. | *32389852* 32389852 | ||
555. Urgent need for evaluating agonists of Angiotensin-(1-7)/ Mas receptor axis for treatment of patients with COVID-19. | *32389847* 32389847 | ||
556. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients. | *32376309* 32376309 | ||
557. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. | *32376308* 32376308 | ||
558. Emergency mental health legislation in response to the Covid-19 (Coronavirus) pandemic in Ireland: Urgency necessity and proportionality. | *C7174175* C7174175 | ||
559. Safety management of nasopharyngeal specimen collection from suspected cases of coronavirus disease 2019☆. | *C7129371* C7129371 | ||
560. Holistic care for patients with severe coronavirus disease 2019: An expert consensus☆. | *C7128660* C7128660 | ||
561. A study on the psychological needs of nurses caring for patients with coronavirus disease 2019 from the perspective of the existence relatedness and growth theory☆. | *32292633* 32292633 | ||
562. A RAPID SYSTEMATIC REVIEW OF THE EFFICACY OF FACE MASKS AND RESPIRATORS AGAINST CORONAVIRUSES AND OTHER RESPIRATORY TRANSMISSIBLE VIRUSES FOR THE COMMUNITY HEALTHCARE WORKERS AND SICK PATIENTS. | *C7191274* C7191274 | ||
563. Nursing s Response to COVID-19: Lessons Learned from SARS in Taiwan. | *32388221* 32388221 | ||
564. Considerations and strategies in the organisation of obstetric anaesthesia care during the 2019 COVID-19 outbreak in Singapore. | *32386993* 32386993 | ||
565. Impact of COVID-19 on maxillofacial surgery practice: a worldwide survey. | *32414678* 32414678 | ||
566. The surgeon and the COVID-19 pandemic - Perspective☆. | *32387620* 32387620 | ||
567. Important considerations regarding the future management of Coronavirus (COVID-19). | *32387212* 32387212 | ||
568. Effects of the COVID-19 pandemic on mental well-being amongst individuals in society- A letter to the editor on “The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review”. | *32380230* 32380230 | ||
569. Optimizing response in surgical systems during and after COVID-19 pandemic: lessons from China and the UK – Perspective. | *32376240* 32376240 | ||
570. COVID-19 pneumonia: different respiratory treatments for different phenotypes? | *C7154064* C7154064 | ||
571. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment. | *32378044* 32378044 | ||
572. An Extended Statement by the British Cardiovascular Intervention Society President Regarding the COVID-19 Pandemic. | *32382317* 32382317 | ||
573. Early COVID-19 Impact on Adolescent Health and Medicine Programs in the United States: LEAH Program Leadership Reflections. | *32402799* 32402799 | ||
574. Coping with the COVID-19 crisis: A call for youth engagement and the inclusion of young people in matters that affect their lives. | *32402796* 32402796 | ||
575. Air pollution racial disparities and COVID-19 mortality. | *32389591* 32389591 | ||
576. Influence of immune aging on vaccine responses. | *32386655* 32386655 | ||
577. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. | *C7152876* C7152876 | ||
578. COVID-19 in children: an epidemiology study from China. | *C7172907* C7172907 | ||
579. COVID-19 and biologics for psoriasis: a high-epidemic area experience - Bergamo Lombardy Italy. | *32387660* 32387660 | ||
580. Perspectives on the Recommendations for Skin Cancer Management During the COVID-19 Pandemic. | *32387656* 32387656 | ||
581. Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic. | *32380214* 32380214 | ||
582. Use of systemic immunomodulatory therapies during the coronavirus disease 2019 (COVID-19) pandemic. | *C7160444* C7160444 | ||
583. Telehealth Utilization in Response to the Novel Coronavirus (COVID-19) Pandemic in Orthopaedic Surgery. | *32459409* 32459409 | ||
584. Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19. | *32387623* 32387623 | ||
585. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership. | *32380033* 32380033 | ||
586. Finding Refuge in the ACC Family in Unprecedented Times. | *32381168* 32381168 | ||
587. ACR Statement on Safe Resumption of Routine Radiology Care During the COVID-19 Pandemic. | *32442427* 32442427 | ||
588. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. | *C7177099* C7177099 | ||
589. Ventilation-perfusion Scans During the Coronavirus (COVID 19) Outbreak. | *C7146721* C7146721 | ||
590. Hospital-at-Home as an alternative to release the overload of healthcare systems during the SARS-CoV-2 pandemic. | *C7196392* C7196392 | ||
591. THE IMPORTANCE OF PHYSICAL ACTIVITY TO CARE FOR FRAIL OLDER ADULTS DURING THE COVID-19 PANDEMIC. | *C7190526* C7190526 | ||
592. Cruise Ships Nursing Homes and Prisons as COVID-19 Epicenters: A ‘Wicked Problem” with Breakthrough Solutions? | *C7190531* C7190531 | ||
593. THE GERIATRICIAN: THE FRONTLINE SPECIALIST IN THE TREATMENT OF COVID-19 PATIENTS. | *C7177102* C7177102 | ||
594. ECHOCARDIOGRAPHY DURING PRONE POSITION MECHANICAL VENTILATION IN COVID-19 PATIENTS: A PROPOSAL FOR A NEW APPROACH. | *32448649* 32448649 | ||
595. Development of a COVID-19 Point-of-Care Ultrasound (POCUS) Protocol. | *C7177132* C7177132 | ||
596. Specific Considerations for the Protection of Patients and Echocardiography Service Providers When Performing Perioperative or Periprocedural Transesophageal Echocardiography During the 2019 Novel Coronavirus Outbreak: Council on Perioperative Echocardiography Supplement to the Statement of the American Society of Echocardiography: Endorsed by the Society of Cardiovascular Anesthesiologists. | *C7151527* C7151527 | ||
597. Echo in Pandemic: Front Line Perspective Expanding Role of Ultrasound and Ethics of Resource Allocation. | *C7151341* C7151341 | ||
598. Echocardiography in the Time of COVID-19. | *C7146691* C7146691 | ||
599. Bedside Focused Cardiac Ultrasound in COVID-19 Infection From the Wuhan Epicenter: The Role of Cardiac Point of Care Ultrasound (POCUS) Limited Transthoracic Echocardiography and Critical Care Echocardiography. | *C7144595* C7144595 | ||
600. Selecting a SARS-CoV-2/COVID molecular testing method for your laboratory. | *C7197557* C7197557 | ||
601. Contingency planning in the clinical laboratory: lessons learned amidst COVID-19. | *C7188123* C7188123 | ||
602. A Laboratory Risk Assessment during the Coronavirus (COVID-19) Pandemic. | *C7184397* C7184397 | ||
603. COVID-19 in Pediatrics: A Laboratory Perspective. | *C7184367* C7184367 | ||
604. How Has COVID-19 Affected Our Orthopedic Implant Industry Partners? Implications for the Surgeon-Industry Relationship in 2020 and Beyond. | *32386882* 32386882 | ||
605. Understanding Antibody Testing for COVID-19. | *32389405* 32389405 | ||
606. Humanitarian Needs: The Arthroplasty Community and the COVID-19 Pandemic. | *32381442* 32381442 | ||
607. COVID-19 Impact on Young Arthroplasty Surgeons. | *32402577* 32402577 | ||
608. After the COVID-19 pandemic: returning to normalcy or returning to a new normal? | *32376171* 32376171 | ||
609. Prevention of Infection and Disruption of the Pathogen Transfer Chain in Elective Surgery. | *32389410* 32389410 | ||
610. The Response of An Orthopedic Department and Specialty Hospital at the Epicenter of a Pandemic: The NYU Langone Health Experience. | *32376169* 32376169 | ||
611. Rechtliche Grundlagen der Berufsausübungsgemeinschaft. | *C7133772* C7133772 | ||
612. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. | *32439209* 32439209 | ||
613. Global efforts on vaccines for COVID-19: Since sooner or later we all will catch the coronavirus. | *32385219* 32385219 | ||
614. Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper. | *C7152868* C7152868 | ||
615. Response to COVID-19 in Breast Imaging. | *C7184368* C7184368 | ||
616. COVID-19: Advice from the Canadian Association of Gastroenterology for Endoscopy Facilities as of March 16 2020. | *32395690* 32395690 | ||
617. Heart Failure in the COVID-19 Pandemic: Where has all New York s congestion gone? | *32389608* 32389608 | ||
618. Successful Use of Limited Transthoracic Echocardiography to Guide VV ECMO Placement in a COVID-19 Patient. | *C7200348* C7200348 | ||
619. Novel Coronavirus Disease 2019 (COVID-19) Aerosolization Box: Design Modifications for Patient Safety. | *32446708* 32446708 | ||
620. Hemodynamic Monitoring Options in COVID-19. | *32457007* 32457007 | ||
621. Cardiothoracic surgery at the time of COVID-19 pandemic: lessons from the East (and from a previous epidemic) for western battlefields. | *C7200373* C7200373 | ||
622. POCUS to guide fluid-therapy in COVID-19. | *C7200367* C7200367 | ||
623. The role of lung ultrasound in the assessment of novel coronavirus pneumonia. | *32471692* 32471692 | ||
624. Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications. | *32451271* 32451271 | ||
625. Cardiopulmonary Resuscitation during the Coronavirus Crisis – important updates for the cardiothoracic and vascular anesthesia community. | *32434725* 32434725 | ||
626. Consider Adjunctive Ketamine in Mechanically Ventilated COVID-19 Patients. | *C7187876* C7187876 | ||
627. Perioperative Preparations for COVID-19: The Pediatric Cardiac Team Perspective. | *32451272* 32451272 | ||
628. The Fellowship Milieu in Adult Cardiothoracic Anesthesiology – fostering psychological wellbeing during the coronavirus crisis. | *32418827* 32418827 | ||
629. Fellowship Training in Adult Cardiothoracic Anesthesiology – navigating the new educational landscape due to the coronavirus crisis. | *32387019* 32387019 | ||
630. Perioperative Echocardiography during the Coronavirus Crisis – considerations in pediatrics and congenital heart disease. | *32387016* 32387016 | ||
631. Critical Care during the Coronavirus Crisis – challenges and considerations for the cardiothoracic and vascular anesthesia community. | *32387015* 32387015 | ||
632. Thoracic Anesthesia of Patients With Suspected or Confirmed 2019 Novel Coronavirus Infection: Preliminary Recommendations for Airway Management by the European Association of Cardiothoracic Anaesthesiology Thoracic Subspecialty Committee. | *32414544* 32414544 | ||
633. Chinese Association of Anesthesiologists Expert Consensus on the Use of Perioperative Ultrasound in Coronavirus Disease 2019 Patients. | *32418832* 32418832 | ||
634. President’s Page: The Impact of the COVID-19 Pandemic on Cardiac CT. | *32423754* 32423754 | ||
635. Lessons from COVID-19 to future evidence synthesis efforts: first living search strategy and out of date scientific publishing and indexing industry (submitted). | *32376119* 32376119 | ||
636. Sustainability of Coronavirus on different surfaces. | *32377058* 32377058 | ||
637. Emerging technologies to combat COVID-19 pandemic. | *32377057* 32377057 | ||
638. COVID-19: Neurology Residents’ Perspective. | *32402610* 32402610 | ||
639. Coexistence of Covid-19 and Acute Ischemic Stroke Report of Four Cases. | *32409210* 32409210 | ||
640. Neurological manifestations and complications of COVID-19: A Literature Review. | *32409215* 32409215 | ||
641. COVID-19 and molecular mimicry: the Columbus’ egg? | *32389543* 32389543 | ||
642. COVID-19 SARS and MERS: A neurological perspective. | *32417124* 32417124 | ||
643. Annotation: The COVID-19 pandemic and clinical orthopaedic and trauma surgery. | *32292257* 32292257 | ||
644. SARS-CoV-2 detection by direct rRT-PCR without RNA extraction. | *32416598* 32416598 | ||
645. SARS-CoV-2 and enhancing antibodies. | *32438257* 32438257 | ||
646. Coronavirus Disease 2019 in Children: Characteristics Antimicrobial Treatment and Outcomes. | *32446167* 32446167 | ||
647. Case fatality rate in patients with COVID-19 infection and its relationship with length of follow up⋆. | *32403011* 32403011 | ||
648. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. | *32403010* 32403010 | ||
577. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. | *C7152876* C7152876 | ||
578. COVID-19 in children: an epidemiology study from China. | *C7172907* C7172907 | ||
579. COVID-19 and biologics for psoriasis: a high-epidemic area experience - Bergamo Lombardy Italy. | *32387660* 32387660 | ||
580. Perspectives on the Recommendations for Skin Cancer Management During the COVID-19 Pandemic. | *32387656* 32387656 | ||
581. Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic. | *32380214* 32380214 | ||
582. Use of systemic immunomodulatory therapies during the coronavirus disease 2019 (COVID-19) pandemic. | *C7160444* C7160444 | ||
583. Telehealth Utilization in Response to the Novel Coronavirus (COVID-19) Pandemic in Orthopaedic Surgery. | *32459409* 32459409 | ||
584. Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19. | *32387623* 32387623 | ||
585. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership. | *32380033* 32380033 | ||
586. Finding Refuge in the ACC Family in Unprecedented Times. | *32381168* 32381168 | ||
587. ACR Statement on Safe Resumption of Routine Radiology Care During the COVID-19 Pandemic. | *32442427* 32442427 | ||
588. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. | *C7177099* C7177099 | ||
589. Ventilation-perfusion Scans During the Coronavirus (COVID 19) Outbreak. | *C7146721* C7146721 | ||
590. Hospital-at-Home as an alternative to release the overload of healthcare systems during the SARS-CoV-2 pandemic. | *C7196392* C7196392 | ||
591. THE IMPORTANCE OF PHYSICAL ACTIVITY TO CARE FOR FRAIL OLDER ADULTS DURING THE COVID-19 PANDEMIC. | *C7190526* C7190526 | ||
592. Cruise Ships Nursing Homes and Prisons as COVID-19 Epicenters: A ‘Wicked Problem” with Breakthrough Solutions? | *C7190531* C7190531 | ||
593. THE GERIATRICIAN: THE FRONTLINE SPECIALIST IN THE TREATMENT OF COVID-19 PATIENTS. | *C7177102* C7177102 | ||
594. ECHOCARDIOGRAPHY DURING PRONE POSITION MECHANICAL VENTILATION IN COVID-19 PATIENTS: A PROPOSAL FOR A NEW APPROACH. | *32448649* 32448649 | ||
595. Development of a COVID-19 Point-of-Care Ultrasound (POCUS) Protocol. | *C7177132* C7177132 | ||
596. Specific Considerations for the Protection of Patients and Echocardiography Service Providers When Performing Perioperative or Periprocedural Transesophageal Echocardiography During the 2019 Novel Coronavirus Outbreak: Council on Perioperative Echocardiography Supplement to the Statement of the American Society of Echocardiography: Endorsed by the Society of Cardiovascular Anesthesiologists. | *C7151527* C7151527 | ||
597. Echo in Pandemic: Front Line Perspective Expanding Role of Ultrasound and Ethics of Resource Allocation. | *C7151341* C7151341 | ||
598. Echocardiography in the Time of COVID-19. | *C7146691* C7146691 | ||
599. Bedside Focused Cardiac Ultrasound in COVID-19 Infection From the Wuhan Epicenter: The Role of Cardiac Point of Care Ultrasound (POCUS) Limited Transthoracic Echocardiography and Critical Care Echocardiography. | *C7144595* C7144595 | ||
600. Selecting a SARS-CoV-2/COVID molecular testing method for your laboratory. | *C7197557* C7197557 | ||
601. Contingency planning in the clinical laboratory: lessons learned amidst COVID-19. | *C7188123* C7188123 | ||
602. A Laboratory Risk Assessment during the Coronavirus (COVID-19) Pandemic. | *C7184397* C7184397 | ||
603. COVID-19 in Pediatrics: A Laboratory Perspective. | *C7184367* C7184367 | ||
604. How Has COVID-19 Affected Our Orthopedic Implant Industry Partners? Implications for the Surgeon-Industry Relationship in 2020 and Beyond. | *32386882* 32386882 | ||
605. Understanding Antibody Testing for COVID-19. | *32389405* 32389405 | ||
606. Humanitarian Needs: The Arthroplasty Community and the COVID-19 Pandemic. | *32381442* 32381442 | ||
607. COVID-19 Impact on Young Arthroplasty Surgeons. | *32402577* 32402577 | ||
608. After the COVID-19 pandemic: returning to normalcy or returning to a new normal? | *32376171* 32376171 | ||
609. Prevention of Infection and Disruption of the Pathogen Transfer Chain in Elective Surgery. | *32389410* 32389410 | ||
610. The Response of An Orthopedic Department and Specialty Hospital at the Epicenter of a Pandemic: The NYU Langone Health Experience. | *32376169* 32376169 | ||
611. Rechtliche Grundlagen der Berufsausübungsgemeinschaft. | *C7133772* C7133772 | ||
612. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. | *32439209* 32439209 | ||
613. Global efforts on vaccines for COVID-19: Since sooner or later we all will catch the coronavirus. | *32385219* 32385219 | ||
614. Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper. | *C7152868* C7152868 | ||
615. Response to COVID-19 in Breast Imaging. | *C7184368* C7184368 | ||
616. COVID-19: Advice from the Canadian Association of Gastroenterology for Endoscopy Facilities as of March 16 2020. | *32395690* 32395690 | ||
617. Heart Failure in the COVID-19 Pandemic: Where has all New York s congestion gone? | *32389608* 32389608 | ||
618. Successful Use of Limited Transthoracic Echocardiography to Guide VV ECMO Placement in a COVID-19 Patient. | *C7200348* C7200348 | ||
619. Novel Coronavirus Disease 2019 (COVID-19) Aerosolization Box: Design Modifications for Patient Safety. | *32446708* 32446708 | ||
620. Hemodynamic Monitoring Options in COVID-19. | *32457007* 32457007 | ||
621. Cardiothoracic surgery at the time of COVID-19 pandemic: lessons from the East (and from a previous epidemic) for western battlefields. | *C7200373* C7200373 | ||
622. POCUS to guide fluid-therapy in COVID-19. | *C7200367* C7200367 | ||
623. The role of lung ultrasound in the assessment of novel coronavirus pneumonia. | *32471692* 32471692 | ||
624. Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications. | *32451271* 32451271 | ||
625. Cardiopulmonary Resuscitation during the Coronavirus Crisis – important updates for the cardiothoracic and vascular anesthesia community. | *32434725* 32434725 | ||
626. Consider Adjunctive Ketamine in Mechanically Ventilated COVID-19 Patients. | *C7187876* C7187876 | ||
627. Perioperative Preparations for COVID-19: The Pediatric Cardiac Team Perspective. | *32451272* 32451272 | ||
628. The Fellowship Milieu in Adult Cardiothoracic Anesthesiology – fostering psychological wellbeing during the coronavirus crisis. | *32418827* 32418827 | ||
629. Fellowship Training in Adult Cardiothoracic Anesthesiology – navigating the new educational landscape due to the coronavirus crisis. | *32387019* 32387019 | ||
630. Perioperative Echocardiography during the Coronavirus Crisis – considerations in pediatrics and congenital heart disease. | *32387016* 32387016 | ||
631. Critical Care during the Coronavirus Crisis – challenges and considerations for the cardiothoracic and vascular anesthesia community. | *32387015* 32387015 | ||
632. Thoracic Anesthesia of Patients With Suspected or Confirmed 2019 Novel Coronavirus Infection: Preliminary Recommendations for Airway Management by the European Association of Cardiothoracic Anaesthesiology Thoracic Subspecialty Committee. | *32414544* 32414544 | ||
633. Chinese Association of Anesthesiologists Expert Consensus on the Use of Perioperative Ultrasound in Coronavirus Disease 2019 Patients. | *32418832* 32418832 | ||
634. President’s Page: The Impact of the COVID-19 Pandemic on Cardiac CT. | *32423754* 32423754 | ||
635. Lessons from COVID-19 to future evidence synthesis efforts: first living search strategy and out of date scientific publishing and indexing industry (submitted). | *32376119* 32376119 | ||
636. Sustainability of Coronavirus on different surfaces. | *32377058* 32377058 | ||
637. Emerging technologies to combat COVID-19 pandemic. | *32377057* 32377057 | ||
638. COVID-19: Neurology Residents’ Perspective. | *32402610* 32402610 | ||
639. Coexistence of Covid-19 and Acute Ischemic Stroke Report of Four Cases. | *32409210* 32409210 | ||
640. Neurological manifestations and complications of COVID-19: A Literature Review. | *32409215* 32409215 | ||
641. COVID-19 and molecular mimicry: the Columbus’ egg? | *32389543* 32389543 | ||
642. COVID-19 SARS and MERS: A neurological perspective. | *32417124* 32417124 | ||
643. Annotation: The COVID-19 pandemic and clinical orthopaedic and trauma surgery. | *32292257* 32292257 | ||
644. SARS-CoV-2 detection by direct rRT-PCR without RNA extraction. | *32416598* 32416598 | ||
645. SARS-CoV-2 and enhancing antibodies. | *32438257* 32438257 | ||
646. Coronavirus Disease 2019 in Children: Characteristics Antimicrobial Treatment and Outcomes. | *32446167* 32446167 | ||
647. Case fatality rate in patients with COVID-19 infection and its relationship with length of follow up⋆. | *32403011* 32403011 | ||
648. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. | *32403010* 32403010 | ||
649. Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay. | *32388470* 32388470 | ||
650. Self-collection: an appropriate alternative during the SARS-CoV-2 pandemic. | *32403007* 32403007 | ||
651. Five-minute point-of-care testing for SARS-CoV-2: Not there yet. | *32403009* 32403009 | ||
652. A RT-PCR Assay for the Detection of Coronaviruses from Four Genera. | *32403008* 32403008 | ||
653. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan China. | *32388472* 32388472 | ||
654. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19. | *32387968* 32387968 | ||
655. The Diagnosis of Pandemic Coronavirus Pneumonia: A Review of Radiology Examination and Laboratory Test. | *32438256* 32438256 | ||
656. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG. | *32416599* 32416599 | ||
657. Gastrointestinal Hepatobiliary and Pancreatic Manifestations of COVID-19. | *32388469* 32388469 | ||
658. A single centre study of viral community-acquired pneumonia in children: no evidence of SARS-CoV-2 from October 2019 to March 2020. | *32387967* 32387967 | ||
659. Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting. | *32388471* 32388471 | ||
660. Issues for conducting meta-analyses in COVID-19. Commentary on “Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis’’. | *32387969* 32387969 | ||
661. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays. | *32380382* 32380382 | ||
662. Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening. | *32388468* 32388468 | ||
663. Critical care capacity during the COVID-19 pandemic: Global availability of intensive care beds. | *32408107* 32408107 | ||
664. A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS. | *32376098* 32376098 | ||
665. Clinical and Histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy. | *32381428* 32381428 | ||
666. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. | *32381430* 32381430 | ||
667. Estimating the COVID-19 infection rate: Anatomy of an inference problem. | *32377030* 32377030 | ||
668. Wide complex tachycardia in a COVID-19 patient: What is the mechanism? | *32413697* 32413697 | ||
669. Radiological Presentation of Coronavirus Disease. | *32423636* 32423636 | ||
670. Integrated infection control strategy to minimize nosocomial infection during outbreak of COVID-19 among ED healthcare workers. | *32418674* 32418674 | ||
671. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach. | *32376368* 32376368 | ||
672. Professional autonomy of the resident doctor: Between the hammer and the anvil. | *32452455* 32452455 | ||
673. COVID-19 in forensic medicine unit personnel: Observation from Thailand. | *32452454* 32452454 | ||
674. Epidemiological and clinical characteristics of 136 cases of COVID-19 in main district of Chongqing. | *32386675* 32386675 | ||
675. Take proactive measures for the pandemic COVID-19 infection in the dialysis facilities. | *C7151404* C7151404 | ||
676. Recommandations COVID-19 pour les ophtalmologistes☆. | *32466832* 32466832 | ||
677. Quelle conduite tenir adopter vis vis des injections intravitréennes (IVT) dans cette période d’épidémie au Covid-19 – SARS-CoV-2 ?☆☆☆. | *32451137* 32451137 | ||
678. Prise en charge des cancers oculaires en période épidémique de Covid-19☆☆☆. | *32389526* 32389526 | ||
679. Quelle conduite tenir pour prendre en charge des pathologies médicales de la surface oculaire pendant l’épidémie de COVID-19?☆☆☆☆☆☆. | *32402410* 32402410 | ||
680. Quelle conduite tenir pour la prise en charge de pathologies chirurgicales vitréo-rétiniennes en cette période d’épidémie de Covid-19 virus SARS-CoV-2 ?☆. | *32386901* 32386901 | ||
681. Protection oculaire en réanimation (SFO–CNPO) pendant la période d’épidémie au Covid-19☆. | *32386903* 32386903 | ||
682. Faut-il une surveillance ophtalmologique en cas de traitement de courte durée par hydroxychloroquine en cette période d’épidémie au COVID-19?1. | *32451138* 32451138 | ||
683. Geriatric Syndromes and SARS-COV-2: More than Just Being Old. | *C7150530* C7150530 | ||
684. SARS-CoV-2: the emergence of a viral pathogen causing havoc on human existence. | *C7189006* C7189006 | ||
685. The Impact of Coronavirus Disease 2019 (COVID-19) on the Practice of Hand Surgery in Singapore. | *32387156* 32387156 | ||
686. Reflections on the quality of health care after the SARS-CoV-2 pandemic. | *C7151300* C7151300 | ||
687. COVID-19 in a pediatric heart transplant recipient: Emergence of Donor Specific Antibodies. | *32430156* 32430156 | ||
688. COVID-19 and Transplant Research from China: an ethical dilemma. | *C7167293* C7167293 | ||
689. COVID-19 PNEUMONIA IN A DUAL HEART-KIDNEY RECIPIENT. | *C7165097* C7165097 | ||
690. Quis custodiet ipsos custodes: are we taking care of healthcare workers in the Italian Covid-19 outbreak? | *32387745* 32387745 | ||
691. SARS-CoV-2: air/aerosols and surfaces in laboratory and clinical settings. | *32387746* 32387746 | ||
692. It’s in our hands: a rapid international initiative to translate a hand hygiene song during the COVID-19 pandemic. | *32387744* 32387744 | ||
693. Minimising intra-hospital transmission of COVID-19: the role of social distancing. | *C7152925* C7152925 | ||
694. Children hospitalized for coronavirus disease 2019 (COVID-19): A multicenter retrospective descriptive study. | *32387474* 32387474 | ||
695. Reactivation of COVID-19 pneumonia: A report of two cases. | *32389787* 32389787 | ||
696. Comparison of CRB-65 and quick sepsis-related organ failure assessment for predicting the need for intensive respiratory or vasopressor support in patients with COVID-19. | *32389785* 32389785 | ||
697. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays. | *32389784* 32389784 | ||
698. Personal respirators for population level control of the COVID19 pandemic. | *32387071* 32387071 | ||
699. COVID-19 diagnoses in South East London peaked before the UK suggesting early measures reduced transmission. | *32376453* 32376453 | ||
700. COVID-19-related prejudice towards Asian medical students: A consequence of SARS-CoV-2 fears in Poland. | *32387102* 32387102 | ||
701. Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine. | *32446813* 32446813 | ||
702. How the COVID-19 Response is Altering the Legal and Regulatory Landscape on Abortion. | *C7197555* C7197555 | ||
703. The United Kingdom’s Coronavirus Act Deprivations of Liberty and The Right to Liberty and Security of the Person. | *C7197562* C7197562 | ||
704. The Legal and Medical Necessity of Abortion Care Amid the COVID-19 Pandemic. | *C7197550* C7197550 | ||
705. Reporting Recording and Communication of COVID-19 Cases in Workplace: Data Protection as a Moving Target. | *C7188145* C7188145 | ||
706. Can the COVID-19 Interstate Travel Restrictions Help Lift the FDA’s Blood Ban? | *C7188137* C7188137 | ||
707. Response of chiropractic organizations to the COVID-19 pandemic: A descriptive report. | *32386752* 32386752 | ||
708. Proposal of the French Society of Vascular Medicine for the prevention diagnosis and treatment of venous thromboembolic disease in out-patients with COVID 19. | *C7183940* C7183940 | ||
709. Ten key points that vascular doctors learned very quickly about COVID-19. | *32402423* 32402423 | ||
710. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2 hypertension multi-organ failure and COVID-19 disease outcome. | *32414646* 32414646 | ||
711. Animal-to-Human Viral Transitions: Is SARS-CoV-2 an Evolutionary Successful One? | *32377932* 32377932 | ||
712. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. | *32464367* 32464367 | ||
713. Myasthenic crisis in COVID-19. | *32413767* 32413767 | ||
714. Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients. | *32413768* 32413768 | ||
715. Has COVID-19 played an unexpected “stroke” on the chain of survival? | *32416370* 32416370 | ||
716. Venous cerebral thrombosis in COVID-19 patient. | *32422428* 32422428 | ||
717. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: A case report. | *32387762* 32387762 | ||
718. Acute ischemic stroke complicating common carotid artery thrombosis during a severe COVID-19 infection. | *32389423* 32389423 | ||
719. Editorial. Neurosurgery in the storm of COVID-19: suggestions from the Lombardy region Italy (ex malo bonum). | *C7161162* C7161162 | ||
720. Editorial. Response to COVID-19 in Chinese neurosurgery and beyond. | *C7161163* C7161163 | ||
649. Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay. | *32388470* 32388470 | ||
650. Self-collection: an appropriate alternative during the SARS-CoV-2 pandemic. | *32403007* 32403007 | ||
651. Five-minute point-of-care testing for SARS-CoV-2: Not there yet. | *32403009* 32403009 | ||
652. A RT-PCR Assay for the Detection of Coronaviruses from Four Genera. | *32403008* 32403008 | ||
653. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan China. | *32388472* 32388472 | ||
654. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19. | *32387968* 32387968 | ||
655. The Diagnosis of Pandemic Coronavirus Pneumonia: A Review of Radiology Examination and Laboratory Test. | *32438256* 32438256 | ||
656. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG. | *32416599* 32416599 | ||
657. Gastrointestinal Hepatobiliary and Pancreatic Manifestations of COVID-19. | *32388469* 32388469 | ||
658. A single centre study of viral community-acquired pneumonia in children: no evidence of SARS-CoV-2 from October 2019 to March 2020. | *32387967* 32387967 | ||
659. Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting. | *32388471* 32388471 | ||
660. Issues for conducting meta-analyses in COVID-19. Commentary on “Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis’’. | *32387969* 32387969 | ||
661. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays. | *32380382* 32380382 | ||
662. Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening. | *32388468* 32388468 | ||
663. Critical care capacity during the COVID-19 pandemic: Global availability of intensive care beds. | *32408107* 32408107 | ||
664. A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS. | *32376098* 32376098 | ||
665. Clinical and Histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy. | *32381428* 32381428 | ||
666. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. | *32381430* 32381430 | ||
667. Estimating the COVID-19 infection rate: Anatomy of an inference problem. | *32377030* 32377030 | ||
668. Wide complex tachycardia in a COVID-19 patient: What is the mechanism? | *32413697* 32413697 | ||
669. Radiological Presentation of Coronavirus Disease. | *32423636* 32423636 | ||
670. Integrated infection control strategy to minimize nosocomial infection during outbreak of COVID-19 among ED healthcare workers. | *32418674* 32418674 | ||
671. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach. | *32376368* 32376368 | ||
672. Professional autonomy of the resident doctor: Between the hammer and the anvil. | *32452455* 32452455 | ||
673. COVID-19 in forensic medicine unit personnel: Observation from Thailand. | *32452454* 32452454 | ||
674. Epidemiological and clinical characteristics of 136 cases of COVID-19 in main district of Chongqing. | *32386675* 32386675 | ||
675. Take proactive measures for the pandemic COVID-19 infection in the dialysis facilities. | *C7151404* C7151404 | ||
676. Recommandations COVID-19 pour les ophtalmologistes☆. | *32466832* 32466832 | ||
677. Quelle conduite tenir adopter vis vis des injections intravitréennes (IVT) dans cette période d’épidémie au Covid-19 – SARS-CoV-2 ?☆☆☆. | *32451137* 32451137 | ||
678. Prise en charge des cancers oculaires en période épidémique de Covid-19☆☆☆. | *32389526* 32389526 | ||
679. Quelle conduite tenir pour prendre en charge des pathologies médicales de la surface oculaire pendant l’épidémie de COVID-19?☆☆☆☆☆☆. | *32402410* 32402410 | ||
680. Quelle conduite tenir pour la prise en charge de pathologies chirurgicales vitréo-rétiniennes en cette période d’épidémie de Covid-19 virus SARS-CoV-2 ?☆. | *32386901* 32386901 | ||
681. Protection oculaire en réanimation (SFO–CNPO) pendant la période d’épidémie au Covid-19☆. | *32386903* 32386903 | ||
682. Faut-il une surveillance ophtalmologique en cas de traitement de courte durée par hydroxychloroquine en cette période d’épidémie au COVID-19?1. | *32451138* 32451138 | ||
683. Geriatric Syndromes and SARS-COV-2: More than Just Being Old. | *C7150530* C7150530 | ||
684. SARS-CoV-2: the emergence of a viral pathogen causing havoc on human existence. | *C7189006* C7189006 | ||
685. The Impact of Coronavirus Disease 2019 (COVID-19) on the Practice of Hand Surgery in Singapore. | *32387156* 32387156 | ||
686. Reflections on the quality of health care after the SARS-CoV-2 pandemic. | *C7151300* C7151300 | ||
687. COVID-19 in a pediatric heart transplant recipient: Emergence of Donor Specific Antibodies. | *32430156* 32430156 | ||
688. COVID-19 and Transplant Research from China: an ethical dilemma. | *C7167293* C7167293 | ||
689. COVID-19 PNEUMONIA IN A DUAL HEART-KIDNEY RECIPIENT. | *C7165097* C7165097 | ||
690. Quis custodiet ipsos custodes: are we taking care of healthcare workers in the Italian Covid-19 outbreak? | *32387745* 32387745 | ||
691. SARS-CoV-2: air/aerosols and surfaces in laboratory and clinical settings. | *32387746* 32387746 | ||
692. It’s in our hands: a rapid international initiative to translate a hand hygiene song during the COVID-19 pandemic. | *32387744* 32387744 | ||
693. Minimising intra-hospital transmission of COVID-19: the role of social distancing. | *C7152925* C7152925 | ||
694. Children hospitalized for coronavirus disease 2019 (COVID-19): A multicenter retrospective descriptive study. | *32387474* 32387474 | ||
695. Reactivation of COVID-19 pneumonia: A report of two cases. | *32389787* 32389787 | ||
696. Comparison of CRB-65 and quick sepsis-related organ failure assessment for predicting the need for intensive respiratory or vasopressor support in patients with COVID-19. | *32389785* 32389785 | ||
697. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays. | *32389784* 32389784 | ||
698. Personal respirators for population level control of the COVID19 pandemic. | *32387071* 32387071 | ||
699. COVID-19 diagnoses in South East London peaked before the UK suggesting early measures reduced transmission. | *32376453* 32376453 | ||
700. COVID-19-related prejudice towards Asian medical students: A consequence of SARS-CoV-2 fears in Poland. | *32387102* 32387102 | ||
701. Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine. | *32446813* 32446813 | ||
702. How the COVID-19 Response is Altering the Legal and Regulatory Landscape on Abortion. | *C7197555* C7197555 | ||
703. The United Kingdom’s Coronavirus Act Deprivations of Liberty and The Right to Liberty and Security of the Person. | *C7197562* C7197562 | ||
704. The Legal and Medical Necessity of Abortion Care Amid the COVID-19 Pandemic. | *C7197550* C7197550 | ||
705. Reporting Recording and Communication of COVID-19 Cases in Workplace: Data Protection as a Moving Target. | *C7188145* C7188145 | ||
706. Can the COVID-19 Interstate Travel Restrictions Help Lift the FDA’s Blood Ban? | *C7188137* C7188137 | ||
707. Response of chiropractic organizations to the COVID-19 pandemic: A descriptive report. | *32386752* 32386752 | ||
708. Proposal of the French Society of Vascular Medicine for the prevention diagnosis and treatment of venous thromboembolic disease in out-patients with COVID 19. | *C7183940* C7183940 | ||
709. Ten key points that vascular doctors learned very quickly about COVID-19. | *32402423* 32402423 | ||
710. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2 hypertension multi-organ failure and COVID-19 disease outcome. | *32414646* 32414646 | ||
711. Animal-to-Human Viral Transitions: Is SARS-CoV-2 an Evolutionary Successful One? | *32377932* 32377932 | ||
712. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. | *32464367* 32464367 | ||
713. Myasthenic crisis in COVID-19. | *32413767* 32413767 | ||
714. Covert COVID-19 complications: Continuing the use of evidence-based drugs to minimize potentially lethal indirect effects of the pandemic in stroke patients. | *32413768* 32413768 | ||
715. Has COVID-19 played an unexpected “stroke” on the chain of survival? | *32416370* 32416370 | ||
716. Venous cerebral thrombosis in COVID-19 patient. | *32422428* 32422428 | ||
717. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: A case report. | *32387762* 32387762 | ||
718. Acute ischemic stroke complicating common carotid artery thrombosis during a severe COVID-19 infection. | *32389423* 32389423 | ||
719. Editorial. Neurosurgery in the storm of COVID-19: suggestions from the Lombardy region Italy (ex malo bonum). | *C7161162* C7161162 | ||
720. Editorial. Response to COVID-19 in Chinese neurosurgery and beyond. | *C7161163* C7161163 | ||
PMC7150532 225. The virus crisis affects Orthopaedic surgery and scientific activities worldwide. | *32279098* 32279098 | ||
PMC7184143 226. Coronavirus epidemic and geriatric mental healthcare in China: how a coordinated response by professional organizations helped older adults during an unprecedented crisis. | *32268928* 32268928 | ||
PMC7087507 227. Lung ultrasound and B-lines quantification inaccuracy: B sure to have the right solution. | *32189008* 32189008 | ||
PMC7080149 228. Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic. | *32166346* 32166346 | ||
PMC7079866 229. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit. | *32123993* 32123993 | ||
PMC7042184 230. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. | *32025779* 32025779 | ||
PMC7176813 231. Missed or delayed diagnosis of ARDS: a common and serious problem. | *32328723* 32328723 | ||
PMC7079935 232. How to face the novel coronavirus infection during the 2019-2020 epidemic: the experience of Sichuan Provincial People's Hospital. | *32072300* 32072300 | ||
PMC7135420 233. Strengthening ICU health security for a coronavirus epidemic. | *32044122* 32044122 | ||
PMC7110265 234. The Coming Coronavirus Crisis: What Can We Learn? | *32287365* 32287365 | ||
PMC7105961 235. A woman with fever and cough: coronavirus disease 2019. | *32232784* 32232784 | ||
PMC7088805 236. Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia. | *32006218* 32006218 | ||
PMC7075978 237. Positive Selection of a Serine Residue in Bat IRF3 Confers Enhanced Antiviral Protection. | *32179480* 32179480 | ||
PMC7191551 238. Evaluating the consequences of health policy decisions. | *32354343* 32354343 | ||
PMC7134506 239. What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus? | *32081700* 32081700 | ||
PMC7146653 240. Converting a Small Surgical Team into a Pandemic Response Team for an Isolated Population. | *32283267* 32283267 | ||
PMC7170520 241. Wish you were here: Meetings, no meetings, meeting reports. | *32303646* 32303646 | ||
PMC7152748 242. Halting coronavirus polymerase. | *32277065* 32277065 | ||
PMC7141583 243. Novel Coronavirus and Orthopaedic Surgery: Early Experiences from Singapore. | *32205660* 32205660 | ||
PMC7194053 244. Therapeutic Strategy for Patients with Coronavirus Disease 2019 During Left Ventricular Assist Device Supports. | *32371279* 32371279 | ||
PMC7162774 245. Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support. | *32305569* 32305569 | ||
PMC7138190 246. Perioperative Echocardiography: Key Considerations During the Coronavirus Pandemic. | *32249075* 32249075 | ||
PMC7194974 247. Cardiovascular Consequences and Considerations of Coronavirus Infection - Perspectives for the Cardiothoracic Anesthesiologist and Intensivist During the Coronavirus Crisis. | *32349897* 32349897 | ||
PMC7141443 248. Extracorporeal Membrane Oxygenation - Crucial Considerations during the Coronavirus Crisis. | *32345529* 32345529 | ||
249. The Renin-Angiotensin-Aldosterone System in Coronavirus Infection-Current Considerations During the Pandemic. | *32360010* 32360010 | ||
PMC7197338 250. Coronavirus disease 2019 and ophthalmologists: introducing a simple protective shield for slitlamp biomicroscopic examination. | *32347689* 32347689 | ||
PMC7166568 251. CRISPR Editing in Biological and Biomedical Investigation. | *28467679* 28467679 | ||
PMC7166750 252. Design of Angiotensin-converting Enzyme 2 (ACE2) Inhibitors by Virtual Lead Optimization and Screening. | *32336762* 32336762 | ||
PMC6868407 253. Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3. | *31420921* 31420921 | ||
PMC6351902 254. Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections. | *30577479* 30577479 | ||
PMC7162053 255. 2019 Novel coronavirus infection and gastrointestinal tract. | *32096611* 32096611 | ||
PMC7166375 256. Use of an Automated Nested Multiplex Respiratory Pathogen PCR Panel Postmortem in the Pediatric Forensic Setting. | *28120330* 28120330 | ||
PMC7167573 257. Prise en charge adaptee au COVID-19. | *32340757* 32340757 | ||
PMC5729325 258. Risk factors for detection failures of chest radiography in diagnosing pneumonia. | *29264071* 29264071 | ||
PMC7197919 259. Virtual House Calls: Telemedicine and Reforming the Health Care Delivery Model with Strategies Implemented in a Novel Coronavirus Pandemic. | *32367391* 32367391 | ||
PMC7155156 260. How Community and Unity Can Help Americans Survive. | *32291724* 32291724 | ||
PMC7166902 261. RNA interference for antiviral therapy. | *16779870* 16779870 | ||
PMC7189258 262. Myocardial injury is associated with higher mortality in patients with coronavirus disease 2019: a meta-analysis. | *32362922* 32362922 | ||
PMC7189261 263. Hypoxia in acute cardiac injury of coronavirus disease 2019: lesson learned from pathological studies. | *32362921* 32362921 | ||
PMC7179981 264. Ophthalmic manifestations of novel coronaviruses: precautionary measures and diagnostic possibilities. | *32355557* 32355557 | ||
PMC7152926 265. Determination of Air Filter Anti-Viral Efficiency against an Airborne Infectious Virus. | *32339873* 32339873 | ||
PMC7152866 266. Donor organ evaluation in the era of coronavirus disease 2019: A case of nosocomial infection. | *32334945* 32334945 | ||
PMC7194850 267. Anti-Microbial Coating Innovations to prevent infectious disease: a consensus view from the AMiCl COST Action. | *32278702* 32278702 | ||
PMC7124368 268. Understanding the emerging coronavirus: what it means for health security and infection prevention. | *32145323* 32145323 | ||
PMC7126654 269. Clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assay. | *32092387* 32092387 | ||
PMC7127192 270. The continuous evolution and dissemination of 2019 novel human coronavirus. | *32092385* 32092385 | ||
PMC7105506 271. Understanding and Interpretation of Case Fatality Rate of Coronavirus Disease 2019. | *32233163* 32233163 | ||
PMC7073318 272. Will the Third Wave of Coronavirus Disease 2019 Really Come in Korea? | *32174068* 32174068 | ||
PMC7167405 273. Potential Hazards of Concern in the Walk-Through Screening System for the Corona Virus Disease 2019 from the Perspective of Infection Preventionists. | *32301301* 32301301 | ||
PMC7152529 274. Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying. | *32281318* 32281318 | ||
PMC7139907 275. An SIS model for the epidemic dynamics with two phases of the human day-to-day activity. | *32270285* 32270285 | ||
PMC7098070 276. alpha-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment. | *32045235* 32045235 | ||
PMC7094172 277. Structure-Based Stabilization of Non-native Protein-Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design. | *32105468* 32105468 | ||
PMC7088294 278. The Role of Augmented Intelligence (AI) in Detecting and Preventing the Spread of Novel Coronavirus. | *32020374* 32020374 | ||
PMC7167012 279. The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019. | *32073161* 32073161 | ||
PMC7166442 280. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses. | *32073157* 32073157 | ||
PMC7166326 281. The progress of 2019 novel coronavirus event in China. | *32048741* 32048741 | ||
PMC7166444 282. Th17 serum cytokines in relation to laboratory-confirmed respiratory viral infection: A pilot study. | *30715745* 30715745 | ||
PMC7163178 283. An epidemiological study exploring a possible impact of treatment with ACE inhibitors or angiotensin receptor blockers on ACE2 plasma concentrations. | *32268149* 32268149 | ||
PMC7128812 284. Corona Virus: Global Pandemic Causing World-Wide Shutdown. | *32253007* 32253007 | ||
PMC7152973 285. Reflections on life in the time of the Coronavirus pandemic, from the viewpoint of two people who have experienced dialysis and kidney transplantation. | *32285349* 32285349 | ||
PMC7195013 286. COVID-19 and Educational Engagement. | *32371146* 32371146 | ||
PMC7151518 287. The UIC COVID Coverage Protocol: A Technical Note for Pandemic Oral and Maxillofacial Surgery Call Coverage. | *32302530* 32302530 | ||
PMC7167655 288. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. | *17031779* 17031779 | ||
PMC7167940 289. An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. | *15892035* 15892035 | ||
PMC7167937 290. Cilia-related diseases. | *15495266* 15495266 | ||
PMC7167761 291. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. | *15141376* 15141376 | ||
PMC7167900 292. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. | *14743497* 14743497 | ||
PMC7168017 293. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. | *12845623* 12845623 | ||
PMC7136960 294. Nurses in Conflict: Providing Care in Extraordinary Times. | *32360084* 32360084 | ||
PMC7166987 295. A review on antiviral activity of the Himalayan medicinal plants traditionally used to treat bronchitis and related symptoms. | *27905101* 27905101 | ||
PMC7136868 296. Portable pulsed xenon ultraviolet light disinfection in a teaching hospital animal laboratory in China. | *32278270* 32278270 | ||
PMC7152864 297. Photopolarimetrical properties of coronavirus model particles: spike proteins number influence. | *32292212* 32292212 | ||
PMC7129695 298. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus. | *16697221* 16697221 | ||
PMC7118632 299. True epidemic growth construction through harmonic analysis. | *32173304* 32173304 | ||
PMC7151391 300. Commentary: Challenges to thoracic surgeons in the global coronavirus pandemic. | *32331818* 32331818 | ||
PMC7194946 301. Pulmonary Pathology of Early Phase 2019 Novel Coronavirus Pneumonia. | *32340677* 32340677 | ||
PMC7162784 302. Rapid Detection of Asymptomatic Coronavirus Disease 2019 by Computed Tomography Image Guidance for Stereotactic Ablative Radiotherapy. | *32311499* 32311499 | ||
PMC7151381 303. Lung Cancer Surgical Management During the Outbreak of Coronavirus Disease 2019. | *32289517* 32289517 | ||
PMC7151422 304. Early Appearance of Coronavirus Disease 2019 Associated Pulmonary Infiltrates During Daily Radiotherapy Imaging for Lung Cancer. | *32283316* 32283316 | ||
PMC7151236 305. Coronavirus Disease 2019 or Lung Cancer: What Should We Treat? | *32283315* 32283315 | ||
PMC7183388 306. Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel. | *32335777* 32335777 | ||
PMC7156795 307. Toward understanding the 2019 Coronavirus and its impact on the heart. | *32297133* 32297133 | ||
PMC7147395 308. Traumacare. | *31856018* 31856018 | ||
309. Society of Interventional Radiology Position Statement on the Role of Percutaneous Ablation in Renal Cell Carcinoma: Endorsed by the Canadian Association for Interventional Radiology and the Society of Interventional Oncology. | *31917025* 31917025 | ||
310. Aortic Disease in the Time of COVID: Repercussions on Patient Care at an Academic Aortic Center. | *32360374* 32360374 | ||
PMC7192086 311. Vascular surgery activity condition is a common language for uncommon times. | *32360373* 32360373 | ||
PMC7175904 312. Distance learning for vascular surgeons in the era of a pandemic. | *32334049* 32334049 | ||
PMC7175885 313. Strategies and recommendations for the safe implementation of vascular surgery during the pandemic period of novel coronavirus pneumonia. | *32334048* 32334048 | ||
PMC1395447 314. Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. | *16501078* 16501078 | ||
PMC7097838 315. Training and Fit Testing of Health Care Personnel for Reusable Elastomeric Half-Mask Respirators Compared With Disposable N95 Respirators. | *32211889* 32211889 | ||
PMC7091374 316. Ethics Committee Reviews of Applications for Research Studies at 1 Hospital in China During the 2019 Novel Coronavirus Epidemic. | *32202608* 32202608 | ||
PMC7186917 317. Exposure to a Surrogate Measure of Contamination From Simulated Patients by Emergency Department Personnel Wearing Personal Protective Equipment. | *32338711* 32338711 | ||
318. Social Support, Exposure to Parental Intimate Partner Violence, and Relationship Abuse Among Marginalized Youth. | *32165077* 32165077 | ||
319. Predictors of Adolescents' First Episode of Homelessness Following Substance Use Treatment. | *32057607* 32057607 | ||
320. The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata. | *32165196* 32165196 | ||
321. Outcome and clinicophenotypical features of acute lymphoblastic leukemia/lymphoblastic lymphoma with cutaneous involvement: A multicenter case series. | *32007515* 32007515 | ||
322. The Accidental Consequences of Student Debt. | *31899182* 31899182 | ||
323. Impact of an Antimicrobial Stewardship Program on Resistance to Fluoroquinolones of Urinary Enterobacteriaceae Isolated From Nursing Home Residents: A Retrospective Cohort Study. | *32199718* 32199718 | ||
324. Prevalence of Clinically Important Abnormalities Found on Transthoracic Echocardiography Ordered for Indication of Heart Murmur Found on Physical Examination. | *32305176* 32305176 | ||
325. Opioid Use After Total Knee Arthroplasty: Does Tramadol Have Lower Risk Than Traditional Opioids? | *32057601* 32057601 | ||
326. Traitement des uveites intermediaires, posterieures et panuveites non infectieuses. | *31818505* 31818505 | ||
327. Rapidly Progressive Soft Tissue Infection of the Upper Extremity With Aeromonas veronii biovar sobria. | *32238279* 32238279 | ||
328. Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. | *32362393* 32362393 | ||
329. Illness as Transformative Experience: Implications of Philosophy for Advance Care Planning. | *30831239* 30831239 | ||
330. Reply. | *31653359* 31653359 | ||
331. Single-Dose Oral Ibuprofen Plus Caffeine for Acute Postoperative Pain in Adults. | *32008715* 32008715 | ||
332. Competency Assessment. | *32247435* 32247435 | ||
333. Identifying Human Trafficking Victims in Health Care. | *32247432* 32247432 | ||
334. Correlations Among Genotype and Outcome in Chinese Male Patients With Congenital Hypogonadotropic Hypogonadism Under HCG Treatment. | *32171629* 32171629 | ||
335. Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure. | *31101350* 31101350 | ||
336. Commentary: Basilar segmentectomy: A new weapon against cancer for the modern thoracic surgeon? | *32192726* 32192726 | ||
721. Introduction. On pandemics: the impact of COVID-19 on the practice of neurosurgery. | *C7161161* C7161161 | ||
722. 3D PRINTING OF FACE SHIELDS DURING COVID-19 PANDEMIC: A TECHNICAL NOTE. | *32404268* 32404268 | ||
723. Evolution of COVID-19 Guidelines for University of Washington Oral and Maxillofacial Surgery Patient Care. | *32389541* 32389541 | ||
724. Clinical evidence based review and recommendations of aerosol generating medical procedures in otolaryngology – head and neck surgery during the COVID-19 pandemic. | *32375884* 32375884 | ||
725. Caring for bereaved family members during the COVID-19 pandemic: before and after the death of a patient. | *32387574* 32387574 | ||
726. COVID-19 – Impact on DNR Orders in the Largest Cancer Center in Jordan. | *32387138* 32387138 | ||
727. Palliative Care in the Time of COVID-19. | *32376263* 32376263 | ||
728. Influence of Community and Culture in the Ethical Allocation of Scarce Medical Resources in a Pandemic Situation: Deliberative Democracy Study. | *C7141421* C7141421 | ||
729. Addressing Faculty Emotional Responses During the COVID19 Pandemic. | *32387715* 32387715 | ||
730. Caring for Pediatric Patients with Diabetes amidst the COVID-19 Storm. | *32387113* 32387113 | ||
731. Rapid Implementation of an Adult COVID-19 Unit in a Children’s Hospital. | *32380026* 32380026 | ||
732. Pediatric and Adolescent Gynecology (PAG) in the Time of a Pandemic. | *32381257* 32381257 | ||
733. Children are at risk from COVID-19. | *32386796* 32386796 | ||
734. Quantitative computed tomography analysis for stratifying the severity of Coronavirus Disease 2019. | *32292624* 32292624 | ||
735. Molecular immune pathogenesis and diagnosis of COVID-19. | *32282863* 32282863 | ||
736. Light as a potential treatment for pandemic coronavirus infections: A perspective. | *32388486* 32388486 | ||
737. Impact of the Covid-19 Outbreak on the Clinical and Research Activities of Memory Clinics: An Alzheimer’s Disease Center Facing the Covid-19 Crisis. | *32463074* 32463074 | ||
738. Covid-19 Coronavirus and Mental Health Rehabilitation at Times of Crisis. | *C7114947* C7114947 | ||
739. Stroke priorities during COVID-19 outbreak: acting both fast and safe. | *32417235* 32417235 | ||
740. Cardiac Surgery and the COVID-19 Pandemic: What We Know What We Don’t Know and What We Need to Do. | *32467022* 32467022 | ||
741. Adult Cardiac Surgery and the COVID-19 Pandemic: Aggressive Infection Mitigation Strategies are Necessary in the Operating Room and Surgical Recovery. | *C7185923* C7185923 | ||
742. Does nasal screening for Staphylococcus aureus before surgery compromise health care professional safety in the COVID-19 era? | *32448698* 32448698 | ||
743. Commentary: When a cardiac surgeon takes care of patients with Coronavirus Disease 2019: It’s gonna be ok! | *32387163* 32387163 | ||
744. Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery. | *32408961* 32408961 | ||
745. COVID-19: Crisis Management in Congenital Heart Surgery. | *C7194800* C7194800 | ||
746. Commentary: Rethinking Surgical Protocols in the Covid-19 Era. | *32448690* 32448690 | ||
747. COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement from Thoracic Surgery Outcomes Research Network. | *C7146695* C7146695 | ||
748. COVID-19 or Lung Cancer: A differential diagnostic experience and management model from Wuhan. | *32387713* 32387713 | ||
749. Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)-Associated Interstitial Lung Disease During the COVID-19 Pandemic. | *32387581* 32387581 | ||
750. The use of PET in COVID 19 cases. | *32387580* 32387580 | ||
751. Anti-IL6R role in treatment of COVID-19-related ARDS. | *C7154570* C7154570 | ||
752. Leveraging Interventional Radiology s Adaptability During COVID-19: A Multi-Center Single Urban Health System Experience. | *C7196407* C7196407 | ||
753. Risk of peripheral arterial thrombosis in COVID-19. | *32417015* 32417015 | ||
754. Caring for Patients with Venous Insufficiency During the COVID-19 Pandemic at a Tertiary Care Center. | *32380086* 32380086 | ||
755. Endocrine surgery during and after the Covid-19 epidemic: Expert guidelines in France. | *32448761* 32448761 | ||
756. Pre- and post-operative screening in limited-term elective cancer surgery patients during the COVID-19 pandemic. | *32381427* 32381427 | ||
757. Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery. | *32381426* 32381426 | ||
758. Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups. | *32387058* 32387058 | ||
759. Management of the COVID-19 epidemic by public health establishments - Analysis by the Fédération Hospitalière de France. | *32417194* 32417194 | ||
760. SARS-CoV-2 infection may result in appendicular syndrome: Chest CT scan before appendectomy. | *32387057* 32387057 | ||
761. Flexible employment relationships and careers in times of the COVID-19 pandemic. | *32382161* 32382161 | ||
762. Understanding the impact of the COVID-19 pandemic on career development: Insights from cultural psychology. | *32382162* 32382162 | ||
763. Efficacy of internet-based integrated intervention on depression and anxiety symptoms in patients with COVID-19. | *32425006* 32425006 | ||
764. Clinical value of the emergency department in screening and diagnosis of COVID-19 in China. | *32425004* 32425004 | ||
765. Possible aerosol transmission of COVID-19 and special precautions in dentistry. | *32425001* 32425001 | ||
766. The Heart in COVID19: Primary Target or Secondary Bystander? | *32292847* 32292847 | ||
767. COVID-19 for the Cardiologist: A Current Review of the Virology Clinical Epidemiology Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies. | *32292848* 32292848 | ||
768. The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and Cancer. | *C7151392* C7151392 | ||
769. Prognostic Value of Right Ventricular Longitudinal Strain in Patients with COVID-19. | *C7195441* C7195441 | ||
770. “Quadruple rule out” with cardiac computed tomography in COVID-19 patient with equivocal acute coronary syndrome presentation. | *C7173805* C7173805 | ||
771. TAVR during the COVID19 Pandemic: The ACC/SCAI Consensus Statement. | *C7196374* C7196374 | ||
772. Role of Teleproctoring in Challenging and Innovative Structural Interventions Amidst the COVID-19 Pandemic and Beyond. | *C7161496* C7161496 | ||
773. Spontaneous Coronary Artery Dissection in a Patient with COVID-19. | *C7142671* C7142671 | ||
774. The Imperfect Cytokine Storm: Severe COVID-19 with ARDS in Patient on Durable LVAD Support. | *C7142699* C7142699 | ||
775. Multi-lead QT Screening is Necessary for QT Measurement: Implications for Management of Patients in the COVID-19 Era. | *C7141442* C7141442 | ||
776. Heart Failure Editorial Emergencies in the COVID-19 Era. | *32466838* 32466838 | ||
777. Tubuloreticular inclusions in COVID-19-related collapsing glomerulopathy. | *32471641* 32471641 | ||
778. A view from the front line of the COVID-19 war. | *32451077* 32451077 | ||
779. Adding insult to injury: kidney replacement therapy during COVID-19 in India. | *32471634* 32471634 | ||
780. Could ferritin help the screening for COVID-19 in hemodialysis patients? | *32471636* 32471636 | ||
781. Collapsing glomerulopathy in a COVID-19 patient. | *32471639* 32471639 | ||
782. Managing the COVID-19 pandemic: international comparisons in dialysis patients. | *32471637* 32471637 | ||
783. Collapsing Glomerulopathy in a Patient With Coronavirus Disease 2019 (COVID-19). | *C7142700* C7142700 | ||
784. Hyperinflammatory shock in children during COVID-19 pandemic. | *32386565* 32386565 | ||
785. COVID-19-associated nephritis: early warning for disease severity and complications? | *32423587* 32423587 | ||
786. Acute limb ischaemia in two young non-atherosclerotic patients with COVID-19. | *32423583* 32423583 | ||
787. Is the HScore useful in COVID-19? | *32423585* 32423585 | ||
788. SARS-CoV-2 and influenza virus co-infection. | *32423586* 32423586 | ||
721. Introduction. On pandemics: the impact of COVID-19 on the practice of neurosurgery. | *C7161161* C7161161 | ||
722. 3D PRINTING OF FACE SHIELDS DURING COVID-19 PANDEMIC: A TECHNICAL NOTE. | *32404268* 32404268 | ||
723. Evolution of COVID-19 Guidelines for University of Washington Oral and Maxillofacial Surgery Patient Care. | *32389541* 32389541 | ||
724. Clinical evidence based review and recommendations of aerosol generating medical procedures in otolaryngology – head and neck surgery during the COVID-19 pandemic. | *32375884* 32375884 | ||
725. Caring for bereaved family members during the COVID-19 pandemic: before and after the death of a patient. | *32387574* 32387574 | ||
726. COVID-19 – Impact on DNR Orders in the Largest Cancer Center in Jordan. | *32387138* 32387138 | ||
727. Palliative Care in the Time of COVID-19. | *32376263* 32376263 | ||
728. Influence of Community and Culture in the Ethical Allocation of Scarce Medical Resources in a Pandemic Situation: Deliberative Democracy Study. | *C7141421* C7141421 | ||
729. Addressing Faculty Emotional Responses During the COVID19 Pandemic. | *32387715* 32387715 | ||
730. Caring for Pediatric Patients with Diabetes amidst the COVID-19 Storm. | *32387113* 32387113 | ||
731. Rapid Implementation of an Adult COVID-19 Unit in a Children’s Hospital. | *32380026* 32380026 | ||
732. Pediatric and Adolescent Gynecology (PAG) in the Time of a Pandemic. | *32381257* 32381257 | ||
733. Children are at risk from COVID-19. | *32386796* 32386796 | ||
734. Quantitative computed tomography analysis for stratifying the severity of Coronavirus Disease 2019. | *32292624* 32292624 | ||
735. Molecular immune pathogenesis and diagnosis of COVID-19. | *32282863* 32282863 | ||
736. Light as a potential treatment for pandemic coronavirus infections: A perspective. | *32388486* 32388486 | ||
737. Impact of the Covid-19 Outbreak on the Clinical and Research Activities of Memory Clinics: An Alzheimer’s Disease Center Facing the Covid-19 Crisis. | *32463074* 32463074 | ||
738. Covid-19 Coronavirus and Mental Health Rehabilitation at Times of Crisis. | *C7114947* C7114947 | ||
739. Stroke priorities during COVID-19 outbreak: acting both fast and safe. | *32417235* 32417235 | ||
740. Cardiac Surgery and the COVID-19 Pandemic: What We Know What We Don’t Know and What We Need to Do. | *32467022* 32467022 | ||
741. Adult Cardiac Surgery and the COVID-19 Pandemic: Aggressive Infection Mitigation Strategies are Necessary in the Operating Room and Surgical Recovery. | *C7185923* C7185923 | ||
742. Does nasal screening for Staphylococcus aureus before surgery compromise health care professional safety in the COVID-19 era? | *32448698* 32448698 | ||
743. Commentary: When a cardiac surgeon takes care of patients with Coronavirus Disease 2019: It’s gonna be ok! | *32387163* 32387163 | ||
744. Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery. | *32408961* 32408961 | ||
745. COVID-19: Crisis Management in Congenital Heart Surgery. | *C7194800* C7194800 | ||
746. Commentary: Rethinking Surgical Protocols in the Covid-19 Era. | *32448690* 32448690 | ||
747. COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement from Thoracic Surgery Outcomes Research Network. | *C7146695* C7146695 | ||
748. COVID-19 or Lung Cancer: A differential diagnostic experience and management model from Wuhan. | *32387713* 32387713 | ||
749. Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)-Associated Interstitial Lung Disease During the COVID-19 Pandemic. | *32387581* 32387581 | ||
750. The use of PET in COVID 19 cases. | *32387580* 32387580 | ||
751. Anti-IL6R role in treatment of COVID-19-related ARDS. | *C7154570* C7154570 | ||
752. Leveraging Interventional Radiology s Adaptability During COVID-19: A Multi-Center Single Urban Health System Experience. | *C7196407* C7196407 | ||
753. Risk of peripheral arterial thrombosis in COVID-19. | *32417015* 32417015 | ||
754. Caring for Patients with Venous Insufficiency During the COVID-19 Pandemic at a Tertiary Care Center. | *32380086* 32380086 | ||
755. Endocrine surgery during and after the Covid-19 epidemic: Expert guidelines in France. | *32448761* 32448761 | ||
756. Pre- and post-operative screening in limited-term elective cancer surgery patients during the COVID-19 pandemic. | *32381427* 32381427 | ||
757. Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery. | *32381426* 32381426 | ||
758. Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups. | *32387058* 32387058 | ||
759. Management of the COVID-19 epidemic by public health establishments - Analysis by the Fédération Hospitalière de France. | *32417194* 32417194 | ||
760. SARS-CoV-2 infection may result in appendicular syndrome: Chest CT scan before appendectomy. | *32387057* 32387057 | ||
761. Flexible employment relationships and careers in times of the COVID-19 pandemic. | *32382161* 32382161 | ||
762. Understanding the impact of the COVID-19 pandemic on career development: Insights from cultural psychology. | *32382162* 32382162 | ||
763. Efficacy of internet-based integrated intervention on depression and anxiety symptoms in patients with COVID-19. | *32425006* 32425006 | ||
764. Clinical value of the emergency department in screening and diagnosis of COVID-19 in China. | *32425004* 32425004 | ||
765. Possible aerosol transmission of COVID-19 and special precautions in dentistry. | *32425001* 32425001 | ||
766. The Heart in COVID19: Primary Target or Secondary Bystander? | *32292847* 32292847 | ||
767. COVID-19 for the Cardiologist: A Current Review of the Virology Clinical Epidemiology Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies. | *32292848* 32292848 | ||
768. The Novel Coronavirus Disease (COVID-19) Threat for Patients with Cardiovascular Disease and Cancer. | *C7151392* C7151392 | ||
769. Prognostic Value of Right Ventricular Longitudinal Strain in Patients with COVID-19. | *C7195441* C7195441 | ||
770. “Quadruple rule out” with cardiac computed tomography in COVID-19 patient with equivocal acute coronary syndrome presentation. | *C7173805* C7173805 | ||
771. TAVR during the COVID19 Pandemic: The ACC/SCAI Consensus Statement. | *C7196374* C7196374 | ||
772. Role of Teleproctoring in Challenging and Innovative Structural Interventions Amidst the COVID-19 Pandemic and Beyond. | *C7161496* C7161496 | ||
773. Spontaneous Coronary Artery Dissection in a Patient with COVID-19. | *C7142671* C7142671 | ||
774. The Imperfect Cytokine Storm: Severe COVID-19 with ARDS in Patient on Durable LVAD Support. | *C7142699* C7142699 | ||
775. Multi-lead QT Screening is Necessary for QT Measurement: Implications for Management of Patients in the COVID-19 Era. | *C7141442* C7141442 | ||
776. Heart Failure Editorial Emergencies in the COVID-19 Era. | *32466838* 32466838 | ||
777. Tubuloreticular inclusions in COVID-19-related collapsing glomerulopathy. | *32471641* 32471641 | ||
778. A view from the front line of the COVID-19 war. | *32451077* 32451077 | ||
779. Adding insult to injury: kidney replacement therapy during COVID-19 in India. | *32471634* 32471634 | ||
780. Could ferritin help the screening for COVID-19 in hemodialysis patients? | *32471636* 32471636 | ||
781. Collapsing glomerulopathy in a COVID-19 patient. | *32471639* 32471639 | ||
782. Managing the COVID-19 pandemic: international comparisons in dialysis patients. | *32471637* 32471637 | ||
783. Collapsing Glomerulopathy in a Patient With Coronavirus Disease 2019 (COVID-19). | *C7142700* C7142700 | ||
784. Hyperinflammatory shock in children during COVID-19 pandemic. | *32386565* 32386565 | ||
785. COVID-19-associated nephritis: early warning for disease severity and complications? | *32423587* 32423587 | ||
786. Acute limb ischaemia in two young non-atherosclerotic patients with COVID-19. | *32423583* 32423583 | ||
787. Is the HScore useful in COVID-19? | *32423585* 32423585 | ||
788. SARS-CoV-2 and influenza virus co-infection. | *32423586* 32423586 | ||
793. COVID-19 immunity passports and vaccination certificates: scientific equitable and legal challenges. | *32380041* 32380041 | ||
794. Obesity could shift severe COVID-19 disease to younger ages. | *32380044* 32380044 | ||
795. The COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises. | *32380045* 32380045 | ||
796. Remdesivir in adults with severe COVID-19: a randomised double-blind placebo-controlled multicentre trial. | *32423584* 32423584 | ||
797. Preventing major outbreaks of COVID-19 in jails. | *32423582* 32423582 | ||
798. Remdesivir for COVID-19: challenges of underpowered studies. | *32423580* 32423580 | ||
799. Institutional not home-based isolation could contain the COVID-19 outbreak. | *32423581* 32423581 | ||
800. 1-week hypofractionated adjuvant whole-breast radiotherapy: towards a new standard? | *C7195114* C7195114 | ||
801. Li Wenliang. | *C7137172* C7137172 | ||
802. The immune system of children: the key to understanding SARS-CoV-2 susceptibility? | *32458804* 32458804 | ||
803. Maintaining safety and service provision in human milk banking: a call to action in response to the COVID-19 pandemic. | *C7202855* C7202855 | ||
804. Promoting healthy movement behaviours among children during the COVID-19 pandemic. | *32458805* 32458805 | ||
805. COVID-19: underlying metabolic health in the spotlight. | *C7202821* C7202821 | ||
806. COVID-19 type 1 diabetes and technology: why paediatric patients are leading the way. | *C7200123* C7200123 | ||
807. Managing diabetes in Qatar during the COVID-19 pandemic. | *C7194789* C7194789 | ||
808. Virtual care: new models of caring for our patients and workforce. | *32382724* 32382724 | ||
809. Resumption of daily services in a gastroenterology department in Guangzhou China in the wake of COVID-19. | *32380008* 32380008 | ||
810. Health system quality in the time of COVID-19. | *32389194* 32389194 | ||
811. Infection prevention and control compliance in Tanzanian outpatient facilities: a cross-sectional study with implications for the control of COVID-19. | *32389195* 32389195 | ||
812. Use of the Demographic and Health Survey framework as a population surveillance strategy for COVID-19. | *C7190287* C7190287 | ||
813. The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study. | *C7190296* C7190296 | ||
814. Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries. | *C7195296* C7195296 | ||
815. Vaccine development during global epidemics: the Zika experience. | *C7202844* C7202844 | ||
816. COVID-19 in Cameroon: a crucial equation to resolve. | *C7202836* C7202836 | ||
817. COVID-19 on the African continent. | *C7202849* C7202849 | ||
818. Testing COVID-19 therapies to prevent progression of mild disease. | *C7202831* C7202831 | ||
819. Progressive respiratory failure in COVID-19: a hypothesis. | *C7190290* C7190290 | ||
820. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. | *C7194818* C7194818 | ||
821. Airway management for COVID-19: a move towards universal videolaryngoscope? | *C7200124* C7200124 | ||
822. Immunomodulation in COVID-19. | *32380023* 32380023 | ||
823. Considerations for ventilator triage during the COVID-19 pandemic. | *32444270* 32444270 | ||
824. Immunotherapies for COVID-19: lessons learned from sepsis. | *32444269* 32444269 | ||
825. Initial data from the COVID-19 Global Rheumatology Alliance provider registries – Authors reply. | *32377642* 32377642 | ||
826. Initial data from the COVID-19 Global Rheumatology Alliance provider registries. | *32377641* 32377641 | ||
827. Dr. Hong Yu leads a team battling against the COVID-19 outbreak in Wuhan. | *C7130075* C7130075 | ||
828. Leadership Management and Command in the time of the Coronavirus. | *C7201192* C7201192 | ||
829. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia. | *32388230* 32388230 | ||
830. Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience. | *32416433* 32416433 | ||
831. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: is immunosuppression a risk factor for SARS-COV2 infection? | *32389426* 32389426 | ||
832. Lung cancer management challenges amidst COVID-19 pandemic: hope lives here. | *C7202360* C7202360 | ||
833. Respiratory Syncytial Virus (RSV). Mandell Douglas and Bennett s Principles and Practice of Infectious Diseases 2015; (): 1948-1960.e3 | *C7173590* C7173590 | ||
834. FERRETS. | *C7170204* C7170204 | ||
835. MICE AND RATS. | *C7152207* C7152207 | ||
836. An overview of functional nanoparticles as novel emerging antiviral therapeutic agents. | *32409074* 32409074 | ||
837. Review on government action plans to reduce energy consumption in buildings amid COVID-19 pandemic outbreak. | *32377508* 32377508 | ||
838. Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia. | *C7200366* C7200366 | ||
839. COVID-19: The forgotten priorities of the pandemic. | *32386664* 32386664 | ||
840. Contact Tracing to Manage COVID19 Spread – Balancing Personal Privacy and Public Health. | *C7196395* C7196395 | ||
841. Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof). | *C7190528* C7190528 | ||
842. Marked Up-Regulation of ACE2 in Hearts of Patients with Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19. | *32448590* 32448590 | ||
843. Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes. | *C7177114* C7177114 | ||
844. The Early Natural History of SARS-CoV-2 Infection: Clinical Observations From an Urban Ambulatory COVID-19 Clinic. | *32451119* 32451119 | ||
845. Public Health Crises and the Human Subjects of Biomedical Research: A Focus on COVID-19. | *32376104* 32376104 | ||
846. Association Between Hypoxemia and Mortality in Patients With COVID-19. | *32376101* 32376101 | ||
847. ST-segment Elevation Myocardial Injury and Suspected or Confirmed COVID-19 Patients: Diagnostic and Treatment Uncertainties. | *32414550* 32414550 | ||
848. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019. | *32376099* 32376099 | ||
849. Severe Acute Respiratory Syndrome (SARS). | *C7149537* C7149537 | ||
850. Retos clínicos en pacientes con enfermedad pulmonar obstructiva crónica que han sufrido una infección por SARS-CoV-2. | *C7203019* C7203019 | ||
851. El test rápido de inmunoglobulinas confirma un caso sospechoso de COVID-19. | *32466975* 32466975 | ||
852. Pericarditis aguda secundaria a covid-19 ¿una enfermedad infradiagnosticada? | *32446685* 32446685 | ||
853. El diagnostico COVID-19 a través de la imagen. | *C7190512* C7190512 | ||
854. MANIFESTACIONES CUTANEAS DE LA INFECCION POR COVID 19. A PROPOSITO DE UN CASO. | *32402385* 32402385 | ||
855. Diagnóstico de pacientes con sospecha de COVID-19: ¿Cuál es el rol de la TC de tórax? | *32402387* 32402387 | ||
856. Cambios de TC de tórax antes y después del tratamiento en un paciente con COVID-19[[[en]]]Pre- and Posttreatment Chest CT Changes in a patient with COVID-19. | *32417029* 32417029 | ||
857. Uso de antipalúdicos en el tratamiento del COVID-19: ¿una ventana de oportunidad? | *32386744* 32386744 | ||
858. COVID-19 y aparato digestivo☆. | *32377565* 32377565 | ||
859. What about the original antigenic sin of the humans versus SARS-CoV-2? | *32408068* 32408068 | ||
860. Lithium for the 2019 novel coronavirus. | *32408073* 32408073 | ||
861. Covid-19 management with Inflammation Resolving Mediators? Perspectives and Potential. | *32416413* 32416413 | ||
862. Genetic Predisposition Models to COVID-19 Infection. | *32416414* 32416414 | ||
863. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win todays battle against COVID-19? | *32408070* 32408070 | ||
793. COVID-19 immunity passports and vaccination certificates: scientific equitable and legal challenges. | *32380041* 32380041 | ||
794. Obesity could shift severe COVID-19 disease to younger ages. | *32380044* 32380044 | ||
795. The COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises. | *32380045* 32380045 | ||
796. Remdesivir in adults with severe COVID-19: a randomised double-blind placebo-controlled multicentre trial. | *32423584* 32423584 | ||
797. Preventing major outbreaks of COVID-19 in jails. | *32423582* 32423582 | ||
798. Remdesivir for COVID-19: challenges of underpowered studies. | *32423580* 32423580 | ||
799. Institutional not home-based isolation could contain the COVID-19 outbreak. | *32423581* 32423581 | ||
800. 1-week hypofractionated adjuvant whole-breast radiotherapy: towards a new standard? | *C7195114* C7195114 | ||
801. Li Wenliang. | *C7137172* C7137172 | ||
802. The immune system of children: the key to understanding SARS-CoV-2 susceptibility? | *32458804* 32458804 | ||
803. Maintaining safety and service provision in human milk banking: a call to action in response to the COVID-19 pandemic. | *C7202855* C7202855 | ||
804. Promoting healthy movement behaviours among children during the COVID-19 pandemic. | *32458805* 32458805 | ||
805. COVID-19: underlying metabolic health in the spotlight. | *C7202821* C7202821 | ||
806. COVID-19 type 1 diabetes and technology: why paediatric patients are leading the way. | *C7200123* C7200123 | ||
807. Managing diabetes in Qatar during the COVID-19 pandemic. | *C7194789* C7194789 | ||
808. Virtual care: new models of caring for our patients and workforce. | *32382724* 32382724 | ||
809. Resumption of daily services in a gastroenterology department in Guangzhou China in the wake of COVID-19. | *32380008* 32380008 | ||
810. Health system quality in the time of COVID-19. | *32389194* 32389194 | ||
811. Infection prevention and control compliance in Tanzanian outpatient facilities: a cross-sectional study with implications for the control of COVID-19. | *32389195* 32389195 | ||
812. Use of the Demographic and Health Survey framework as a population surveillance strategy for COVID-19. | *C7190287* C7190287 | ||
813. The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study. | *C7190296* C7190296 | ||
814. Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries. | *C7195296* C7195296 | ||
815. Vaccine development during global epidemics: the Zika experience. | *C7202844* C7202844 | ||
816. COVID-19 in Cameroon: a crucial equation to resolve. | *C7202836* C7202836 | ||
817. COVID-19 on the African continent. | *C7202849* C7202849 | ||
818. Testing COVID-19 therapies to prevent progression of mild disease. | *C7202831* C7202831 | ||
819. Progressive respiratory failure in COVID-19: a hypothesis. | *C7190290* C7190290 | ||
820. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. | *C7194818* C7194818 | ||
821. Airway management for COVID-19: a move towards universal videolaryngoscope? | *C7200124* C7200124 | ||
822. Immunomodulation in COVID-19. | *32380023* 32380023 | ||
823. Considerations for ventilator triage during the COVID-19 pandemic. | *32444270* 32444270 | ||
824. Immunotherapies for COVID-19: lessons learned from sepsis. | *32444269* 32444269 | ||
825. Initial data from the COVID-19 Global Rheumatology Alliance provider registries – Authors reply. | *32377642* 32377642 | ||
826. Initial data from the COVID-19 Global Rheumatology Alliance provider registries. | *32377641* 32377641 | ||
827. Dr. Hong Yu leads a team battling against the COVID-19 outbreak in Wuhan. | *C7130075* C7130075 | ||
828. Leadership Management and Command in the time of the Coronavirus. | *C7201192* C7201192 | ||
829. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia. | *32388230* 32388230 | ||
830. Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience. | *32416433* 32416433 | ||
831. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: is immunosuppression a risk factor for SARS-COV2 infection? | *32389426* 32389426 | ||
832. Lung cancer management challenges amidst COVID-19 pandemic: hope lives here. | *C7202360* C7202360 | ||
833. Respiratory Syncytial Virus (RSV). Mandell Douglas and Bennett s Principles and Practice of Infectious Diseases 2015; (): 1948-1960.e3 | *C7173590* C7173590 | ||
834. FERRETS. | *C7170204* C7170204 | ||
835. MICE AND RATS. | *C7152207* C7152207 | ||
836. An overview of functional nanoparticles as novel emerging antiviral therapeutic agents. | *32409074* 32409074 | ||
837. Review on government action plans to reduce energy consumption in buildings amid COVID-19 pandemic outbreak. | *32377508* 32377508 | ||
838. Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia. | *C7200366* C7200366 | ||
839. COVID-19: The forgotten priorities of the pandemic. | *32386664* 32386664 | ||
840. Contact Tracing to Manage COVID19 Spread – Balancing Personal Privacy and Public Health. | *C7196395* C7196395 | ||
841. Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof). | *C7190528* C7190528 | ||
842. Marked Up-Regulation of ACE2 in Hearts of Patients with Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19. | *32448590* 32448590 | ||
843. Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes. | *C7177114* C7177114 | ||
844. The Early Natural History of SARS-CoV-2 Infection: Clinical Observations From an Urban Ambulatory COVID-19 Clinic. | *32451119* 32451119 | ||
845. Public Health Crises and the Human Subjects of Biomedical Research: A Focus on COVID-19. | *32376104* 32376104 | ||
846. Association Between Hypoxemia and Mortality in Patients With COVID-19. | *32376101* 32376101 | ||
847. ST-segment Elevation Myocardial Injury and Suspected or Confirmed COVID-19 Patients: Diagnostic and Treatment Uncertainties. | *32414550* 32414550 | ||
848. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019. | *32376099* 32376099 | ||
849. Severe Acute Respiratory Syndrome (SARS). | *C7149537* C7149537 | ||
850. Retos clínicos en pacientes con enfermedad pulmonar obstructiva crónica que han sufrido una infección por SARS-CoV-2. | *C7203019* C7203019 | ||
851. El test rápido de inmunoglobulinas confirma un caso sospechoso de COVID-19. | *32466975* 32466975 | ||
852. Pericarditis aguda secundaria a covid-19 ¿una enfermedad infradiagnosticada? | *32446685* 32446685 | ||
853. El diagnostico COVID-19 a través de la imagen. | *C7190512* C7190512 | ||
854. MANIFESTACIONES CUTANEAS DE LA INFECCION POR COVID 19. A PROPOSITO DE UN CASO. | *32402385* 32402385 | ||
855. Diagnóstico de pacientes con sospecha de COVID-19: ¿Cuál es el rol de la TC de tórax? | *32402387* 32402387 | ||
856. Cambios de TC de tórax antes y después del tratamiento en un paciente con COVID-19[[[en]]]Pre- and Posttreatment Chest CT Changes in a patient with COVID-19. | *32417029* 32417029 | ||
857. Uso de antipalúdicos en el tratamiento del COVID-19: ¿una ventana de oportunidad? | *32386744* 32386744 | ||
858. COVID-19 y aparato digestivo☆. | *32377565* 32377565 | ||
859. What about the original antigenic sin of the humans versus SARS-CoV-2? | *32408068* 32408068 | ||
860. Lithium for the 2019 novel coronavirus. | *32408073* 32408073 | ||
861. Covid-19 management with Inflammation Resolving Mediators? Perspectives and Potential. | *32416413* 32416413 | ||
862. Genetic Predisposition Models to COVID-19 Infection. | *32416414* 32416414 | ||
863. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win todays battle against COVID-19? | *32408070* 32408070 | ||
PMC7189332 337. A Simple Technique for Droplet Control During Mastoid Surgery. | *32343347* 32343347 | ||
PMC7133222 338. The Novel Coronavirus 2019 epidemic and kidneys. | *32204907* 32204907 | ||
PMC7185939 339. An international registry for emergent pathogens and pregnancy. | *32353329* 32353329 | ||
PMC7155742 340. Middle East respiratory syndrome. | *32145185* 32145185 | ||
PMC7134552 341. First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia. | *32061312* 32061312 | ||
PMC7180009 342. Offline: Why President Trump is wrong about WHO. | *32334691* 32334691 | ||
PMC7136991 343. Super-spreading events of MERS-CoV infection. | *27402382* 27402382 | ||
PMC7137132 344. WHO's Director-General candidates: visions and priorities. | *27745880* 27745880 | ||
PMC7195509 345. Pandemic school closures: risks and opportunities. | *32277875* 32277875 | ||
PMC7128924 346. A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units. | *32043976* 32043976 | ||
PMC7194950 347. A new paradigm for drug development. | *32373787* 32373787 | ||
PMC7158995 348. Crowdsourcing data to mitigate epidemics. | *32296776* 32296776 | ||
PMC7185933 349. A new vehicle to accelerate the UN Sustainable Development Goals. | *32353307* 32353307 | ||
PMC7146698 350. Softening the blow of the pandemic: will the International Monetary Fund and World Bank make things worse? | *32278363* 32278363 | ||
PMC7190301 351. The resurgence of convalescent plasma therapy. | *32359447* 32359447 | ||
PMC7194968 352. When pandemics collide. | *32339471* 32339471 | ||
PMC7118528 353. The value of early transmission dynamic studies in emerging infectious diseases. | *32171058* 32171058 | ||
PMC7128282 354. Challenges of coronavirus disease 2019. | *32078810* 32078810 | ||
PMC7128260 355. Outbreak of coronavirus disease 2019. | *32078809* 32078809 | ||
PMC7128697 356. Mysterious pneumonia in China. | *32006509* 32006509 | ||
PMC7172901 357. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. | *32325038* 32325038 | ||
PMC7172833 358. Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines? | *32325036* 32325036 | ||
PMC7128141 359. First clinical trial of a MERS coronavirus DNA vaccine. | *31351923* 31351923 | ||
PMC7158990 360. Herd immunity: hyperimmune globulins for the 21st century. | *29329956* 29329956 | ||
PMC7128598 361. Infectious disease emergencies: taking the long-term view. | *27998579* 27998579 | ||
PMC7106397 362. Urbanisation and infectious diseases in a globalised world. | *21272793* 21272793 | ||
PMC7129431 363. Deadly "paleoviruses": a bioweapon Pandora's box? | *16631539* 16631539 | ||
PMC7128555 364. Meticillin-resistant Staphylococcus aureus. | *16183520* 16183520 | ||
PMC7146734 365. Lack of protective gear disrupts oncology care. | *32278357* 32278357 | ||
PMC7170793 366. Can a virus undermine human rights? | *32325013* 32325013 | ||
PMC7129941 367. Authoritarianism, outbreaks, and information politics. | *32061319* 32061319 | ||
PMC7129529 368. Coronavirus outbreak: the role of companies in preparedness and responses. | *32119831* 32119831 | ||
PMC7154507 369. Coronavirus epidemic: preparing for extracorporeal organ support in intensive care. | *32035509* 32035509 | ||
PMC7130021 370. Coronavirus in China. | *32027848* 32027848 | ||
PMC7154510 371. Pandemic: examining readiness for infectious disease outbreaks. | *32087773* 32087773 | ||
PMC7129337 372. ECMO in severe acute respiratory distress syndrome. | *30642777* 30642777 | ||
PMC7103930 373. Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome. | *28664850* 28664850 | ||
PMC7129770 374. ECMO as an emergency medical countermeasure. | *25209989* 25209989 | ||
PMC7198216 375. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. | *32373790* 32373790 | ||
PMC7027533 376. The expanding role of mass spectrometry in the field of vaccine development. | *29852530* 29852530 | ||
PMC7168406 377. Advances in mass spectrometry for the identification of pathogens. | *21557290* 21557290 | ||
PMC7103905 378. Dysosmia and dysgeusia due to the 2019 Novel Coronavirus; a hypothesis that needs further investigation. | *32289035* 32289035 | ||
PMC7094318 379. Guide to Understanding the 2019 Novel Coronavirus. | *32122636* 32122636 | ||
PMC7201201 380. Glycerol Monolaurate, an Analogue to a Factor Secreted by Lactobacillus, Is Virucidal against Enveloped Viruses, Including HIV-1. | *32371599* 32371599 | ||
PMC7018658 381. Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection. | *32047128* 32047128 | ||
PMC7161434 382. Medical conspiracy theories: cognitive science and implications for ethics. | *32301040* 32301040 | ||
PMC7138388 383. Correlation between atmospheric particulate matter and antibiotic resistance: A hypothesis. | *32298918* 32298918 | ||
384. The puzzle of sharing bio-molecular targets between coronaviruses and mediators of the cardiovascular system in humans: Looking for plausible hypotheses. | *32361530* 32361530 | ||
385. Codigo Sepsis Interhospitalario en Catalunya: modelo organizativo territorial para la atencion inicial al paciente con sepsis. | *31542182* 31542182 | ||
386. Alveolar hemorrhage due to cardiac massage. | *31103224* 31103224 | ||
PMC6617970 387. The impact of rapid molecular diagnostic testing for respiratory viruses on outcomes for emergency department patients. | *30838671* 30838671 | ||
PMC7018532 388. Repurposing approved drugs on the pathway to novel therapies. | *31432544* 31432544 | ||
PMC7168425 389. Norovirus antivirals: Where are we now? | *30584800* 30584800 | ||
PMC7168445 390. Recent progress in the antiviral activity and mechanism study of pentacyclic triterpenoids and their derivatives. | *29350407* 29350407 | ||
391. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection. | *32360210* 32360210 | ||
PMC7110773 392. Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle. | *17194611* 17194611 | ||
PMC7110495 393. Molecular pathogenesis of severe acute respiratory syndrome. | *17142081* 17142081 | ||
PMC7168429 394. Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. | *31692019* 31692019 | ||
PMC7168513 395. Cytosolic DNA-sensing immune response and viral infection. | *30677166* 30677166 | ||
PMC7168434 396. Determination of the cell tropism of serotype 1 feline infectious peritonitis virus using the spike affinity histochemistry in paraffin-embedded tissues. | *28675506* 28675506 | ||
PMC7168497 397. Engineering large viral DNA genomes using the CRISPR-Cas9 system. | *25040500* 25040500 | ||
PMC7168487 398. Chloroquine interferes with dengue-2 virus replication in U937 cells. | *24773578* 24773578 | ||
PMC3955375 399. Social media and internet-based data in global systems for public health surveillance: a systematic review. | *24597553* 24597553 | ||
PMC7100450 400. Fortbildung in Zeiten von COVID-19. | *32221904* 32221904 | ||
PMC7101663 401. COVID-19 in der Allgemeinarztpraxis. | *32189286* 32189286 | ||
PMC7184538 402. Corona: "Starke Vorliebe fur die Niere". | *32342401* 32342401 | ||
PMC7184551 403. COVID-19: Keine Entwarnung im Sommer? | *32342390* 32342390 | ||
PMC7184545 404. "Anwendung von Antikorper-Schnelltests ist Korperverletzung" : SARS-CoV-2-Diagnostik -- Interviewpartner: Dr. Matthias Orth. | *32342388* 32342388 | ||
PMC7127837 405. Coronavirus - Aktuelle Empfehlungen fur den Hausarzt : Neue DEGAM-Leitlinie. | *32248491* 32248491 | ||
PMC7127857 406. Vergessen Sie die Schnellteste auf Coronavirus! | *32248474* 32248474 | ||
PMC7144710 407. On February 20, Physicians Lost One of Our Greatest Heroes. | *32308229* 32308229 | ||
PMC7004108 408. Demographic and environmental drivers of metagenomic viral diversity in vampire bats. | *31561274* 31561274 | ||
PMC7180491 409. Synthesis and Biological Evaluation of Novel (thio)semicarbazone-Based Benzimidazoles as Antiviral Agents against Human Respiratory Viruses. | *32218301* 32218301 | ||
PMC7144386 410. A Review on Applications of Computational Methods in Drug Screening and Design. | *32197324* 32197324 | ||
PMC7146279 411. Spontaneous Hinge-Bending Motions of Angiotensin I Converting Enzyme: Role in Activation and Inhibition. | *32178362* 32178362 | ||
PMC6259191 412. Small interfering RNA effectively inhibits the expression of SARS coronavirus membrane gene at two novel targeting sites. | *20956884* 20956884 | ||
PMC7166104 413. The importance of being a neurologist (during a dramatic pandemic). | *32361263* 32361263 | ||
PMC7179962 414. Visualizing Speech-Generated Oral Fluid Droplets with Laser Light Scattering. | *32294341* 32294341 | ||
PMC7173776 415. Developing therapeutic monoclonal antibodies at pandemic pace. | *32317764* 32317764 | ||
PMC7186216 416. The new scope of virus taxonomy: partitioning the virosphere into 15 hierarchical ranks. | *32341570* 32341570 | ||
PMC7097208 417. Rapid outbreak response requires trust. | *31969714* 31969714 | ||
PMC7095397 418. We shouldn't worry when a virus mutates during disease outbreaks. | *32071422* 32071422 | ||
PMC7181109 419. Mechanisms by which angiotensin-receptor blockers increase ACE2 levels. | *32332868* 32332868 | ||
PMC7199649 420. Avoiding collateral mortality in a pandemic - time to change our mindset in surgical oncology. | *32372035* 32372035 | ||
PMC7132218 421. Managing cancer during a pandemic. | *32249843* 32249843 | ||
PMC7113912 422. Endocrine and metabolic link to coronavirus infection. | *32242089* 32242089 | ||
PMC7187143 423. Advancing scientific knowledge in times of pandemics. | *32327718* 32327718 | ||
PMC7186934 424. Hydroxychloroquine: small effects in mild disease. | *32286537* 32286537 | ||
PMC7186921 425. Coronaviruses hijack the complement system. | *32286536* 32286536 | ||
PMC7115351 426. Mechano-genomic regulation of coronaviruses and its interplay with ageing. | *32242128* 32242128 | ||
PMC7110432 427. eHealth in kidney care. | *32238923* 32238923 | ||
PMC7095235 428. Urology in the time of corona. | *32203310* 32203310 | ||
PMC7107983 429. Evolutionary perspectives on novel coronaviruses identified in pneumonia cases in China. | *32288962* 32288962 | ||
PMC7184494 430. The aftermath of coronavirus disease of 2019: devastation or a new dawn for nephrology? | *32301978* 32301978 | ||
PMC7166023 431. Sindrome de Guillain-Barre fatal tras infeccion por virus SARS-CoV2. | *32364124* 32364124 | ||
PMC7195417 432. The problems with so-called immunity tests. | *32372836* 32372836 | ||
PMC7195098 433. Do you become immune once you have been infected? | *32372779* 32372779 | ||
PMC7131731 434. Inside Wuhan's lockdown. | *32287788* 32287788 | ||
PMC7131107 435. Calculating virus spread. | *32287801* 32287801 | ||
PMC7131627 436. China uses mass surveillance tech to fight spread of coronavirus. | *32287800* 32287800 | ||
PMC7194960 437. The hunt to find the coronavirus pandemic's patient zero. | *32372785* 32372785 | ||
PMC7194927 438. The problems with contact-tracing apps. | *32372819* 32372819 | ||
PMC7194641 439. Is wearing a face mask a good idea? | *32372813* 32372813 | ||
PMC7194715 440. Concern coronavirus may trigger post-viral fatigue syndromes. | *32372811* 32372811 | ||
PMC7195085 441. The fever paradox. | *32372807* 32372807 | ||
PMC7191552 442. Covid-19. | *32362776* 32362776 | ||
PMC7163346 443. Bariatric Surgery in the Times of Corona. | *32304010* 32304010 | ||
444. Exploring the Association Between Organizational Culture and Large-Scale Adverse Events: Evidence from the Veterans Health Administration. | *32238298* 32238298 | ||
445. 91-Year-Old Man With Upper Extremity Ecchymoses. | *32138895* 32138895 | ||
446. Reexamining the Ethics of Human Germline Editing in the Wake of Scandal. | *32029087* 32029087 | ||
447. Conceptualizacion evolutiva de los mecanismos lesionales en el traumatismo craneoencefalico. | *32192779* 32192779 | ||
448. Factores de riesgo de fracaso de ventilacion no invasiva en neumonia primaria por influenza A en pacientes criticos. | *31924443* 31924443 | ||
865. Relation between BCG coverage rate and COVID-19 infection worldwide. | *32408071* 32408071 | ||
866. Free DNA a reason for severe COVID-19 infection? | *32416412* 32416412 | ||
867. Can beta-adrenergic blockers be used in the treatment of COVID-19? | *32388480* 32388480 | ||
868. Is Copper beneficial for COVID-19 patients? | *32388476* 32388476 | ||
869. Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection. | *32402766* 32402766 | ||
870. The Powerful Immune System Against Powerful COVID-19: A Hypothesis. | *32388390* 32388390 | ||
871. SARS – CoV -2: reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus diphtheria and Bordetella pertussis). | *32387756* 32387756 | ||
872. Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency? | *32387757* 32387757 | ||
873. 5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus COVID-19 infection. | *32438240* 32438240 | ||
874. Hypothesized behavioral host manipulation by SARS-CoV2 / COVID-19 infection. | *32388138* 32388138 | ||
875. Is Global BCG Vaccination Coverage Relevant To The Progression Of SARS-CoV-2 Pandemic? | *C7136957* C7136957 | ||
876. REVISIÓNEcografía en el manejo del paciente crítico con infección por SARS-CoV-2 (COVID-19): aplicaciones clínicas en Medicina Intensiva-una revisión narrativa. | *C7198178* C7198178 | ||
877. Síndrome de Guillain-Barré asociado a infección por Covid-19. | *C7198200* C7198200 | ||
878. Ventilación mecánica no invasiva y oxigenoterapia de alto flujo en la pandemia COVID-19: el valor de un empate. | *C7198163* C7198163 | ||
879. DETECCIÓN VIRAL Y RESPUESTA SEROLÓGICA EN PACIENTES CRÍTICOS INTUBADOS CON SARS-CoV-2. IMPLICACIONES PARA RETIRADA DE AISLAMIENTO. | *32402531* 32402531 | ||
880. Evidencia viva frente al SARS-CoV-2. | *32408962* 32408962 | ||
881. Síndrome post-cuidados intensivos después de la pandemia por SARS-CoV-2. | *32402534* 32402534 | ||
882. Routine use of Point-of-Care lung ultrasound during the COVID-19 pandemic. | *32386997* 32386997 | ||
883. Nuevo coronavirus (2019-nCov): ¿tiene suficientes unidades de cuidados intensivos? | *C7158803* C7158803 | ||
884. How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus. | *32292234* 32292234 | ||
885. German recommendations for critically ill patients with COVID‑19. | *C7155395* C7155395 | ||
886. Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients. | *32387320* 32387320 | ||
887. Limited effectiveness of systematic screening by nasopharyngeal RT-PCR of medicalized nursing home staff after a first case of COVID-19 in a resident. | *32376476* 32376476 | ||
888. Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19). | *32387389* 32387389 | ||
889. Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2. | *32376359* 32376359 | ||
890. Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan China. | *32387682* 32387682 | ||
891. The Forrest Gump approach to preventing severe COVID-19 – reverse the predisposing pro-inflammatory state with exercise. | *32387334* 32387334 | ||
892. Could nitric oxide help to prevent or treat COVID-19? | *32387333* 32387333 | ||
893. Current development of COVID-19 diagnostics vaccines and therapeutics. | *32387332* 32387332 | ||
894. Covid-19-Pandemie: Das macht sie mit der Psyche. | *C7155159* C7155159 | ||
895. Außerklinische Beatmung: Lungenerkrankungen. | *C7155153* C7155153 | ||
896. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? | *32380958* 32380958 | ||
897. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. | *32382135* 32382135 | ||
898. Molecular Basis of Pulmonary Disease. | *C7158196* C7158196 | ||
899. Coronaviren: von der banalen Erkältung zum schweren Lungenversagen: Chronologie einer Pandemie. | *C7110433* C7110433 | ||
900. Innate Humoral Defense Factors. | *C7149504* C7149504 | ||
901. Defensins and Other Antimicrobial Peptides and Proteins. | *C7149371* C7149371 | ||
902. Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid Spain. | *32408147* 32408147 | ||
903. Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod. | *32408155* 32408155 | ||
904. Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis parkinsonism and cognitive impairment. | *32388458* 32388458 | ||
905. COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach. | *32388451* 32388451 | ||
906. Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients. | *32388452* 32388452 | ||
907. Rethinking high-risk groups in COVID-19. | *32388461* 32388461 | ||
908. Can graphene take part in the fight against COVID-19? | *32382315* 32382315 | ||
909. Preparing for a responsible lockdown exit strategy. | *32405055* 32405055 | ||
910. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. | *32376901* 32376901 | ||
911. The multifaceted long-term effects of the COVID-19 pandemic on urology. | *32377015* 32377015 | ||
912. Plasma Metabolomic and Lipidomic Alterations Associated with COVID-19. | *C7197563* C7197563 | ||
913. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. | *C7108005* C7108005 | ||
914. Elevated levels of plasma cytokines in COVID-19 reflect viral load and lung injury. | *C7107806* C7107806 | ||
915. On the origin and continuing evolution of SARS-CoV-2. | *C7107875* C7107875 | ||
916. Moral imperative for the immediate release of 2019-nCoV sequence data. | *C7107834* C7107834 | ||
917. Supresión de angiotensia II en la infección por el virus SARS-CoV-2: una propuesta terapeútica. | *32456945* 32456945 | ||
918. Alta prevalencia de covid19 asintomático en hemodiálisis. Aprendiendo dia a dia el primer mes de pandemia de covid19. | *32456944* 32456944 | ||
919. Situación de la infección por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo Informe del Registro COVID-19 de la Sociedad Española de Nefrología (S.E.N.). | *32389518* 32389518 | ||
920. Neurological Complications in Critically Ill Patients. | *C7152411* C7152411 | ||
921. The COVID-19 pandemic: consideration for brain infection. | *32380269* 32380269 | ||
922. A short review on antibody therapy for COVID-19. | *32313660* 32313660 | ||
923. All about COVID-19 in brief. | *32292590* 32292590 | ||
924. The preventive strategies of GI physicians during the COVID-19 pandemic. | *32292589* 32292589 | ||
925. A Sever case of of SARS-CoV-2 infection in Gansu. | *C7128843* C7128843 | ||
926. Triagestrategie für COVID-19-Verdachtsfälle bei steigender Patientenzahl. | *C7115349* C7115349 | ||
927. Chatbots in the fight against the COVID-19 pandemic. | *32377576* 32377576 | ||
928. COVID-19 vaccines: breaking record times to first-in-human trials. | *32377399* 32377399 | ||
929. COVID-19 und die Geschichte der sozialwissenschaftlichen Katastrophenforschung. | *32382898* 32382898 | ||
930. Die Corona-Pandemie 2020 – über eine allumfassende Prävention hinaus. | *32382897* 32382897 | ||
931. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19. | *32456948* 32456948 | ||
932. A close-up on COVID-19 and cardiovascular diseases. | *32423664* 32423664 | ||
933. The mutual effects of COVID-19 and obesity. | *32382684* 32382684 | ||
934. Recommendations for Metabolic and Bariatric Surgery During the COVID-19 Pandemic from IFSO. | *C7155392* C7155392 | ||
935. Social Distancing in the Covid-19 Pandemic. | *C7197539* C7197539 | ||
865. Relation between BCG coverage rate and COVID-19 infection worldwide. | *32408071* 32408071 | ||
866. Free DNA a reason for severe COVID-19 infection? | *32416412* 32416412 | ||
867. Can beta-adrenergic blockers be used in the treatment of COVID-19? | *32388480* 32388480 | ||
868. Is Copper beneficial for COVID-19 patients? | *32388476* 32388476 | ||
869. Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection. | *32402766* 32402766 | ||
870. The Powerful Immune System Against Powerful COVID-19: A Hypothesis. | *32388390* 32388390 | ||
871. SARS – CoV -2: reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus diphtheria and Bordetella pertussis). | *32387756* 32387756 | ||
872. Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency? | *32387757* 32387757 | ||
873. 5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus COVID-19 infection. | *32438240* 32438240 | ||
874. Hypothesized behavioral host manipulation by SARS-CoV2 / COVID-19 infection. | *32388138* 32388138 | ||
875. Is Global BCG Vaccination Coverage Relevant To The Progression Of SARS-CoV-2 Pandemic? | *C7136957* C7136957 | ||
876. REVISIÓNEcografía en el manejo del paciente crítico con infección por SARS-CoV-2 (COVID-19): aplicaciones clínicas en Medicina Intensiva-una revisión narrativa. | *C7198178* C7198178 | ||
877. Síndrome de Guillain-Barré asociado a infección por Covid-19. | *C7198200* C7198200 | ||
878. Ventilación mecánica no invasiva y oxigenoterapia de alto flujo en la pandemia COVID-19: el valor de un empate. | *C7198163* C7198163 | ||
879. DETECCIÓN VIRAL Y RESPUESTA SEROLÓGICA EN PACIENTES CRÍTICOS INTUBADOS CON SARS-CoV-2. IMPLICACIONES PARA RETIRADA DE AISLAMIENTO. | *32402531* 32402531 | ||
880. Evidencia viva frente al SARS-CoV-2. | *32408962* 32408962 | ||
881. Síndrome post-cuidados intensivos después de la pandemia por SARS-CoV-2. | *32402534* 32402534 | ||
882. Routine use of Point-of-Care lung ultrasound during the COVID-19 pandemic. | *32386997* 32386997 | ||
883. Nuevo coronavirus (2019-nCov): ¿tiene suficientes unidades de cuidados intensivos? | *C7158803* C7158803 | ||
884. How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus. | *32292234* 32292234 | ||
885. German recommendations for critically ill patients with COVID‑19. | *C7155395* C7155395 | ||
886. Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients. | *32387320* 32387320 | ||
887. Limited effectiveness of systematic screening by nasopharyngeal RT-PCR of medicalized nursing home staff after a first case of COVID-19 in a resident. | *32376476* 32376476 | ||
888. Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19). | *32387389* 32387389 | ||
889. Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2. | *32376359* 32376359 | ||
890. Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan China. | *32387682* 32387682 | ||
891. The Forrest Gump approach to preventing severe COVID-19 – reverse the predisposing pro-inflammatory state with exercise. | *32387334* 32387334 | ||
892. Could nitric oxide help to prevent or treat COVID-19? | *32387333* 32387333 | ||
893. Current development of COVID-19 diagnostics vaccines and therapeutics. | *32387332* 32387332 | ||
894. Covid-19-Pandemie: Das macht sie mit der Psyche. | *C7155159* C7155159 | ||
895. Außerklinische Beatmung: Lungenerkrankungen. | *C7155153* C7155153 | ||
896. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? | *32380958* 32380958 | ||
897. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. | *32382135* 32382135 | ||
898. Molecular Basis of Pulmonary Disease. | *C7158196* C7158196 | ||
899. Coronaviren: von der banalen Erkältung zum schweren Lungenversagen: Chronologie einer Pandemie. | *C7110433* C7110433 | ||
900. Innate Humoral Defense Factors. | *C7149504* C7149504 | ||
901. Defensins and Other Antimicrobial Peptides and Proteins. | *C7149371* C7149371 | ||
902. Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid Spain. | *32408147* 32408147 | ||
903. Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod. | *32408155* 32408155 | ||
904. Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis parkinsonism and cognitive impairment. | *32388458* 32388458 | ||
905. COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach. | *32388451* 32388451 | ||
906. Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients. | *32388452* 32388452 | ||
907. Rethinking high-risk groups in COVID-19. | *32388461* 32388461 | ||
908. Can graphene take part in the fight against COVID-19? | *32382315* 32382315 | ||
909. Preparing for a responsible lockdown exit strategy. | *32405055* 32405055 | ||
910. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. | *32376901* 32376901 | ||
911. The multifaceted long-term effects of the COVID-19 pandemic on urology. | *32377015* 32377015 | ||
912. Plasma Metabolomic and Lipidomic Alterations Associated with COVID-19. | *C7197563* C7197563 | ||
913. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. | *C7108005* C7108005 | ||
914. Elevated levels of plasma cytokines in COVID-19 reflect viral load and lung injury. | *C7107806* C7107806 | ||
915. On the origin and continuing evolution of SARS-CoV-2. | *C7107875* C7107875 | ||
916. Moral imperative for the immediate release of 2019-nCoV sequence data. | *C7107834* C7107834 | ||
917. Supresión de angiotensia II en la infección por el virus SARS-CoV-2: una propuesta terapeútica. | *32456945* 32456945 | ||
918. Alta prevalencia de covid19 asintomático en hemodiálisis. Aprendiendo dia a dia el primer mes de pandemia de covid19. | *32456944* 32456944 | ||
919. Situación de la infección por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo Informe del Registro COVID-19 de la Sociedad Española de Nefrología (S.E.N.). | *32389518* 32389518 | ||
920. Neurological Complications in Critically Ill Patients. | *C7152411* C7152411 | ||
921. The COVID-19 pandemic: consideration for brain infection. | *32380269* 32380269 | ||
922. A short review on antibody therapy for COVID-19. | *32313660* 32313660 | ||
923. All about COVID-19 in brief. | *32292590* 32292590 | ||
924. The preventive strategies of GI physicians during the COVID-19 pandemic. | *32292589* 32292589 | ||
925. A Sever case of of SARS-CoV-2 infection in Gansu. | *C7128843* C7128843 | ||
926. Triagestrategie für COVID-19-Verdachtsfälle bei steigender Patientenzahl. | *C7115349* C7115349 | ||
927. Chatbots in the fight against the COVID-19 pandemic. | *32377576* 32377576 | ||
928. COVID-19 vaccines: breaking record times to first-in-human trials. | *32377399* 32377399 | ||
929. COVID-19 und die Geschichte der sozialwissenschaftlichen Katastrophenforschung. | *32382898* 32382898 | ||
930. Die Corona-Pandemie 2020 – über eine allumfassende Prävention hinaus. | *32382897* 32382897 | ||
931. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19. | *32456948* 32456948 | ||
932. A close-up on COVID-19 and cardiovascular diseases. | *32423664* 32423664 | ||
933. The mutual effects of COVID-19 and obesity. | *32382684* 32382684 | ||
934. Recommendations for Metabolic and Bariatric Surgery During the COVID-19 Pandemic from IFSO. | *C7155392* C7155392 | ||
935. Social Distancing in the Covid-19 Pandemic. | *C7197539* C7197539 | ||
937. COVID-19 lockdowns throughout the world. | *C7197518* C7197518 | ||
938. Health and safety considerations for hotel cleaners during Covid-19. | *C7197552* C7197552 | ||
939. The SARS-CoV-2 outbreak from a one health perspective. | *C7102578* C7102578 | ||
940. C reactive protein level may predict the risk of COVID-19 aggravation. | *32455147* 32455147 | ||
941. Analysis of mortality in patients of COVID-19: clinical and laboratory parameters. | *32457924* 32457924 | ||
942. Risks Posed to Corneal Transplant Recipients by COVID-19-Affected Donors. | *32378180* 32378180 | ||
943. Ophthalmology Practice During the Coronavirus Disease 2019 Pandemic: The University of Pittsburgh Experience in Promoting Clinic Safety and Embracing Video Visits. | *32377502* 32377502 | ||
944. Neuro-Ophthalmology in the Era of COVID-19: Future Implications of a Public Health Crisis. | *32387481* 32387481 | ||
945. Living with COVID-19: A Perspective from New York Area Ophthalmology Residency Program Directors at the Epicenter of the Pandemic. | *32387482* 32387482 | ||
946. Coping with COVID-19: An Italian Perspective on Corneal Surgery and Eye Banking in the Time of a Pandemic and Beyond. | *32376056* 32376056 | ||
947. Management of Tracheostomy during COVID-19 Outbreak: Heat and Moisture Exchanger Filter and Closed Suctioning System. | *32402655* 32402655 | ||
948. Utilization of COVID-19 testing for opportunistic screening of oral cancer. | *32423662* 32423662 | ||
949. Impact of COVID-19 on the early detection of oral cancer: A special emphasis on high risk populations. | *32423663* 32423663 | ||
950. The Kerala Model of Health Care delivery and its impact on Oral cancer care during the Covid 19 pandemic. | *32387029* 32387029 | ||
951. Surgical tracheostomies in COVID-19 patients: A multidisciplinary approach and lessons learned. | *32389538* 32389538 | ||
952. What dentists need to know about COVID-19. | *32380453* 32380453 | ||
953. Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members. | *32387082* 32387082 | ||
954. Interleukin-6 levels in children developing SARS-CoV-2 infection. | *32414693* 32414693 | ||
955. Practical Bioethics during the Exceptional Circumstances of a Pandemic. | *32381278* 32381278 | ||
956. In Silico Design of Antiviral Peptides Targeting the Spike Protein of SARS-CoV-2. | *32380200* 32380200 | ||
957. Flaviviruses. | *C7126740* C7126740 | ||
958. Substantial direct medical costs for symptomatic COVID-19 cases in the US. | *32382248* 32382248 | ||
959. Costs vs benefits of tackling COVID-19. | *32382246* 32382246 | ||
960. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. | *32389859* 32389859 | ||
961. The CoV-2 outbreak: how hematologists could help to fight Covid-19. | *32387301* 32387301 | ||
962. The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence. | *32380051* 32380051 | ||
963. Granulocyte-targeted therapies for airway diseases. | *32380052* 32380052 | ||
964. Better prepare for the next one. Lifestyle lessons from the COVID-19 pandemic. | *32382499* 32382499 | ||
965. COVID-19 pandemic planning: considerations for radiation oncology medical physics. | *C7153354* C7153354 | ||
966. Covid-19: automatic detection from X-ray images utilizing transfer learning with convolutional neural networks. | *C7118364* C7118364 | ||
967. Pneumonia. | *C7152463* C7152463 | ||
968. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis. | *32389584* 32389584 | ||
969. The psychological well-being of physicians during COVID-19 outbreak in Oman. | *32388173* 32388173 | ||
970. Access barriers to electroconvulsive therapy during COVID-19 pandemic. | *32450452* 32450452 | ||
971. COVID-19 Pandemic: Impact on Psychiatric Care in the United States a Review. | *32413707* 32413707 | ||
972. Mental health of family friends and co-workers of COVID-19 patients in Japan. | *C7202826* C7202826 | ||
973. Psychological underpinning of panic buying during pandemic (COVID-19). | *32413711* 32413711 | ||
974. Contamination and infection: what the coronavirus pandemic could reveal about the evolutionary origins of obsessive-compulsive disorder. | *32413712* 32413712 | ||
975. COVID19 pandemic and people with opioid use disorder: innovation to reduce risk. | *32387795* 32387795 | ||
976. Danger in danger: Interpersonal violence during COVID-19 quarantine. | *32387794* 32387794 | ||
977. Implementation of quarantine in China during the outbreak of COVID-19. | *32387796* 32387796 | ||
978. Psychological crisis intervention response to the COVID 19 pandemic: A Tunisian centralised Protocol. | *32387792* 32387792 | ||
979. Does COVID-19 pandemic affect sexual behaviour? A cross-sectional cross-national online survey. | *32387790* 32387790 | ||
980. How an Epidemic Outbreak Impacts Happiness: Factors that Worsen (vs. Protect) Emotional Well-being during the Coronavirus Pandemic. | *32388418* 32388418 | ||
981. Role of electronic media in mitigating the psychological impacts of novel coronavirus (COVID-19). | *32388417* 32388417 | ||
982. Covid-19: An Urgent Need For A Psychoneuroendocrine Perspective. | *32387180* 32387180 | ||
983. Consultation-Liaison Psychiatry in the Age of COVID-19: Reaffirming Ourselves and Our Worth. | *32439183* 32439183 | ||
984. COVID-19 associated psychiatric symptoms in healthcare workers: viewpoint from internal medicine and psychiatry residents. | *32439184* 32439184 | ||
985. Indoor Air Quality and Coronavirus Disease (COVID-19). | *C7203025* C7203025 | ||
986. NON-COVID-19 VISITS TO EMERGENCY DEPARTMENTS DURING THE PANDEMIC: THE IMPACT OF FEAR. | *32417567* 32417567 | ||
987. The disguised pandemic: the importance of data normalization in COVID-19 web mapping. | *32416476* 32416476 | ||
988. We must not forget the most disadvantaged people facing the COVID-19 crisis. | *C7200338* C7200338 | ||
989. Disinfection tunnels: potentially counterproductive in the context of a prolonged pandemic of COVID-19. | *32422441* 32422441 | ||
990. Examining the Effect of Social Distancing on the Compound Growth Rate of SARS-CoV-2 at the County Level (United States) Using Statistical Analyses and a Random Forest Machine Learning Model. | *C7186211* C7186211 | ||
991. Potential Threats of COVID-19 On Quarantined Families. | *32380343* 32380343 | ||
992. Is home isolation appropriate for preventing the spread of COVID-19? | *32388010* 32388010 | ||
993. Helmet Continuous Positive Airway Pressure and prone positioning: a proposal for an early management of COVID-19 patients. | *32386886* 32386886 | ||
994. Chest CT Findings of Early and Progressive Phase COVID-19 Infection from a US Patient. | *32313588* 32313588 | ||
995. What is our threshold? Departmental planning for radiation oncology’s future in the time of COVID-19. | *32389753* 32389753 | ||
996. Response to: low dose radiation therapy for COVID-19 pneumonia a double-edged sword. | *32387544* 32387544 | ||
997. Response letter: handling of COVID-19 positive patients during the pandemic. | *32389757* 32389757 | ||
998. RILI model and the Covid-19 pneumonia: the radiation oncologist point of view. | *32389754* 32389754 | ||
999. Radiotherapy and COVID-19: Practical recommendations from iran☆☆☆. | *32387545* 32387545 | ||
1000. Radiotherapy & oncology during the COVID-19 pandemic. | *32389420* 32389420 | ||
1001. Application of immunofluorescence technique to clinical virology. | *C7151846* C7151846 | ||
1002. Human Coronavirus-229E -OC43 -NL63 and -HKU1. | *C7204879* C7204879 | ||
1003. La rehabilitación en los tiempos del COVID-19. | *32441268* 32441268 | ||
1004. Diagnostik und Management der wichtigsten Reiseund Tropenkrankheiten. | *C7156010* C7156010 | ||
1005. Potential risks of SARS-Cov-2 infection on reproductive health. | *32466994* 32466994 | ||
937. COVID-19 lockdowns throughout the world. | *C7197518* C7197518 | ||
938. Health and safety considerations for hotel cleaners during Covid-19. | *C7197552* C7197552 | ||
939. The SARS-CoV-2 outbreak from a one health perspective. | *C7102578* C7102578 | ||
940. C reactive protein level may predict the risk of COVID-19 aggravation. | *32455147* 32455147 | ||
941. Analysis of mortality in patients of COVID-19: clinical and laboratory parameters. | *32457924* 32457924 | ||
942. Risks Posed to Corneal Transplant Recipients by COVID-19-Affected Donors. | *32378180* 32378180 | ||
943. Ophthalmology Practice During the Coronavirus Disease 2019 Pandemic: The University of Pittsburgh Experience in Promoting Clinic Safety and Embracing Video Visits. | *32377502* 32377502 | ||
944. Neuro-Ophthalmology in the Era of COVID-19: Future Implications of a Public Health Crisis. | *32387481* 32387481 | ||
945. Living with COVID-19: A Perspective from New York Area Ophthalmology Residency Program Directors at the Epicenter of the Pandemic. | *32387482* 32387482 | ||
946. Coping with COVID-19: An Italian Perspective on Corneal Surgery and Eye Banking in the Time of a Pandemic and Beyond. | *32376056* 32376056 | ||
947. Management of Tracheostomy during COVID-19 Outbreak: Heat and Moisture Exchanger Filter and Closed Suctioning System. | *32402655* 32402655 | ||
948. Utilization of COVID-19 testing for opportunistic screening of oral cancer. | *32423662* 32423662 | ||
949. Impact of COVID-19 on the early detection of oral cancer: A special emphasis on high risk populations. | *32423663* 32423663 | ||
950. The Kerala Model of Health Care delivery and its impact on Oral cancer care during the Covid 19 pandemic. | *32387029* 32387029 | ||
951. Surgical tracheostomies in COVID-19 patients: A multidisciplinary approach and lessons learned. | *32389538* 32389538 | ||
952. What dentists need to know about COVID-19. | *32380453* 32380453 | ||
953. Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members. | *32387082* 32387082 | ||
954. Interleukin-6 levels in children developing SARS-CoV-2 infection. | *32414693* 32414693 | ||
955. Practical Bioethics during the Exceptional Circumstances of a Pandemic. | *32381278* 32381278 | ||
956. In Silico Design of Antiviral Peptides Targeting the Spike Protein of SARS-CoV-2. | *32380200* 32380200 | ||
957. Flaviviruses. | *C7126740* C7126740 | ||
958. Substantial direct medical costs for symptomatic COVID-19 cases in the US. | *32382248* 32382248 | ||
959. Costs vs benefits of tackling COVID-19. | *32382246* 32382246 | ||
960. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. | *32389859* 32389859 | ||
961. The CoV-2 outbreak: how hematologists could help to fight Covid-19. | *32387301* 32387301 | ||
962. The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence. | *32380051* 32380051 | ||
963. Granulocyte-targeted therapies for airway diseases. | *32380052* 32380052 | ||
964. Better prepare for the next one. Lifestyle lessons from the COVID-19 pandemic. | *32382499* 32382499 | ||
965. COVID-19 pandemic planning: considerations for radiation oncology medical physics. | *C7153354* C7153354 | ||
966. Covid-19: automatic detection from X-ray images utilizing transfer learning with convolutional neural networks. | *C7118364* C7118364 | ||
967. Pneumonia. | *C7152463* C7152463 | ||
968. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis. | *32389584* 32389584 | ||
969. The psychological well-being of physicians during COVID-19 outbreak in Oman. | *32388173* 32388173 | ||
970. Access barriers to electroconvulsive therapy during COVID-19 pandemic. | *32450452* 32450452 | ||
971. COVID-19 Pandemic: Impact on Psychiatric Care in the United States a Review. | *32413707* 32413707 | ||
972. Mental health of family friends and co-workers of COVID-19 patients in Japan. | *C7202826* C7202826 | ||
973. Psychological underpinning of panic buying during pandemic (COVID-19). | *32413711* 32413711 | ||
974. Contamination and infection: what the coronavirus pandemic could reveal about the evolutionary origins of obsessive-compulsive disorder. | *32413712* 32413712 | ||
975. COVID19 pandemic and people with opioid use disorder: innovation to reduce risk. | *32387795* 32387795 | ||
976. Danger in danger: Interpersonal violence during COVID-19 quarantine. | *32387794* 32387794 | ||
977. Implementation of quarantine in China during the outbreak of COVID-19. | *32387796* 32387796 | ||
978. Psychological crisis intervention response to the COVID 19 pandemic: A Tunisian centralised Protocol. | *32387792* 32387792 | ||
979. Does COVID-19 pandemic affect sexual behaviour? A cross-sectional cross-national online survey. | *32387790* 32387790 | ||
980. How an Epidemic Outbreak Impacts Happiness: Factors that Worsen (vs. Protect) Emotional Well-being during the Coronavirus Pandemic. | *32388418* 32388418 | ||
981. Role of electronic media in mitigating the psychological impacts of novel coronavirus (COVID-19). | *32388417* 32388417 | ||
982. Covid-19: An Urgent Need For A Psychoneuroendocrine Perspective. | *32387180* 32387180 | ||
983. Consultation-Liaison Psychiatry in the Age of COVID-19: Reaffirming Ourselves and Our Worth. | *32439183* 32439183 | ||
984. COVID-19 associated psychiatric symptoms in healthcare workers: viewpoint from internal medicine and psychiatry residents. | *32439184* 32439184 | ||
985. Indoor Air Quality and Coronavirus Disease (COVID-19). | *C7203025* C7203025 | ||
986. NON-COVID-19 VISITS TO EMERGENCY DEPARTMENTS DURING THE PANDEMIC: THE IMPACT OF FEAR. | *32417567* 32417567 | ||
987. The disguised pandemic: the importance of data normalization in COVID-19 web mapping. | *32416476* 32416476 | ||
988. We must not forget the most disadvantaged people facing the COVID-19 crisis. | *C7200338* C7200338 | ||
989. Disinfection tunnels: potentially counterproductive in the context of a prolonged pandemic of COVID-19. | *32422441* 32422441 | ||
990. Examining the Effect of Social Distancing on the Compound Growth Rate of SARS-CoV-2 at the County Level (United States) Using Statistical Analyses and a Random Forest Machine Learning Model. | *C7186211* C7186211 | ||
991. Potential Threats of COVID-19 On Quarantined Families. | *32380343* 32380343 | ||
992. Is home isolation appropriate for preventing the spread of COVID-19? | *32388010* 32388010 | ||
993. Helmet Continuous Positive Airway Pressure and prone positioning: a proposal for an early management of COVID-19 patients. | *32386886* 32386886 | ||
994. Chest CT Findings of Early and Progressive Phase COVID-19 Infection from a US Patient. | *32313588* 32313588 | ||
995. What is our threshold? Departmental planning for radiation oncology’s future in the time of COVID-19. | *32389753* 32389753 | ||
996. Response to: low dose radiation therapy for COVID-19 pneumonia a double-edged sword. | *32387544* 32387544 | ||
997. Response letter: handling of COVID-19 positive patients during the pandemic. | *32389757* 32389757 | ||
998. RILI model and the Covid-19 pneumonia: the radiation oncologist point of view. | *32389754* 32389754 | ||
999. Radiotherapy and COVID-19: Practical recommendations from iran☆☆☆. | *32387545* 32387545 | ||
1000. Radiotherapy & oncology during the COVID-19 pandemic. | *32389420* 32389420 | ||
1001. Application of immunofluorescence technique to clinical virology. | *C7151846* C7151846 | ||
1002. Human Coronavirus-229E -OC43 -NL63 and -HKU1. | *C7204879* C7204879 | ||
1003. La rehabilitación en los tiempos del COVID-19. | *32441268* 32441268 | ||
1004. Diagnostik und Management der wichtigsten Reiseund Tropenkrankheiten. | *C7156010* C7156010 | ||
1005. Potential risks of SARS-Cov-2 infection on reproductive health. | *32466994* 32466994 | ||
1009. A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy. | *32451301* 32451301 | ||
1010. An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic. | *32409150* 32409150 | ||
1011. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. | *32377638* 32377638 | ||
1012. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. | *32421541* 32421541 | ||
1013. Correlation analysis of the severity and clinical prognosis of 32 cases of patients with COVID-19. | *32421546* 32421546 | ||
1014. Coronavirus Disease 2019-related dyspnea cases difficult to interpret using chest computed tomography. | *32421539* 32421539 | ||
1015. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). | *32421537* 32421537 | ||
1016. Bronchoscopy use in the COVID-19 era. | *C7204699* C7204699 | ||
1017. Venous thromboembolism and COVID-19. | *C7187811* C7187811 | ||
1018. Biological Agents. | *C7152118* C7152118 | ||
1019. Drone delivery of AED s and personal protective equipment in the era of SARS-CoV-2. | *32380028* 32380028 | ||
1020. PROPUESTA DE USO DE ANAKINRA EN EL DISTRESS RESPIRATORIO AGUDO SECUNDARIO A COVID-19. | *C7183956* C7183956 | ||
1021. A novel coronavirus emerges. | *C7130038* C7130038 | ||
1022. Coronavirus: la emergencia geriátrica de 2020. Documento conjunto de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología y la Sociedad Española de Geriatría y Gerontología. | *C7129713* C7129713 | ||
1023. Fatal outcome of COVID-19 disease in a 5-month infant with comorbidities. | *32423738* 32423738 | ||
1024. Pulmonary embolism in COVID-19. When nothing is what it seems. | *32376225* 32376225 | ||
1025. Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography. | *32402687* 32402687 | ||
1026. COVID-19 y shock cardiogénico: diferentes formas de presentación cardiovascular con alta mortalidad. | *C7184000* C7184000 | ||
1027. ST-segment elevation myocardial infarction in times of COVID-19: back to the last century? A call for attention. | *32381326* 32381326 | ||
1028. NEUMONÍA VÍRICA BILATERAL POR COVID-19 COMO HALLAZGO CAUSAL EN 18F-FDG-PET-TC DE ESTADIFICACIÓN DE PACIENTE CON MELANOMA GEMELAR DERECHO. | *C7151367* C7151367 | ||
1029. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19. | *32376072* 32376072 | ||
1030. Recommendations for a safety dental care management during SARS-CoV-2 pandemic. | *32382259* 32382259 | ||
1031. Caring for cardiac patients amidst the SARS-CoV-2 pandemic: The scrambled pieces of the puzzle. | *32423627* 32423627 | ||
1032. Reactive psychoses in the context of the COVID-19 pandemic: clinical perspectives from a case series. | *32389516* 32389516 | ||
1033. LA PSIQUIATRÍA EN LAS SECUELAS DE COVID-19. | *32376131* 32376131 | ||
1034. Perspectivas Internacionales en Salud Mental ante la pandemia por el nuevo coronavirus SARS-CoV-2. | *32389514* 32389514 | ||
1035. Comment et pourquoi les rhumatologues sont importants face la crise du COVID-19? | *32382245* 32382245 | ||
1036. COVID-19 and Middle East Respiratory Syndrome Infections in Health-Care Workers in Korea. | *32382448* 32382448 | ||
1037. Preventing intra-hospital infection and transmission of COVID-19 in healthcare workers. | *C7102575* C7102575 | ||
1038. The scientific literature on Coronaviruses COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review. | *32382213* 32382213 | ||
1039. Ferrets. | *C7150118* C7150118 | ||
1040. Long acting injectable antipsychotic medications: Ensuring care continuity during the COVID-19 pandemic restrictions. | *32389613* 32389613 | ||
1041. The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research. | *32389615* 32389615 | ||
1042. Science Education in the Era of a Pandemic: How Can History Philosophy and Sociology of Science Contribute to Education for Understanding and Solving the Covid-19 Crisis? | *C7111621* C7111621 | ||
1043. Possible environmental effects on the spread of COVID-19 in China. | *32402910* 32402910 | ||
1044. Changes in air quality related to the control of coronavirus in China: Implications for traffic and industrial emissions. | *32402905* 32402905 | ||
1045. Letter to editor regarding Ogen Y 2020 paper: “Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality”. | *32402462* 32402462 | ||
1046. Response to the commentary by Alexandra A. Chudnovsky on ‘Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality’. | *32402464* 32402464 | ||
1047. On airborne transmission and control of SARS-Cov-2. | *32388162* 32388162 | ||
1048. Assessing air quality changes in large cities during COVID-19 lockdowns: The impacts of traffic-free urban conditions in Almaty Kazakhstan. | *32387822* 32387822 | ||
1049. Asymmetric nexus between temperature and COVID-19 in the top ten affected provinces of China: A current application of quantile-on-quantile approach. | *32470687* 32470687 | ||
1050. SARS-CoV-2 in wastewater: State of the knowledge and research needs. | *C7191289* C7191289 | ||
1051. Nurture to nature via COVID-19 a self-regenerating environmental strategy of environment in global context. | *32388136* 32388136 | ||
1052. Does lockdown reduce air pollution? Evidence from 44 cities in northern China. | *32413655* 32413655 | ||
1053. COVID-19 pandemic: Impacts on the air quality during the partial lockdown in São Paulo state Brazil. | *32380370* 32380370 | ||
1054. Evidence that high temperatures and intermediate relative humidity might favor the spread of COVID-19 in tropical climate: A case study for the most affected Brazilian cities. | *32388137* 32388137 | ||
1055. COVID-19 and surface water quality: Improved lake water quality during the lockdown. | *32388159* 32388159 | ||
1056. Lockdown one two none or smart. Modeling containing covid-19 infection. A conceptual model. | *32387821* 32387821 | ||
1057. The nexus between COVID-19 temperature and exchange rate in Wuhan city: New findings from partial and multiple wavelet coherence. | *32388129* 32388129 | ||
1058. Factors determining the diffusion of COVID-19 and suggested strategy to prevent future accelerated viral infectivity similar to COVID. | *C7169901* C7169901 | ||
1059. First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community. | *32387778* 32387778 | ||
1060. Pollen likely seasonal factor in inhibiting flu-like epidemics. A Dutch study into the inverse relation between pollen counts hay fever and flu-like incidence 2016–2019. | *C7162772* C7162772 | ||
1061. Association between ambient temperature and COVID-19 infection in 122 cities from China. | *32408450* 32408450 | ||
1062. Effects of temperature variation and humidity on the death of COVID-19 in Wuhan China. | *32408453* 32408453 | ||
1063. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. | *32253226* 32253226 | ||
1064. Estimando el número de casos de COVID-19 a tiempo real utilizando un formulario web a través de las redes sociales: Proyecto COVID19-TRENDS. | *32467013* 32467013 | ||
1065. Correction: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. | *32377400* 32377400 | ||
1066. COVID-19 Outbreak: an Update on Therapeutic Options. | *C7110269* C7110269 | ||
1067. Determining the spatial effects of COVID-19 using the spatial panel data model. | *C7139267* C7139267 | ||
1068. Covid-19: Situationsbericht über die initialen Maßnahmen an österreichischen Augenabteilungen. | *32377035* 32377035 | ||
1069. Spine surgery in Atlantic Canada in COVID-19 era: lessons learned so far. | *32389734* 32389734 | ||
1070. On a Statistical Transmission Model in Analysis of the Early Phase of COVID-19 Outbreak. | *C7113380* C7113380 | ||
1071. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. | *C7187856* C7187856 | ||
1072. Small bowel ischemia and SARS-CoV-2 infection: an underdiagnosed distinct clinical entity. | *C7198136* C7198136 | ||
1073. Is it Ethically Appropriate to Continue Surgical Clinical Trials During the COVID-19 Pandemic? EDITED BY DR SARR. | *C7184004* C7184004 | ||
1074. Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus. | *32296735* 32296735 | ||
1075. Demyelinating Disorders of the Central Nervous System. | *C7158368* C7158368 | ||
1076. What Are We Talking About? The History and Theory of Post-Truth Communication ; (): 1-10 | *C7153724* C7153724 | ||
1077. “Off-label” use of hydroxychloroquine azithromycin lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. | *32418730* 32418730 | ||
1078. Non-steroidal anti-inflammatory drugs pharmacology and COVID-19 infection. | *32418728* 32418728 | ||
1079. THERAP–COVID-19. | *C7194540* C7194540 | ||
1009. A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy. | *32451301* 32451301 | ||
1010. An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic. | *32409150* 32409150 | ||
1011. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. | *32377638* 32377638 | ||
1012. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. | *32421541* 32421541 | ||
1013. Correlation analysis of the severity and clinical prognosis of 32 cases of patients with COVID-19. | *32421546* 32421546 | ||
1014. Coronavirus Disease 2019-related dyspnea cases difficult to interpret using chest computed tomography. | *32421539* 32421539 | ||
1015. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). | *32421537* 32421537 | ||
1016. Bronchoscopy use in the COVID-19 era. | *C7204699* C7204699 | ||
1017. Venous thromboembolism and COVID-19. | *C7187811* C7187811 | ||
1018. Biological Agents. | *C7152118* C7152118 | ||
1019. Drone delivery of AED s and personal protective equipment in the era of SARS-CoV-2. | *32380028* 32380028 | ||
1020. PROPUESTA DE USO DE ANAKINRA EN EL DISTRESS RESPIRATORIO AGUDO SECUNDARIO A COVID-19. | *C7183956* C7183956 | ||
1021. A novel coronavirus emerges. | *C7130038* C7130038 | ||
1022. Coronavirus: la emergencia geriátrica de 2020. Documento conjunto de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología y la Sociedad Española de Geriatría y Gerontología. | *C7129713* C7129713 | ||
1023. Fatal outcome of COVID-19 disease in a 5-month infant with comorbidities. | *32423738* 32423738 | ||
1024. Pulmonary embolism in COVID-19. When nothing is what it seems. | *32376225* 32376225 | ||
1025. Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography. | *32402687* 32402687 | ||
1026. COVID-19 y shock cardiogénico: diferentes formas de presentación cardiovascular con alta mortalidad. | *C7184000* C7184000 | ||
1027. ST-segment elevation myocardial infarction in times of COVID-19: back to the last century? A call for attention. | *32381326* 32381326 | ||
1028. NEUMONÍA VÍRICA BILATERAL POR COVID-19 COMO HALLAZGO CAUSAL EN 18F-FDG-PET-TC DE ESTADIFICACIÓN DE PACIENTE CON MELANOMA GEMELAR DERECHO. | *C7151367* C7151367 | ||
1029. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19. | *32376072* 32376072 | ||
1030. Recommendations for a safety dental care management during SARS-CoV-2 pandemic. | *32382259* 32382259 | ||
1031. Caring for cardiac patients amidst the SARS-CoV-2 pandemic: The scrambled pieces of the puzzle. | *32423627* 32423627 | ||
1032. Reactive psychoses in the context of the COVID-19 pandemic: clinical perspectives from a case series. | *32389516* 32389516 | ||
1033. LA PSIQUIATRÍA EN LAS SECUELAS DE COVID-19. | *32376131* 32376131 | ||
1034. Perspectivas Internacionales en Salud Mental ante la pandemia por el nuevo coronavirus SARS-CoV-2. | *32389514* 32389514 | ||
1035. Comment et pourquoi les rhumatologues sont importants face la crise du COVID-19? | *32382245* 32382245 | ||
1036. COVID-19 and Middle East Respiratory Syndrome Infections in Health-Care Workers in Korea. | *32382448* 32382448 | ||
1037. Preventing intra-hospital infection and transmission of COVID-19 in healthcare workers. | *C7102575* C7102575 | ||
1038. The scientific literature on Coronaviruses COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review. | *32382213* 32382213 | ||
1039. Ferrets. | *C7150118* C7150118 | ||
1040. Long acting injectable antipsychotic medications: Ensuring care continuity during the COVID-19 pandemic restrictions. | *32389613* 32389613 | ||
1041. The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research. | *32389615* 32389615 | ||
1042. Science Education in the Era of a Pandemic: How Can History Philosophy and Sociology of Science Contribute to Education for Understanding and Solving the Covid-19 Crisis? | *C7111621* C7111621 | ||
1043. Possible environmental effects on the spread of COVID-19 in China. | *32402910* 32402910 | ||
1044. Changes in air quality related to the control of coronavirus in China: Implications for traffic and industrial emissions. | *32402905* 32402905 | ||
1045. Letter to editor regarding Ogen Y 2020 paper: “Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality”. | *32402462* 32402462 | ||
1046. Response to the commentary by Alexandra A. Chudnovsky on ‘Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality’. | *32402464* 32402464 | ||
1047. On airborne transmission and control of SARS-Cov-2. | *32388162* 32388162 | ||
1048. Assessing air quality changes in large cities during COVID-19 lockdowns: The impacts of traffic-free urban conditions in Almaty Kazakhstan. | *32387822* 32387822 | ||
1049. Asymmetric nexus between temperature and COVID-19 in the top ten affected provinces of China: A current application of quantile-on-quantile approach. | *32470687* 32470687 | ||
1050. SARS-CoV-2 in wastewater: State of the knowledge and research needs. | *C7191289* C7191289 | ||
1051. Nurture to nature via COVID-19 a self-regenerating environmental strategy of environment in global context. | *32388136* 32388136 | ||
1052. Does lockdown reduce air pollution? Evidence from 44 cities in northern China. | *32413655* 32413655 | ||
1053. COVID-19 pandemic: Impacts on the air quality during the partial lockdown in São Paulo state Brazil. | *32380370* 32380370 | ||
1054. Evidence that high temperatures and intermediate relative humidity might favor the spread of COVID-19 in tropical climate: A case study for the most affected Brazilian cities. | *32388137* 32388137 | ||
1055. COVID-19 and surface water quality: Improved lake water quality during the lockdown. | *32388159* 32388159 | ||
1056. Lockdown one two none or smart. Modeling containing covid-19 infection. A conceptual model. | *32387821* 32387821 | ||
1057. The nexus between COVID-19 temperature and exchange rate in Wuhan city: New findings from partial and multiple wavelet coherence. | *32388129* 32388129 | ||
1058. Factors determining the diffusion of COVID-19 and suggested strategy to prevent future accelerated viral infectivity similar to COVID. | *C7169901* C7169901 | ||
1059. First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community. | *32387778* 32387778 | ||
1060. Pollen likely seasonal factor in inhibiting flu-like epidemics. A Dutch study into the inverse relation between pollen counts hay fever and flu-like incidence 2016–2019. | *C7162772* C7162772 | ||
1061. Association between ambient temperature and COVID-19 infection in 122 cities from China. | *32408450* 32408450 | ||
1062. Effects of temperature variation and humidity on the death of COVID-19 in Wuhan China. | *32408453* 32408453 | ||
1063. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. | *32253226* 32253226 | ||
1064. Estimando el número de casos de COVID-19 a tiempo real utilizando un formulario web a través de las redes sociales: Proyecto COVID19-TRENDS. | *32467013* 32467013 | ||
1065. Correction: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. | *32377400* 32377400 | ||
1066. COVID-19 Outbreak: an Update on Therapeutic Options. | *C7110269* C7110269 | ||
1067. Determining the spatial effects of COVID-19 using the spatial panel data model. | *C7139267* C7139267 | ||
1068. Covid-19: Situationsbericht über die initialen Maßnahmen an österreichischen Augenabteilungen. | *32377035* 32377035 | ||
1069. Spine surgery in Atlantic Canada in COVID-19 era: lessons learned so far. | *32389734* 32389734 | ||
1070. On a Statistical Transmission Model in Analysis of the Early Phase of COVID-19 Outbreak. | *C7113380* C7113380 | ||
1071. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. | *C7187856* C7187856 | ||
1072. Small bowel ischemia and SARS-CoV-2 infection: an underdiagnosed distinct clinical entity. | *C7198136* C7198136 | ||
1073. Is it Ethically Appropriate to Continue Surgical Clinical Trials During the COVID-19 Pandemic? EDITED BY DR SARR. | *C7184004* C7184004 | ||
1074. Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus. | *32296735* 32296735 | ||
1075. Demyelinating Disorders of the Central Nervous System. | *C7158368* C7158368 | ||
1076. What Are We Talking About? The History and Theory of Post-Truth Communication ; (): 1-10 | *C7153724* C7153724 | ||
1077. “Off-label” use of hydroxychloroquine azithromycin lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. | *32418730* 32418730 | ||
1078. Non-steroidal anti-inflammatory drugs pharmacology and COVID-19 infection. | *32418728* 32418728 | ||
1079. THERAP–COVID-19. | *C7194540* C7194540 | ||
1081. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. | *32407937* 32407937 | ||
1082. Early thromboembolic events in hospitalized COVID-19 patients. | *32403032* 32403032 | ||
1083. Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19 infection. | *32416365* 32416365 | ||
1084. Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid. | *32403033* 32403033 | ||
1085. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. | *32381264* 32381264 | ||
1086. Thrombotic complications in critically ill patients with COVID 19. | *32388068* 32388068 | ||
1087. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. | *C7146714* C7146714 | ||
1088. Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a meta-analysis. | *32382258* 32382258 | ||
1089. Wuhan Covid19 data – more questions than answers. | *32387286* 32387286 | ||
1090. Convalescent Plasma an Apheresis Research Project Targeting and Motivating the Fully Recovered COVID 19 Patients: A Rousing Message of Clinical Benefit To Both Donors and Recipients Alike. | *32448638* 32448638 | ||
1091. Convalescent Plasma an Apheresis Research Project Targeting and Motivating the Fully Recovered COVID 19 Patients: A Rousing Message of Clinical Benefit To Both Donors and Recipients Alike. | *32417123* 32417123 | ||
1092. COVID-19: A perspective of a frontline worker. | *32409154* 32409154 | ||
1093. A quick “Can I donate blood” self-assessment tool amid the COVID-19 outbreak. | *32417113* 32417113 | ||
1094. The blood supply management amid the COVID-19 outbreak. | *32386966* 32386966 | ||
1095. COVID-19-Related Stroke. | *32378030* 32378030 | ||
1096. eClinic: increasing use of telehealth as a risk reduction strategy during the covid-19 pandemic. | *32377571* 32377571 | ||
1097. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review. | *32387694* 32387694 | ||
1098. Refugees besieged: The lurking threat of COVID-19 in Syrian war refugee camps. | *32380153* 32380153 | ||
1099. Full-length title: Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille France. | *32387409* 32387409 | ||
1100. Potential infectious risk from the pets carrying SARS-CoV-2. | *32380152* 32380152 | ||
1101. Cold plasma a new hope in the field of virus inactivation. | *32418663* 32418663 | ||
1102. Managing Cancer Care during the COVID-19 Pandemic and Beyond. | *32386875* 32386875 | ||
1103. Pangolins Harbor SARS-CoV-2-Related Coronaviruses. | *C7136945* C7136945 | ||
1104. The COVID-19 Pandemic from an Ophthalmologist’s Perspective. | *32470381* 32470381 | ||
1105. COVID-19 randomised trial protocols: rapid publication without barriers. | *C7156793* C7156793 | ||
1106. Lung Ultrasound in Patients with Acute Respiratory Failure Reduces Conventional Imaging and Health Care Provider Exposure to COVID-19. | *32451194* 32451194 | ||
1107. Lung Ultrasound in Children with COVID-19: Preliminary Findings. | *32409232* 32409232 | ||
1108. Extended urbanisation and the spatialities of infectious disease: Demographic change infrastructure and governance. | *C7201199* C7201199 | ||
1109. Urologic Oncology: News and Topics: Ethics of Urologic Care in the Time of COVID-19. | *C7177087* C7177087 | ||
1110. Personal Protective Equipment for common urologic procedures before and during the United States COVID-19 pandemic: a single institution study. | *32380154* 32380154 | ||
1111. The biological characteristics of SARS-CoV-2 Spike protein Pro330-Leu650. | *C7190498* C7190498 | ||
1112. An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design. | *32418793* 32418793 | ||
1113. Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic. | *32381478* 32381478 | ||
1114. Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses. | *32402329* 32402329 | ||
1115. An Introduction to the Evolutionary Ecology of Viruses. | *C7149709* C7149709 | ||
1116. Virus Morphology Replication and Assembly. | *C7149369* C7149369 | ||
1117. Association of viral load with serum biomakers among COVID-19 cases. | *32452410* 32452410 | ||
1118. Antiviral activity of lycorine against Zika virus in vivo and in vitro. | *32452420* 32452420 | ||
1119. New insights into the evolutionary features of viral overlapping genes by discriminant analysis. | *32452417* 32452417 | ||
1120. No evidence for distinct types in the evolution of SARS-CoV-2. | *C7197565* C7197565 | ||
1121. The Impacts of Viral Inactivating Methods On Quantitative RT-PCR for COVID-19. | *32380210* 32380210 | ||
1122. A COMPREHENSIVE ANALYSIS OF GENOME COMPOSITION AND CODON USAGE PATTERNS OF EMERGING CORONAVIRUSES. | *C7152894* C7152894 | ||
1123. Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019–2020. | *C7138902* C7138902 | ||
1124. Structural glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). | *C7085496* C7085496 | ||
1125. The Structure of Viruses. | *C7173534* C7173534 | ||
1126. Subviral Agents. | *C7150261* C7150261 | ||
1127. Emerging and Reemerging Viral Diseases. | *C7149993* C7149993 | ||
1128. Overview of Viruses and Virus Infection. | *C7149408* C7149408 | ||
1129. Minus-Strand RNA Viruses. | *C7150229* C7150229 | ||
1130. Plus-Strand RNA Viruses. | *C7149648* C7149648 | ||
1131. Understanding of guidance for acupuncture and moxibustion interventions on COVID-19 (Second edition) issued by CAAM. | *C7118592* C7118592 | ||
1132. Suggestions on the prevention of COVID-19 for health care workers in department of otorhinolaryngology head and neck surgery. | *C7128200* C7128200 | ||
1133. EARLY REPORT ON THE IMPACT OF COVID-19 OUTBREAK IN NEUROSURGICAL PRACTICE AMONG MEMBERS OF THE LATIN AMERICAN FEDERATION OF NEUROSURGICAL SOCIETIES. | *32389878* 32389878 | ||
1134. New Design for Aerosol Protection During Endotracheal Intubation in the COVID-19 Pandemic Era: The "Anti-Aerosol Igloo" (AAI). | *32389877* 32389877 | ||
1135. Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community. | *32387786* 32387786 | ||
1136. Neurosurgical practice during the SARS-CoV-2 pandemic: a worldwide survey. | *32380337* 32380337 | ||
1137. Letter to the editor Regarding Effects of the COVID-19 Outbreak in Northern Italy: Perspectives from the Bergamo Neurosurgery Department. | *32380338* 32380338 | ||
1138. Impact of the COVID-19 Pandemic on Neurosurgical Residency Training in New Orleans. | *32380334* 32380334 | ||
1139. Neurosurgical training during the COVID-19 pandemic: a British perspective. | *32414670* 32414670 | ||
1140. Neuartiges Coronavirus (SARS-CoV-2). | *C7117085* C7117085 | ||
1081. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. | *32407937* 32407937 | ||
1082. Early thromboembolic events in hospitalized COVID-19 patients. | *32403032* 32403032 | ||
1083. Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19 infection. | *32416365* 32416365 | ||
1084. Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid. | *32403033* 32403033 | ||
1085. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. | *32381264* 32381264 | ||
1086. Thrombotic complications in critically ill patients with COVID 19. | *32388068* 32388068 | ||
1087. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. | *C7146714* C7146714 | ||
1088. Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a meta-analysis. | *32382258* 32382258 | ||
1089. Wuhan Covid19 data – more questions than answers. | *32387286* 32387286 | ||
1090. Convalescent Plasma an Apheresis Research Project Targeting and Motivating the Fully Recovered COVID 19 Patients: A Rousing Message of Clinical Benefit To Both Donors and Recipients Alike. | *32448638* 32448638 | ||
1091. Convalescent Plasma an Apheresis Research Project Targeting and Motivating the Fully Recovered COVID 19 Patients: A Rousing Message of Clinical Benefit To Both Donors and Recipients Alike. | *32417123* 32417123 | ||
1092. COVID-19: A perspective of a frontline worker. | *32409154* 32409154 | ||
1093. A quick “Can I donate blood” self-assessment tool amid the COVID-19 outbreak. | *32417113* 32417113 | ||
1094. The blood supply management amid the COVID-19 outbreak. | *32386966* 32386966 | ||
1095. COVID-19-Related Stroke. | *32378030* 32378030 | ||
1096. eClinic: increasing use of telehealth as a risk reduction strategy during the covid-19 pandemic. | *32377571* 32377571 | ||
1097. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review. | *32387694* 32387694 | ||
1098. Refugees besieged: The lurking threat of COVID-19 in Syrian war refugee camps. | *32380153* 32380153 | ||
1099. Full-length title: Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille France. | *32387409* 32387409 | ||
1100. Potential infectious risk from the pets carrying SARS-CoV-2. | *32380152* 32380152 | ||
1101. Cold plasma a new hope in the field of virus inactivation. | *32418663* 32418663 | ||
1102. Managing Cancer Care during the COVID-19 Pandemic and Beyond. | *32386875* 32386875 | ||
1103. Pangolins Harbor SARS-CoV-2-Related Coronaviruses. | *C7136945* C7136945 | ||
1104. The COVID-19 Pandemic from an Ophthalmologist’s Perspective. | *32470381* 32470381 | ||
1105. COVID-19 randomised trial protocols: rapid publication without barriers. | *C7156793* C7156793 | ||
1106. Lung Ultrasound in Patients with Acute Respiratory Failure Reduces Conventional Imaging and Health Care Provider Exposure to COVID-19. | *32451194* 32451194 | ||
1107. Lung Ultrasound in Children with COVID-19: Preliminary Findings. | *32409232* 32409232 | ||
1108. Extended urbanisation and the spatialities of infectious disease: Demographic change infrastructure and governance. | *C7201199* C7201199 | ||
1109. Urologic Oncology: News and Topics: Ethics of Urologic Care in the Time of COVID-19. | *C7177087* C7177087 | ||
1110. Personal Protective Equipment for common urologic procedures before and during the United States COVID-19 pandemic: a single institution study. | *32380154* 32380154 | ||
1111. The biological characteristics of SARS-CoV-2 Spike protein Pro330-Leu650. | *C7190498* C7190498 | ||
1112. An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design. | *32418793* 32418793 | ||
1113. Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic. | *32381478* 32381478 | ||
1114. Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses. | *32402329* 32402329 | ||
1115. An Introduction to the Evolutionary Ecology of Viruses. | *C7149709* C7149709 | ||
1116. Virus Morphology Replication and Assembly. | *C7149369* C7149369 | ||
1117. Association of viral load with serum biomakers among COVID-19 cases. | *32452410* 32452410 | ||
1118. Antiviral activity of lycorine against Zika virus in vivo and in vitro. | *32452420* 32452420 | ||
1119. New insights into the evolutionary features of viral overlapping genes by discriminant analysis. | *32452417* 32452417 | ||
1120. No evidence for distinct types in the evolution of SARS-CoV-2. | *C7197565* C7197565 | ||
1121. The Impacts of Viral Inactivating Methods On Quantitative RT-PCR for COVID-19. | *32380210* 32380210 | ||
1122. A COMPREHENSIVE ANALYSIS OF GENOME COMPOSITION AND CODON USAGE PATTERNS OF EMERGING CORONAVIRUSES. | *C7152894* C7152894 | ||
1123. Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019–2020. | *C7138902* C7138902 | ||
1124. Structural glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). | *C7085496* C7085496 | ||
1125. The Structure of Viruses. | *C7173534* C7173534 | ||
1126. Subviral Agents. | *C7150261* C7150261 | ||
1127. Emerging and Reemerging Viral Diseases. | *C7149993* C7149993 | ||
1128. Overview of Viruses and Virus Infection. | *C7149408* C7149408 | ||
1129. Minus-Strand RNA Viruses. | *C7150229* C7150229 | ||
1130. Plus-Strand RNA Viruses. | *C7149648* C7149648 | ||
1131. Understanding of guidance for acupuncture and moxibustion interventions on COVID-19 (Second edition) issued by CAAM. | *C7118592* C7118592 | ||
1132. Suggestions on the prevention of COVID-19 for health care workers in department of otorhinolaryngology head and neck surgery. | *C7128200* C7128200 | ||
1133. EARLY REPORT ON THE IMPACT OF COVID-19 OUTBREAK IN NEUROSURGICAL PRACTICE AMONG MEMBERS OF THE LATIN AMERICAN FEDERATION OF NEUROSURGICAL SOCIETIES. | *32389878* 32389878 | ||
1134. New Design for Aerosol Protection During Endotracheal Intubation in the COVID-19 Pandemic Era: The "Anti-Aerosol Igloo" (AAI). | *32389877* 32389877 | ||
1135. Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community. | *32387786* 32387786 | ||
1136. Neurosurgical practice during the SARS-CoV-2 pandemic: a worldwide survey. | *32380337* 32380337 | ||
1137. Letter to the editor Regarding Effects of the COVID-19 Outbreak in Northern Italy: Perspectives from the Bergamo Neurosurgery Department. | *32380338* 32380338 | ||
1138. Impact of the COVID-19 Pandemic on Neurosurgical Residency Training in New Orleans. | *32380334* 32380334 | ||
1139. Neurosurgical training during the COVID-19 pandemic: a British perspective. | *32414670* 32414670 | ||
1140. Neuartiges Coronavirus (SARS-CoV-2). | *C7117085* C7117085 | ||
PMC7188027 449. A Local Crash Course in Global Pandemics. | *32282586* 32282586 | ||
PMC7197533 450. The novel coronavirus and challenges for general and paediatric dentists. | *32359151* 32359151 | ||
PMC7182746 451. From cornea to corona. | *32344149* 32344149 | ||
PMC7105965 452. Ein Schutz gegen die Tropfcheninfektion an der Spaltlampe. Sicherheit fur die Augenarzte UND die Patienten. | *32232544* 32232544 | ||
PMC7151388 453. Hydroxychloroquine and "off-label" utilization in the treatment of oral conditions. | *32331804* 32331804 | ||
PMC7108517 454. Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium. | *23821437* 23821437 | ||
PMC7168075 455. Tight junction-related human diseases. | *23356220* 23356220 | ||
PMC7184944 456. Situation der Deutschen Universitatspathologien unter den Einschrankungen der Corona-Pandemie - Auswertung einer ersten reprasentativen Umfrage. | *32342174* 32342174 | ||
PMC7167905 457. Non-immediate hypersensitivity reactions to beta-lactam antibiotics in children - our 10-year experience in allergy work-up. | *26999792* 26999792 | ||
PMC7176259 458. Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature. | *32265372* 32265372 | ||
PMC7167752 459. A review of cutaneous hypersensitivity reactions in infants: From common to concerning. | *31025427* 31025427 | ||
PMC7111719 460. Monoclonal antibodies for prophylactic and therapeutic use against viral infections. | *32287402* 32287402 | ||
PMC7168067 461. A novel approach to the diagnosis and treatment of hemoptysis in infants: A case series. | *30226294* 30226294 | ||
PMC7124255 462. Prediction of amino acid pairs sensitive to mutations in the spike protein from SARS related coronavirus. | *15127935* 15127935 | ||
PMC4530502 463. Dendritic cells: microbial clearance via autophagy and potential immunobiological consequences for periodontal disease. | *26252408* 26252408 | ||
PMC7151298 464. Statins in coronavirus outbreak: It's time for experimental and clinical studies. | *32289478* 32289478 | ||
PMC5461643 465. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. | *28596841* 28596841 | ||
PMC7102585 466. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions. | *32061923* 32061923 | ||
PMC1693395 467. Viral evolution and the emergence of SARS coronavirus. Philos Trans R Soc Lond B Biol Sci 2004; 359 (1447): 1059-65 | *15306390* 15306390 | ||
PMC7159239 468. Every fifth published metagenome is not available to science. | *32243442* 32243442 | ||
PMC7147755 469. Ozone efficacy for the control of airborne viruses: Bacteriophage and norovirus models. | *32275685* 32275685 | ||
PMC3454321 470. Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model. | *23029269* 23029269 | ||
PMC7122826 471. BRD4 inhibition exerts anti-viral activity through DNA damage-dependent innate immune responses. | *32208449* 32208449 | ||
PMC7140233 472. 2019-nCoV-Pneumonie ahnelt radiologisch SARS und MERS. | *32288853* 32288853 | ||
PMC7149396 473. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors. | *32198201* 32198201 | ||
PMC3595458 474. Evidences for the unfolding mechanism of three-dimensional domain swapping. | *23238853* 23238853 | ||
PMC7167888 475. Advancing translational research with next-generation protein microarrays. | *26749402* 26749402 | ||
PMC7168038 476. Correlation between TGF-beta1 expression and proteomic profiling induced by severe acute respiratory syndrome coronavirus papain-like protease. | *22936401* 22936401 | ||
PMC7133679 477. The psychiatric impact of the novel coronavirus outbreak. | *32146248* 32146248 | ||
PMC7112608 478. Psychological crisis intervention during the outbreak period of new coronavirus pneumonia from experience in Shanghai. | *32146245* 32146245 | ||
PMC7133610 479. Psychological crisis interventions in Sichuan Province during the 2019 novel coronavirus outbreak. | *32120170* 32120170 | ||
PMC7184195 480. Mental health characteristics associated with dysfunctional coronavirus anxiety. | *32297852* 32297852 | ||
PMC7144596 481. Novel Coronavirus and Related Public Health Interventions Are Negatively Impacting Mental Health Services. | *32331770* 32331770 | ||
PMC7179517 482. The Decline of Pluralism in Medicine: Dissent Is Welcome. | *31838479* 31838479 | ||
PMC7177049 483. Culture, institutions and democratization. | *32327859* 32327859 | ||
PMC7107240 484. Coronavirus disease-2019: An update on third coronavirus outbreak of 21st century. | *32125418* 32125418 | ||
PMC7151277 485. On general principles at the sustainability science-policy interface. | *32300262* 32300262 | ||
PMC7118616 486. An integrated response to the impact of coronavirus outbreak on the Emergency Medical Services of Emilia Romagna. | *32205158* 32205158 | ||
PMC7164896 487. La medecine interne dans la pandemie a SARS-CoV-2. | *32334859* 32334859 | ||
PMC7169154 488. What should virologists be teaching their students? | *32064701* 32064701 | ||
PMC7181992 489. Medicaments rhumatologiques pour le traitement de l'infection par le COVID-19. | *32355446* 32355446 | ||
PMC7181970 490. Pistes urgentes dans le traitement de l'infection par le COVID-19 : cibler l'inflammation en aval pour prevenir un syndrome catastrophique. | *32355445* 32355445 | ||
PMC7181981 491. Implications du COVID-19 pour la prise en charge des rhumatismes inflammatoires chroniques. | *32355444* 32355444 | ||
PMC7169485 492. Type I IFN exhaustion is a host defence protecting against secondary bacterial infections. | *24006947* 24006947 | ||
PMC7195097 493. A new approach to modeling the fade-out threshold of coronavirus disease. | *32363046* 32363046 | ||
PMC7088771 494. Bat origin of a new human coronavirus: there and back again. | *32048160* 32048160 | ||
PMC7163913 495. Association between population migration and epidemic control of Coronavirus disease 2019. | *32303965* 32303965 | ||
PMC7169597 496. Genes & cells: Drug candidate may stop MERS: Chemical disrupts assembly centers of coronaviruses. | *32327847* 32327847 | ||
PMC7118648 497. On biological evolution and environmental solutions. | *32251887* 32251887 | ||
PMC7169535 498. Investigating a disease outbreak. | *32328118* 32328118 | ||
PMC7186112 499. Coronavirus disease 2019 and obstructive sleep apnea syndrome. | *32342265* 32342265 | ||
PMC7169479 500. Glycyrrhizic-Acid-Based Carbon Dots with High Antiviral Activity by Multisite Inhibition Mechanisms. | *32077621* 32077621 | ||
PMC7169483 501. Functional nanomaterials can optimize the efficacy of vaccines. | *25238620* 25238620 | ||
PMC7169612 502. Recent Trends in Nanomaterials-Based Colorimetric Detection of Pathogenic Bacteria and Viruses. | *32328530* 32328530 | ||
PMC7132549 503. Now, more than ever, our community is needed: spinal cord injury care during a global pandemic. | *32249763* 32249763 | ||
PMC7086445 504. Organoids as a Powerful Model for Respiratory Diseases. | *32256609* 32256609 | ||
PMC7154512 505. Breaking the Enigma Code of Angiotensin II Type 2 Receptor Signaling. | *32268077* 32268077 | ||
PMC7169565 506. What can system dynamics learn from the public policy implementation literature? | *32327920* 32327920 | ||
PMC7154569 507. Italian society of colorectal surgery recommendations for good clinical practice in colorectal surgery during the novel coronavirus pandemic. | *32291566* 32291566 | ||
PMC7168532 508. Novel coronavirus 2019, an emerging public health emergency. | *32077206* 32077206 | ||
PMC7168751 509. Pathogenicity of porcine deltacoronavirus (PDCoV) strain NH and immunization of pregnant sows with an inactivated PDCoV vaccine protects 5-day-old neonatal piglets from virulent challenge. | *31541590* 31541590 | ||
PMC7168554 510. Rapid identification of human-infecting viruses. | *31373773* 31373773 | ||
PMC7027813 511. Co-localization of Middle East respiratory syndrome coronavirus (MERS-CoV) and dipeptidyl peptidase-4 in the respiratory tract and lymphoid tissues of pigs and llamas. | *30520548* 30520548 | ||
PMC7169683 512. Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress. | *23926897* 23926897 | ||
PMC6917841 513. Butyrate-producing gut bacteria and viral infections in kidney transplant recipients: A pilot study. | *31544324* 31544324 | ||
PMC7169875 514. Stewardship opportunities in viral pneumonia: Why not the immunocompromised? | *29423923* 29423923 | ||
PMC7169710 515. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative. | *26923867* 26923867 | ||
PMC7129460 516. SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? - A bibliometric analysis. | *32007621* 32007621 | ||
PMC7102564 517. Coronavirus infections reported by ProMED, February 2000-January 2020. | *32036011* 32036011 | ||
PMC7128323 518. Fatal human coronavirus 229E (HCoV-229E) and RSV-Related pneumonia in an AIDS patient from Colombia. | *32035270* 32035270 | ||
PMC7102632 519. SARS Coronavirus Redux. | *32173256* 32173256 | ||
PMC7119031 520. Cellular entry of the SARS coronavirus. | *15381196* 15381196 | ||
PMC7195981 521. Global surveillance, travel, and trade during a pandemic | *32299207* 32299207 | ||
PMC7195983 522. Quarantine and its legal dimension | *32293836* 32293836 | ||
PMC7167540 523. Extraordinary diseases require extraordinary solutions. | *32331807* 32331807 | ||
PMC7115371 524. Monoclonal antibodies for prophylactic and therapeutic use against viral infections. | *23370150* 23370150 | ||
PMC6925494 525. Antiviral activity of interleukin-11 as a response to porcine epidemic diarrhea virus infection. | *31864417* 31864417 | ||
PMC1087510 526. Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies. | *15833113* 15833113 | ||
PMC7090748 527. Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases. | *32048130* 32048130 | ||
PMC7035235 528. Cryo-EM Studies of Virus-Antibody Immune Complexes. | *31916022* 31916022 | ||
PMC7111820 529. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. | *16690096* 16690096 | ||
PMC7111839 530. Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs. | *16678878* 16678878 | ||
PMC7111745 531. Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine. | *16043204* 16043204 | ||
PMC7151644 532. Newly identified viral genomes in pangolins with fatal disease. | *32296543* 32296543 | ||
PMC7114681 533. Drug repurposing for new, efficient, broad spectrum antivirals. | *30794895* 30794895 | ||
PMC7167492 534. Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives. | *32313824* 32313824 | ||
PMC3509690 535. Virus pathogen database and analysis resource (ViPR): a comprehensive bioinformatics database and analysis resource for the coronavirus research community. | *23202522* 23202522 | ||
PMC7169309 536. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light. | *31930543* 31930543 | ||
PMC7124127 537. Verzerrte Informationen: Zwischen Panikmache und Sorglosigkeit. | *32288866* 32288866 | ||
PMC7169818 538. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011; 3 (2): 174-196 | *20872839* 20872839 | ||
PMC7169711 539. Delivery of RNAi mediators. | *21935894* 21935894 | ||
PMC7100427 540. Take precautions beforehand: calling for clinical trials of pediatric drugs for treating coronavirus disease 2019. | *32215827* 32215827 | ||
PMC7090514 541. Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019. | *32166483* 32166483 | ||
PMC7091265 542. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue. | *32026147* 32026147 | ||
PMC7090857 543. New coronavirus: new challenges for pediatricians. | *32037473* 32037473 | ||
544. Neurological Etiologies and Pathophysiology of Cyclic Vomiting Syndrome. | *32107138* 32107138 | ||
545. Les therapeutiques non chirurgicales de la maladie de Lapeyronie : etat des lieux des connaissances actuelles. | *32279954* 32279954 | ||
546. Sleep, resilience and suicide. | *31859035* 31859035 | ||
547. Splanchnic vein thrombosis predicts worse survival in patients with advanced pancreatic cancer. | *31812026* 31812026 | ||